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ABSTRACT 
This dissertation describes 1) strategies for the rapid synthesis and arraying of 
carbohydrates and 2) the synthesis and application of stable carbon-based 
glycomimetics. An alternative fluorous tag-assisted solution-phase strategy described 
herein has these advantages of solid-phase synthesis, but requires substantially lower 
amounts of donor building blocks at each coupling cycle. The requisite fluorous tag is 
designed not only to aid in saccharide purification but is demonstrated to also allow 
direct formation of carbohydrate microarrays on fluorous-derivatized glass slides for 
biological screening with lectins, such as concanavalin A. The noncovalent 
interactions in the fluorous-based array are even strong enough to withstand the 
detergents used in assays with the Erythrina crystagalli lectin. This work is the first 
demonstration of surface patterning of compounds based on noncovalent fluorous-
fluorous interactions. 
The second part of this dissertation describes the chemoenzymatic synthesis of 
deoxysugar nucleotides and a stable carbasugar nucleotide and the synthesis and use 
of a stable mimic of isopropylthiogalactoside. The carbaglucose-1-phosphate and 
deoxyglucose-1 -phosphate studies present evidence that sugar nucleotidyltransferases 
can exercise kinetic discrimination in choosing carbohydrates of comparable binding 
affinity for catalytic turnover. Synthetic 6-deoxy-, 4-deoxy-, and 3-deoxy-glucose-l-
X 
phosphate and the natural substrate glucose-1-phosphate were tested with a 
representative prokaryotic glucose-1-phosphate uridylyltransferase from Escherichia 
coli and the analogous eukaryotic enzyme from yeast. The bacterial enzyme shows 
greater substrate promiscuity than the yeast enzyme for the synthesis of deoxygenated 
glucose-1-phosphate analogs. The first synthesis of the carbocyclic version of 
glucose-1-phosphate and its evaluation with these bacterial and yeast sugar 
nucleotidyltransferases also showed the bacterial enzyme to be more promiscuous. In 
contrast to results with the eukaryotic enzyme, carbaglucose-1-phosphate serves as a 
substrate for the bacterial enzyme to provide the carbocyclic 
uiidinediphosphoglucose. This result demonstrates the first chemoenzymatic strategy 
to this class of glycosyltransferase inhibitors. Replacement of the glycosidic oxygen 
rather than the ring oxygen imparts stability that can be exploited in the induction of 
protein expression based on lac promoters. To this end, the first synthesis of isobutyl-
C-galactoside (IBCG) as an isopropylthiogalactoside (IPTG) substitute is reported 
herein. The more stable C-glycoside analogue, IBCG, can serve as a surrogate for the 
commonly used inducer of protein expression IPTG and shows advantages over IPTG 
at long protein induction times. 
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CHAPTER 1 
General introduction 
1. Dissertation organization 
This dissertation is divided into seven chapters. The first chapter is a general 
literature review that is related to the chemistry discussed in chapters 2 through 6. 
Chapter 1 discusses a general review and the fluorous-phase versus solid-phase 
synthesis of bacterial oligoglucosamines with a new method for colorimetric monitoring 
of the reaction cycles.1 Solid phase oligoglucosamine synthesis requires excess donor 
building blocks for high yields, but has advantages over conventional solution-phase 
synthesis in the ease of intermediate purification and the ability for synthesis 
automation. An alternative fluorous tag-assisted solution-phase strategy described 
herein has the advantages of solution-phase synthesis, but requires significantly lower 
donor building block amounts at each coupling cycle. Chapter 2 was published in the 
Journal of American Chemical Society in 2005.2 This chapter demonstrates a new 
simple concept in microarray formation based on noncovalent fluorous-based 
interactions. A fluorous tail is designed not only to aid in saccharide purification but 
also to allow direct formation of carbohydrate microarrays on fluorous-derivatized glass 
slides for biological screening with lectins. Firoz Jaipuri performed the synthesis of 
derivatized galactose and fucose compounds (described elsewhere) and helped to 
perform microarray assays. Chapter 3 is published in The Journal of Organic Chemistry 
in 2005.3 This chapter discusses strategies for the chemoenzymatic synthesis of 
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deoxysugar nucleotides. Synthetic 6-deoxy, 4-deoxy, and 3-deoxyglucose-1 -phosphate 
and the natural substrate glucose-1 -phosphate were tested with a representative 
prokaryotic glucose-1 -phosphate uridylyltransferase from Escherichia coli, which is 
also known to accept thymidine triphosphate, and the comparable eukaryotic enzyme 
from yeast. I present evidence that this class of enzymes can exercise kinetic 
discrimination in choosing carbohydrates of comparable binding affinity for catalytic 
turnover. This section contains an expanded version of the experimental section of the 
synthetic part from the original paper. Corbin Zea helped with the enzymatic reactions 
and provided the data of the kinetic performance in this paper. Chapter 4 is published in 
the Journal of the American Chemical Society in 2004.4 This chapter discusses the 
surprising bacterial nucleotidyltransferase selectivity in the conversion of carbaglucose-
1-phosphate as a substrate for a bacterial enzyme and marks the first chemoenzymatic 
strategy to this class of glycosyltransferase inhibitors. Corbin Zea also helped with 
enzymatic reactions and provided the data of the kinetic performance in this chapter. 
Chapter 5 describes a mass-differentiated library strategy for functional proteomic 
identification of sugar nucleotidyltransferase activities in cell lysates.5 Dr. Rahman 
Mizanur helped with the enzymatic reactions and provided the data of an enzymatic 
reaction in this chapter. Chapter 6 is published in Organic Letters in 2003.6 This chapter 
describes the synthesis of isobutyl-C-galactoside (IBCG) as an isopropylthiogalactoside 
(IPTG) substitute for increased induction of protein expression. I show that the more 
stable ^-glycoside analogue, IBCG, serves as a surrogate for the commonly used 
inducer of protein expression IPTG and shows advantages over IPTG at long protein 
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induction times. Jerrid Kruse contributed some initial experimental strategies for the 
synthesis of IBCG. Chapter 7 provides general conclusions for the entire dissertation. 
2. Importance of carbohydrates 
Carbohydrates are the most abundant class of organic compounds on earth.7 
These compounds play important biological roles in cell-surface receptors, intercellular 
recognition, cell-cell communication, immunological recognition, and protein folding.8' 
9
'
10 Oligosaccharides are involved in many cell-cell processes including immune system 
interactions between saccharides and their receptors.11 The formation of specific 
oligosaccharides correlates with a host of diseases from infection to ovarian cancer, 
cystic fibrosis, respiratory capacity diseases, and diabetes.12'13 Carbohydrates are used 
as therapeutics, for example heparin is an important anticoagulation therapeutic and 
bacterial surface carbohydrates form glycoconjugate vaccines against meningitis.14 
However, the difficulty in obtaining pure oligosaccharides remains a challenge that 
limits the study and application of this class of compounds. 
3. Iterative chemical oligosaccharide synthesis 
To match the achievements of commercial automated solid-phase synthesis of 
other biopolymers such as nucleic acids and peptides, many scientists have tried to 
develop simple methods for the iterative synthesis of oligosaccharides. The first report 
of the solid-phase synthesis of oligosaccharides was described by Frechet and 
coworkers with the production of a disaccharide and trisaccharide.15' 16 Solid-phase 
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synthesis can provide high yields by use of excess donors and has the advantages of 
ease of purification and synthesis automation when compared to conventional solution-
phase methods. After a lull in activity for decades, more recently solid-phase synthesis 
of oligosaccharides has been automated by conversion of a standard peptide-
synthesizer.17 However, there are still unsolved matters in solid-phase synthesis of 
oligosaccharides that prevent its widespread use. Monitoring of reaction progress on 
solid-phase in the context of automation has not been demonstrated and a way to 
overcome the need for great excesses of amount donor group is needed for practicality. 
There are, in principle, four important variables to consider when using an 
alternative phase for the synthesis of oligosaccharides: 1) the glycosylating agents 
(donors), 2) linker design, 3) the supporting group, and 4) general analysis of reaction 
progress (Figure 1.1). 
Monitoring of reaction progress 
r 
Z Sugar ) Q f Linker J 
^  t L  
Solid or Fluorous support \ / 1 ' ™™"— 
_ Soluble or insoluble Selectively sleavable jn so,vent 
— Donor activation method 
Figure 1.1. General strategy for the synthesis of oligosaccharides on an alternate phase. 
3.1 Glycosylating agents (donors) 
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The generation of an anomeric leaving group for use in glycosyl donor building 
blocks has been accomplished in a variety of ways (Table 1.1). Glycosyl 
trichloroacetimidates as developed by Schmidt have emerged as the most commonly 
used donors due to their easy preparation from ^-substituted reducing sugars.18 
Glycosyl trichloroacetimidates can be activated with mild Lewis acids such as BF3-
etherate and TMSOTf.19 These agents can be introduced without harm to ester, silyl (for 
example, TBDPS), and any alkyl ether linkages. Other anomeric activating methods are 
less commonly used. According to Ikegami,20 glycosyl phosphates can be activated in 
the presence of an acceptor -OH with TMSOTf. Seeberger and coworkers have recently 
reported that glycosyl phosphates are activated by catalytic amounts of TMSOTf to 
react with hindered glycosyl acceptors in high yield.21 Glycosyl fluorides22 are used as 
glycosyl donors and can be activated by strong Lewis acids, such as BF3 and SiF4, or 
organometallic reagents.23 Thioglycosides24 are activated by NBS, MeOTf, 
dimethyl(methylthio)sulfonium triflate (DMTST), iodonium dicollidine perchlorate 
(IDCP), and NIS. According to Kahne,25 anomeric glycosyl sulfoxides are highly 
reactive glycosylating agents upon activation with Lewis acidic promoters such as triflic 
anhydride. This method has been useful for the glycosylation of unreactive hydroxy 
groups in acceptors. 
Table 1.1. Glycosyl donors with activated reagents. 
no PO<—^ 
ox 
Acid (Y), HOR 
PO Q 
OR 
Glycosyl Donors-
Leaving Groups (X) 
Activated Reagents (Y) References 
T richloroacetamidates Lewis acids- BF3, TMSOTf 19 
Phosphates TMSOTf, BF4 20, 21 
Phosphites TMSOTf, BF4 26 
Thioglycosides Thiophilic reagents- NBS, MeOTf, 
PhHgOTf, NIS, TrCI04, Dimethyl-
(methylthio)perchlorate(IDCP), 
Single electrontransfer reagent 
24, 27 
Fluorides Strong Lewis acids-
AgCIOVSnCh, BF3, Cp2HfCI2/ 
AgCI04 
22 
Iodides BF4, SiF4 28 
n-pentenyl NIS;TfOH, NIS;TMSOTf 29 
Glycate Electrophilic reangets-
Oxocarbenium ion 
30 
Sulfoxides Triflic anhydride 25 
Glycosyl 2-propenyl 
carbonates TMSOTf 31 
3.2 Linker design 
The linkers that attach the first sugar to the support are crucial for success of 
solid-phase and related approaches to oligosaccharide synthesis. They should allow easy 
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attachment of the starting material to the support and be stable under the required 
reaction conditions. These linkers must enable selective cleavage at the end of the 
oligosaccharide synthesis without any damage or modification to the product. A variety 
of linkers have been developed to use many conflicting conditions, a few of which are 
outlined in Figure 1.2. Silyl ethers can be cleaved under mild acidic conditions.32 
Takahashi and coworkers have reported the compatibility of the silane with a range of 
different glycosylation agents such as thioglycosides, trichloroacetimidates, sulfoxides, 
and anomeric fluorides using various acidic activators.32 For the cleavage of olefins 
from a support by metathesis the linker is stable under mild reaction conditions which 
efficiently catalyze olefin metathesis and which are compatible with a range of 
functional groups. Ring-closing metathesis (RCM) with Grubbs' catalyst was 
introduced by Schmidt et al.33 This olefin linker has been utilized in the automated 
chemical synthesis of oligosaccharides on solid-phase by Seeberger and coworkers.34 
Cleavage conditions for alkyl benzyl ethers have been reported by treatment of the resin 
with triphenylmethylborontetrafluoride (TrBF4).35 Thiols can be cleaved by NBS in the 
presence of di-ferf-butyl pyridine (DTBP).36 According to Fraser-Reid, a secondary o-
nitrobenzyl ether linkage can be cleaved from the resin by photolytic cleavage.37 
(TFA, AcOH) 
ro 
».S, 
(TrBF4 or DDQ) 
.Se 
•°Y^ 
(Olefin Metathesis) 
(NBS, DTBP, MeOH) 
(mCPBA) (NaOMe, MeOH) (hv) 
( ) Linkers can be cleaved by reagents 
(PdCI2, NaOAc, AcOH) 
Figure 1.2. Several functional groups used as linkers for attaching sugars to supports 
such as solid-phase resins. 
3.3 Supporting groups 
The two types of supports for oligosaccharide synthesis to allow facile 
mechanical separation of the intermediates from reactants and solvents are 1) insoluble 
material or 2) soluble materials that can be phase-switched. 
Copolymers of styrene with divinylbenzene are commonly used as the support 
for solid-phase synthesis because these resins are commercially available as beads with 
a broad choice of functional groups and linkers. Merrifield's resin (polystyrene)38 has 
been used the most for solid-phase oligosaccharide synthesis because the required 
solvents can penetrate into the cross-linked polystyrene. Support swelling behavior is 
very important for reaction success and minimization of building block usage. 
Danishefsky and coworkers have reported solid-phase oligosaccharide synthesis using a 
divinylbenzene polystyrene copolymer as the supporting gourp.39 Merrifield's resin (1% 
cross-linked polystyrene) and polystyrene-based Argopore have been used for the only 
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reported automated solid-phase synthesis of oligosaccharides.40 Poly (ethylene glycol) 
(PEG)-polystyrene graft polymers allow increased mobility of intermediates linked to 
this Tentagel and have more desirable swelling properties.41 Boons and co-worker have 
used the glycine-derivatized Tentagel hydroxyl resin for the solid-phase synthesis of 
trisaccharide libraries.42 Kahne and coworker also have used the Tentagel resin for 
parallel synthesis and screening of a solid phase carbohydrate library.43, 44 
Unfortunately, all the solid-phase approaches require large excesses of building block 
amounts at each coupling cycle and therefore have found limited use. 
Supports that allow solution-phase reaction kinetics but that can be switched to 
another phase for ease of purification can circumvent some of the problems of solid-
phase approaches. Janda and coworkers have reported soluble polymer-supported small 
organic molecule synthesis using poly (ethylene glycol)45 They mention that this soluble 
polymer can be easily removed from the unreacted components and be used in 
automation equipment, although automation has not yet been demonstrated. However, 
the method is limited by difficulties in reliable and quantitative phase-switching. Curran 
and co-workers have developed fluorous synthesis as an alternative to solid-phase 
synthesis for use in combinatorial chemistry and parallel synthesis.46 Inazu and 
coworkers have reported a trisaccharide synthesis on a fluorous support in the liquid 
phase using liquid-liquid extraction to isolate the supported compound from other 
reagents.47 Unfortunately, the large fluorous tags required often are not compatible with 
the range of solvents required in organic synthesis. More recently, solid-phase 
extraction using modified silica supports have proven useful as they require smaller, 
more readily soluble supports. Manzoni and coworker have applied this fluorous-phase 
strategy to the synthesis of carbohydrates and have recently reported an anomeric silyl 
fluorous tag for the synthesis of a trisaccharide.48,49'50 This approach has been used with 
fluorous tags with fluorous silica gel51 and alkyl tags with C-18 supports.52 
3.4 Analytical tools for reaction monitoring 
Solution-phase supports have the advantage that reactions can be monitored 
using all the common techniques used in solution-phase organic synthesis. The use of 
solid-phase supports makes tracking reaction progress much more difficult. Current 
efforts to solve this problem include the use of FT-IR and FT-Raman spectrometry,53,54 
solid-state and gel-phase 13C NMR spectrometry, as well as *H and 13C correlation 
NMR spectrometry,55 high-resolution *H MAS (magic angle spinning) and MAS-CH 
correlation NMR spectrometry,56,57'58,59 19F NMR spectroscopy,60, 61, 62' 63, 64 matrix-
assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-
MS),65 and gel-phase 19F NMR spectrometry66 have been developed as a simple and 
versatile method for monitoring solid-phase synthesis. Commercial automated DNA and 
peptide synthesizers rely on the release of spectrophotometry tags such as FMOC and 
DMT during each deprotection cycle that allows the machines to simply gauge reaction 
success.67 Although FMOC has been used in oligosaccharide synthesis,68 this group has 
not been incorporated into an automated sequence with reaction monitoring using this 
tag. Also, unlike peptides and most nucleic acids, oligosaccharides are often branched 
and therefore a second group that can be used with FMOC is needed to apply 
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spectrophotometry reaction monitoring successfully to the carbohydrate synthesis 
problem. 
4. Carbohydrate Microarray Formation 
Given the difficulty of carbohydrate synthesis, the development of methods to 
array small quantities of sugars for bioactivity testing has been very active in recent 
years. Such biochip microarrays have focused on the important roles of sugars in many 
biological processes, including events of molecular recognition at fertilization, 
differentiation, and tumor-cell metastasis through carbohydrate-protein interactions.69"80 
Feizi and co-worker developed the first sugar microarray for high-throughput detection 
and specificity assignments of carbohydrate-protein interactions in 1985.81 Mrksich and 
coworkers have reported an example of a carbohydrate chip made by Diels-Alder 
mediated immobilization of carbohydrates to a self-assembled monolayer presenting 
benzoquinone and penta(ethylene glycol) groups.72 Many other methods for preparing 
carbohydrate microarrays have become available now that rely on either covalent or 
noncovalent attachment of sugars onto an array support (Figure 1.3). 
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Glc I I Man I I GlcNAc I I Glc 
Materia coated s ide 
Covalent or noncovalent bond 
Lectins, Enzyme, or Bacteria - Biological Screening 
V 
Specific interation 
Gk I I Man I I GlcNAc I I Glc 
0 0 0 0 
Material coated slide 
Figure 1.3. General strategy of carbohydrate microarrays. 
A noncovalent carbohydrate microarray was described by attachment of 
relatively large glycoproteins and polysaccharides onto nitrocellulose-coated glass 
slides by Wang et al.73 Wong and coworkers have described a different noncovalent 
attachment strategy for use with monosaccharides in microtiter plates.75'80 They have 
shown that galactosyl lipids containing hydrophobic groups at the anomeric position 
allow noncovalent binding to microtiter plates. The limitation of this approach is that 
commonly-used detergents found in assay buffers have to be avoided as they will rinse 
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away the noncovalently-bound sugars from the plates. Feizi and co-workers have further 
developed their microarrays of oligosaccharide as neoglycolipids.82'83 
Multiple groups have used glass slides modified by thiol ether groups for 
covalent binding of sugars to solid supports.84' 85 They have described a method for 
constructing carbohydrate microarrays that relied on covalent immobilization of 
carbohydrates on glass slides via chemoselective ligation between maleimide-linked 
monosaccharides and thiol ether to modified glass surface. Mrksich and coworkers have 
reported another approach to a microarray of ten monosaccharides on gold-coated glass 
slides.72 They have developed self-assembled monolayers of alkanethiolates on gold-
coated glass slides in a mixture of alkanethiol and penta(ethylene glycol) groups for 
immobilizing an array of carbohydrates. One limitation of this work is the many 
required step to make the penta(ethylene glycol) linkage. To date, no method to form 
carbohydrate methods has emerged as the clear best solution. 
Monitoring of protein binding to the arrayed carbohydrates, however, is almost 
always carried out by modification of the protein either directly by a dye or indirectly 
through an antibody-mediated process. For instance, FITC-labeled lectins 
(carbohydrate-binding proteins) can be monitored using a fluorescent laser scanner.73'11 ' 
84 Alternatively, the protein can be detected by standard enzyme-linked immunoassay 
(ELISA) methods.75'85 
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5. Enzymatic synthesis of carbohydrates 
Enzymes can also be used to make carbohydrate structures and thereby 
sometimes avoid some of the problems associated with chemical oligosaccharide 
synthesis. There are three main types of enzymes in carbohydrate chemistry: sugar 
nucleotidyltransferases, glycosyltransferases, and glycosidases. Although genome 
sequencing projects have uncovered a range of sequences that could code for proteins 
involved in carbohydrate biosynthesis, a variety of methods to understand the chemical 
and biological functions of these carbohydrate-active enzymes and to exploit them for 
organic synthesis are largely still lacking.86 
5.1 Sugar nucleotidyltransferases 
Sugar nucleotidyltransferases can catalyze the formation of a nucleotide 
diphosphate (NDP)-sugar from sugar-1 -phosphate and nucleotide triphosphates (NTPs) 
with suitable buffer, metal, temperature, and pH conditions. These activated forms of 
NDP-sugars produced by these sugar nucleotidyltransferases then serve as glycosyl 
donors in glycosyltransferase reactions. Sugar nucleotidyltransferases, enzymes 
expressed in prokaryotic and eukaryotic organisms, catalyze both the forward and 
reverse reactions shown in Scheme 1,87 
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X -— I I Al 1 O" O" r 7 + 
° ° ?\ j/ PPi NDP-Sugar H  
-o—p—o—p —o—p—O—I R OH OH I I I  0" O" O" 
NTP 
OH OH 
Scheme 1. Sugar nucleotidyltransferases catalyze the synthesis of NDP-sugars from 
sugar-1 -phosphates and NTPs. 
5.2 Glycosyltransferases 
Glycosyltransferases catalyze the formation of glycosidic linkages in 
oligosaccharide biosynthesis from activated sugar nucleophiles. Palcic and coworker 
have shown that synthetic thio-analogs, with sulfur replacing a pyranose oxygen, of 
GDP-sugars such as GDP-5-thio-mannose (Scheme 1.2, A), GDP-5-thio-galactose 
(Scheme 1.2, B) and GDP-5-thio-L-fucose are accepted as substrates for 
glycosyltransferases.88' 89 These analogs serve as carbohydrate antigens, such as the 
sialyl-Lex tetrasaccharide, that can be enzymatically prepared and used in studies to 
develop carbohydrate-based drugs that are more stable to glycosidases, enzymes that 
cleave glycosidic linkages. Interestingly, the same group chemically prepared an 
activated galactose substrate with carbon rather than sulfur replacing the ring oxygen.88 
This carbasugar analog served as an inhibitor rather than substrate for the 
galactosyltransferase. 
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Scheme 1.2. Biosynthetic method to obtain 5-thiosugar-mimetics with 
glycosyltransferases.88,89 
6. Strategies for the synthesis of sugar nucleotides 
Because sugar nucleotides are important as inhibitors or substrates of 
glycosyltransferases, chemical and enzymatic methods for their synthesis are needed. 
Several naturally-occurring monosaccharide-1-phosphates are commercially available. 
However, modified and less common sugar-1 -phosphates are not commercially 
available. To this end, Thorson and coworkers have reported the synthesis of various 
activated deoxysugars by a bacterial sugar nucleotidyltransferase.90'91'92 Several natural 
and nonnatural sugar nucleotides have also been synthesized using archaeal enzymes.93' 
94 Although the chemical synthesis of a few NDP-sugars have been reported by some 
groups,95 the methods were complicated by the many steps involving protecting and 
deprotecting groups to make the target molecule. For example, Wong and coworker 
have reported the chemical synthesis of various NDP-sugars with lH-tetrazole as 
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catalyst in phosphomorpholidate coupling reactions, but the reactions required 2-3 
days.96 
7. Glycomimetics: Enhancing carbohydrate stability 
The resistance of a glycosidic linkage to enzymatic hydrolysis as well as the 
search for more chemically and biochemically stable sugar derivatives and 
carbohydrate-based therapeutics has led to the synthesis of a variety of analogs that 
replace the glycosidic oxygen with sulfur, nitrogen and carbon. These analogs serve as 
components of biologically important compounds which can inhibit the growth of 
malignant or pathogenic cells.97 There are two important parts to define non-
hydrolysable sugar mimetics: 1) replacement of the glycosidic oxygen with S, NH, or 
CH2 and 2) replacement of the ring oxygen with one of these groups. 
7.1 Strategies for the synthesis of carbasugars 
Sugars whose ring oxygen is replaced with a carbon are known as carbasugars.98 
A few synthetic strategies to carbasugars have been based on the Diels-Alder reaction of 
a 1,4-disubstituted 1,3-butadiene with a dienophile," radical cyclization,100 and a Ferrier 
rearrangement.101 Ogawa and his coworker have developed the synthesis of racemic 
carbasugars based on cyclohexane derivatives from the Diels-Alder cycloaddition of 
furan and acrylic acid.99 Gomez and coworker have described two synthetic tools based 
on radical cyclizations as the key step in the formation of the carbasugar cyclohexane 
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ring and on a stereodivergent strategy for the preparation of carbasugars from a single 
carbocyclic intermediate as shown in Scheme I.3.100'101 
X>5 
° " \ A ° r  
9 
o . . o  
X (2 " 
'IOR 
°x° 
B 
AcO 
steps 
AcO OAc 
AcO OAc 
Scheme 1.3. Synthetic strategies based on radical reactions for the production of 
carbasugars from monosaccharides, A100and B101. 
Sinay and coworker have reported the development of the Ferrier rearragement 
by using the triisobutylaluminum-(TIBAL) promoted conversion of carbohydrates as 
shown in Scheme 1.4.102 
BnOI" o TIBAL, toluene, 50 —•- BnOI" ( /'""^ o 
BnO OBn BnO OBn 
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Scheme 1.4. Ferrier rearrangement to produce carbasugars.102 
7.2 Strategies for the synthesis of C-glycosides 
Cyclic C-glycosides can serve as enzyme inhibitors,103 antimicrobial 
antibiotics,104 and antitumor antibiotics.105 This class of glycomimetics has attracted 
more interest and therefore more methods have been developed for C-glycosides than 
for carbasugars.106 
For example, most recently Fairbanks and co-worker have reported the stereoselective 
synthesis of C-glycosides via Tebbe methylenation and Claisen rearrangement to 
produce compounds for biological screening purposes.107 Bertozzi and coworker have 
described a stereoselective C-C bond formation at the anomeric center to make 
metabolically stable glycopeptide mimetics.108 The range of synthetic methods to make 
C-glycosides has now made the discovery of new applications of these glycomimetics a 
key direction. 
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CHAPTER 2 
Fluorous-Based Carbohydrate Microarrays 
A paper published in The Journal of the American Chemical Society1 
Kwang-Seuk Ko, Firoz A. Jaipuria, and Nicola L. Pohl* 
Abstract 
The success of microarrays, such as DNA chips, for biosample screening with 
minimal sample usage has led to a variety of technologies for assays on glass slides. 
Unfortunately, for small molecules, such as carbohydrates, these methods usually rely on 
covalent bond formation, which requires unique functional handles and multiple chemical 
steps. A new simpler concept in microarray formation is based on noncovalent fluorous-
based interactions. A fluorous tail is designed not only to aid in saccharide purification but 
also to allow direct formation of carbohydrate microarrays on fluorous-derivatized glass 
slides for biological screening with lectins, such as concanavalin A. The noncovalent 
interactions in the fluorous-based array are even strong enough to withstand the detergents 
used in assays with the Erythrina crystagalli lectin. Additionally, the utility of benzyl 
carbonate protecting groups on fucose building blocks for the formation of ^-linkages is 
demonstrated. 
1 Reproduced with permission of J. Am. Chem. Soc. (2005), 127, 13162-13163. Copyright 2005 
American Chemical Society. 
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Introduction 
The success of microarrays, such as DNA chips, for biosample screening with 
minimal sample usage has led to a variety of technologies for assays on glass slides.1 
Unfortunately, for small molecules, such as sugars, these methods usually rely on covalent 
bond formation, which requires unique functional handles and multiple chemical steps.2 
Herein, we present a new simpler concept in microarray formation that is based on 
noncovalent fluorous-based interactions and demonstrate the strength of these interactions 
in the direct formation of carbohydrate microarrays for biological screening. 
Unlike comparable lipid tails interacting with hydrophobic solid phases,3 a single C8F17 tail 
is sufficient to bind biomolecules, such as peptides, to fluorinated solid supports.4 The use 
of such fluorinated solid supports for affinity chromatography can substantially simplify 
the purification of synthetic carbohydrate intermediates in a process amenable to 
automation (Figure l).5 An additional potential advantage of a fluorous-based approach is 
the direct formation of microarrays; the production of carbohydrate microarrays from 
compounds made on solid-phase still requires multiple solution-phase deprotection and 
derivatization steps.20 
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Figure 1 Strategy for the synthesis of carbohydrates and direct formation of fluorous-based 
carbohydrate microarrays. 
Results and discussion 
We began our studies with the design of a suitable fluorous tag for carbohydrate 
synthesis that could survive the necessary sequential reaction conditions and also be 
removed if desired. An allyl group would be orthogonal to the trichloroacetimidate 
coupling conditions and other deprotection conditions. Therefore, to create a fluorous allyl 
protecting group as well as potential anchor for microarray formation, a fluorous tail was 
synthesized in one step by reaction of cis-1,4-butenediol with substoichiometric amounts 
of IH,l//,2fl,2//-perfluorodecyl iodide to produce an alcohol for use in glycosylations. 
Sugars commonly found in plants were chosen as initial targets to test the feasibility of a 
noncovalent fluorous-based array for protein-binding studies (Scheme 1). Genome 
sequencing projects have revealed that the number of genes related to carbohydrate 
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metabolism is far greater in plants, such as Arabidopsis thaliana, than in animals or fungi.6 
In addition to providing an understanding of plant biology, the study of carbohydrate-
protein interactions in plants could lead to the discovery of new sugar-binding lectins for 
use as glycobiology tools.7 The known trichloroacetimidates of peracylated mannose,8 
galactose,9 and Af-acetylglucosamine10 were reacted with the fluorous-tagged allyl alcohol, 
and subsequent deacylation and hydrogénation of the double bond yielded the initial array 
components 1-3. 
AcHN 
1 Man 2 GlcNAc 3 Gal 4 Foe 
Scheme 1 
Although neighboring-group participation could be used to control the 
stereochemistry of glycosylation for mannose, galactose, and Af-acetylglucosamine, the 
synthesis of «.-linked fucose required a different approach. Fucose glycosyl donors are 
usually built with nonparticipating benzyl protecting groups to provide predominantly the 
«.-configured glycosylation products. Unfortunately, such electron-donating groups on a 6-
deoxysugar also serve to make the resulting glycosidic linkage more acid sensitive. Several 
strategies alleviate this problem, for example, the use of more electron-withdrawing 
halobenzyl groups11 or replacing the 3- and 4-OH protecting groups with an ester2 that can 
potentially serve as a distant participating group. The latter approach is appealing, but 
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requires an additional basic deprotection step. To avoid this extra step, we decided to test if 
a benzyl carbonate protecting group could serve the same purpose with the advantage of 
removal during the hydrogénation step. The requisite glycosyl donor was synthesized from 
the known allylated compound13 5 in three steps to provide the desired trichloroacetimidate 
6 (Scheme 2). This donor was glycosylated with the fluorous-tagged alcohol using 
trimethylsilyl triflate to yield only the axially linked product in 90% yield. Indeed, the 
benzyl carbonate could serve to direct formation of the a-anomer and be removed by 
hydrogénation. 
D 1) benzyichloroformate, TMEDA, CHgClz, 92% 
2) PdCI2, NaOAc, H20, 
I OH 3) CIsCCN. CsgCOg. 
H0 k CHgClg, 4 À M.S., 92% 
1) TMSOTf, 
CHgClg,90% 
HO-
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Scheme 2 
After synthesis of the requisite fluorous-tagged sugars, the next challenge was to 
find a suitable fluorinated surface. Solutions of each sugar were spotted onto a 
commercially available glass microscope slide coated with a Teflon/epoxy mixture 
employing a standard robot used for DNA arraying. The spots were dried, incubated with a 
solution of the fluorescein isothiocyanate-labeled jack bean lectin concanavalin A (FTTC-
ConA) for 20 min, rinsed repeatedly with assay buffer and distilled water, and then 
scanned with a standard fluorescent slide scanner. The scan clearly showed binding of 
FITC-ConA only to the mannose-containing spots. The anomeric position could be 
distinguished as the ^-linked GlcNAc (2) was not recognized. 
This lectin experiment demonstrated the ability of the C8Fi7 tail to anchor the 
carbohydrates to the slide surface even after repeated washes. However, the slide was also 
intrinsically and unevenly fluorescent at 488 nM, a wavelength that is commonly used to 
detect labeled analytes. Clearly, a new approach was necessary to obtain an optically and 
fluorescently clear surface for the formation of compound microarrays. To this end, a glass 
microscope slide was reacted14 with a fluoroalkylsilane to provide a clear coating on which 
water forms beads. 
With the new microarray substrate in hand, we next probed the scope of a fluorous-
based microarray approach for compound screening. Fluorous-tagged sugars were spotted 
on the coated slide using an arraying robot, and then the slides were incubated with FITC-
labeled lectins (Figure 2). To test the reproducibility of the process, the same concentration 
of sugar was spotted repeatedly. In addition, several different concentrations of sugars 
were spotted. To test the ability of the array to withstand detergents often included in 
biological screens, the labeled plant lectin from the bush Erythrina crystagalli (FITC-
ECA) was used to probe the microarrays with Tween-20. The array withstood the 20 min 
incubation time and repeated rinsing with this detergent-containing buffer. 
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Man (1) GlcNAc (2) Gal (3) Fuc(4) 
Figure 2 Fluorescence images of arrayed carbohydrates probed with FITC-labeled lectins. 
Columns of 4 spots each of 2, 1, 0.5, and 0.1 mM carbohydrates were incubated for 20 min 
with FITC-ConA (top) or FITC-ECA with 1 % 
Conclusion 
A fluorous-based microarray method allows the facile formation of a range of 
carbohydrate chips for the plant and other sciences using synthetic sugars produced with 
the aid of fluorous-tagged synthesis. Efforts are underway to automate portions of the 
solution-phase fluorous-based synthetic process and to incorporate enzymatic steps to 
expand the scope of carbohydrates that can be easily arrayed for biological screening. 
Although not limited to carbohydrates, the approach should be especially valuable for the 
production of arrays containing compounds, such as glycosaminoglycan fragments, that 
contain nucleophiles that complicate current defined covalent attachment strategies. 
Experimental section 
General methods 
Reaction solvents were distilled from calcium hydride for dichloromethane and 
from sodium metal and benzophenone for diethyl ether. Amberlyst 15 ion-exchange resin 
was washed repeatedly with methanol before use. All other commercial reagents and 
solvents were used as received without further purification. The reactions were monitored 
and the Rf values determined using analytical thin layer chromatography (tic) with 0.25 
mm EM Science silica gel plates (60F-254). The developed tic plates were visualized by 
immersion in /?-anisaldehyde solution followed by heating on a hot plate. Flash 
chromatography was performed with Selecto Scientific silica gel, 32-63 ^im particle size. 
All moisture-sensitive reactions were performed in flame- or oven-dried glassware under a 
nitrogen atmosphere. Bath temperatures were used to record the reaction temperature in all 
cases run without microwave irradiation. All reactions were stirred magnetically at 
ambient temperature unless otherwise indicated. *H NMR, 13C NMR, and l?F spectra were 
obtained with a Bruker DRX400 at 400 MHz, 100 MHz, and 162 MHz respectively. 'H 
NMR spectra were reported in parts per million (6) relative to CDCI3 (7.27 ppm) as an 
internal reference. 13C NMR spectra were reported in parts per million (6) relative to 
CDCI3 (77.23 ppm) or CD3OD (49.15 ppm). 
Cleaning of glass slide15: Glass slides were cleaned by immersion for 2 h in 60% ethanol 
containing NaOH 10 g/100 mL. The slides were washed twice in distilled water and then 
submerged in 95% ethanol. 
Microarray Preparation and Screening. 
Formation of fluorous-derivatized glass slides. Cleaned slides were immersed three times 
in a solution of Rf8-ethyl-SiCl3 (3% solution 100 mL in methanol) and then dried for a few 
minutes and repeated two times more. The slides were washed twice by immersion in 
MilliQ-filtered water and then dried in a dessicator at room temperature. 
Formation of carbohydrate microarrays. Flurous-tagged carbohydrate compounds were 
dissolved in 60% methanol in water and spotted on the fluorinated glass slide using robot 
(Cartesian PixSys 5500 Arrayerand arrayer) at 30% humidity. The glass slide was dried in 
a humidifying chamber at 30% humidity for 2 h. 
Detection of protein-carbohydrate binding16'11. For Con A; FTTC-labeled Con A in HEPES 
buffer (pH = 7.5, 10 mM) 1 mM CaCl2, 1 mM MnCl2, 100 mM NaCl, 1% BSA (w/v) or 
without BSA, and for EC A; FITC-labeled ECA in PBS buffer (pH = 6.8), 1.0% TWEEN 
20, ECA (25 ug mL-1; EY laboratoris) were used the detection of protein-carbohydrate 
interactions. For protein incubation, 0.5 mL of protein solution was applied to the printed 
glass slide. The arrays was incubated by using a PC500 CoverWell incubation chamber 
and gently shaken to every 5 min for 30 min. It was then washed three times with the same 
buffer followed by three washes with distilled water. It was then dried for 30 min in a dark 
humidity chamber. Glass slide was scanned using fluorescence scanner. 
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Synthetic Procedures. 
°
eF
" HO. 
CsFi7 
lH,lH,2H,2H-perfluorodecyloxybutenyl alcohol18. 
1,4-butenediol (140 mg, 1.59 mmol) was dissolved with 20 mL of DMF. TBAB (153 mg, 
48.0 mmol and IH, IH, 2H, 2H-perfluorodecyliodide (1.8 g, 3.18 mmol) were added into a 
solution. The reaction mixture was heated at 50 °C for 10 min and then KOH (267 mg, 
4.77 mmol) was added into the mixture. The reaction mixture was heated at 70 °C for 30 
min. The reaction mixture was poured into ice water. The organic layer was extracted with 
ethyl ether (100 mL x 2) and dried with over MgS04, filtered, and the solvent removed 
under reduced pressure. The crude product was purified by solid-phase extraction5 using 
fluoro flash column. Non-fluorous compounds were eluted with 80% MeOH/water and the 
desired product was eluted by 100% MeOH ( 1 H, 1 H,2H,2H-perfluorodecyloxybutenyl 
alcohol as a colorless oil, 1.12 g, 2.1 mmol, 67% as a clear oil. 
Rf.= 0.46 (ethyl acetate/hexane/2/3). 
*H NMR (CDC13,400 MHz): 8 (ppm) 5.75 (m, IH), 5.62 (m, IH), 4.26 (m, 2H), 4.14 (m, 
4H), 2.36 (m, 2H). 
13C NMR (CDCI3,160 MHz): 6 (ppm) 132.8, 127.5, 66.2, 61.9, 61.8, 58.7,46.8. 
17F NMR (CDCI3, 400 MHz): 8 (ppm) -81.3(m), -118.2(4), -112.5(m), -123.3(m), -
126.6(m), -127.l(m). 
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MS (ESI) m/z = 535 [M+H]+ 
H
°\ 
T O— O 
NH 
!H,lH,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-0-acetyl-a-D-
mannopyranoside. 
To a solution of 2,3,4,6-tetra-O-acetyl-a/P-D-mannopyranoside trichloroacetimidate6 
(165.0 mg, 0.34 mmol) and 1 H, 1 H,2H,2H-perfluorodecyloxybutenyl alcohol (140.0 mg, 
0.25 mmol) in dichloromethane (5 mL) were added powdered 4Â molecular sieves (10 
mg) and the mixture was cooled down to -15 °C. TMSOTf (40 fiL, 0.17 mmol) was added 
and the reaction mixture was stirred at -15 °C for 30 min. The reaction was quenched with 
triethylamine (0.1 mL) and concentrated. The crude product was purified by solid-phase 
extraction using fluoro flash column. Non-fluorous compounds were eluted with 80% 
MeOH/water and the desired product was eluted by 100% MeOH (1H,1H,2H,2H-
perfluorodecyloxybutenyl-2,3,4,6-tetra-0-acetyl-a-D-mannopyranoside as a colorless oil, 
207.1 mg, 24.0 mmol, 93%). 
Rf = 0.26 (ethyl acetate/hexane/2/3). 
H NMR (CDC13, 400 MHz): 6 (ppm) 5.69 - 5.74 (m, 2H), 5.32 (dd, IH, J = 10.0, 3.2 
Hz), 5.26 (t, IH, /= 9.6 Hz), 5.20 (m, IH), 4.81 (m, IH), 4.26-4.18 (m, 3H), 4.10-4.0.2 
(m, 5H), 3.96 (m, IH), 2.14 (s, 3H), 2.07 (s, 3H), 2.01 (s, 3H), 1.97 (s, 3H). 
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13C NMR (CDCI3, 160 MHz): Ô (ppm) 171.4, 170.9, 170.2, 170.0, 129.7, 128.9, 98.5, 
71.6, 69.3, 68.5, 66.3, 66.2, 63.1,62.4, 62.0, 21.0, 20.9(2), 20.8. 
MS (ESI) m/z = 887 [M + Na] 
NH 
lH,lH,2H,2H-perfluorodecyloxybutanyl-a-D-mannopyranoside. 
1 H, 1 H,2H,2H-perfluorodecyloxybutenyl-2,3,4,6-tetra-O-acetyl-a-D-mannopyranoside 
(184.0 mg, 0.21 mmol) was dissolved in MeOH (5 mL) and 5% Pd/C (10 mg) was added. 
The reaction mixture was put under hydrogen atmosphere and stirred for 1 h. It was then 
filtered over Celite and ethanol was removed under reduced pressure to give the 
hydrogenated product in quantitative yield. To a solution of the resulting compound (184.0 
mg, 21.3 mmol) in methanol (10 mL) was added K2CO3 (117.0 mg, 0.85 mmol) and the 
reaction mixture was stirred for 2 h. The mixture was then neutralized using Amberlyst-15 
ion-exchange resin and filtered. The solvent was removed under reduced pressure and 
1 H, 1 H,2H,2H-perfluorodecyloxybutanyl-a-D-mannopyranoside was obtained as white 
solid (146.0 mg, 0.21mmol, 100%). 
Rf = 0.36 (methanol/ethyl acetate/hexane/2/2/3). 
^H NMR (MeOD, 400 MHz): Ô (ppm) 4.71 (br, IH), 3.80 (dd, IH, J = 12.0, 2.4 Hz), 3.75 
(m, 2H), 3.70 (d, IH, /= 5.6 Hz), 3.65 (m, IH), 3.60 (m, 2H), 3.55 (m,2H), 3.48 (m, 2H), 
3.40 (m, IH), 2.03 (m, 2H), 1.64 (m, 4H). 
HO 
40 
13C NMR (MeOD, 160 MHz): 6 (ppm) 100.2, 73.3, 71.3, 70.9, 70.5, 67.2, 66.9, 61.4, 
61.3, 27.4 (2), 26.1(2). 
MS (ESI) m/z = 721 [M + Na]+ 
lH,lH,2H,2H-perfluorodecyloxybutenyl-3,4,6-tri-0-acetyl-2-deoxy-2-aceyIamino-P-
D-glucopyranoside. 
To a solution of 3,4,6-tri-0-acetyl-2-deoxy-2-acetylamino-a/p-D-mannopyranoside 
trichloroacetimidate7 (148.8 mg, 0.30 mmol) and lH,lH,2H,2H-perfluorodecyloxybutenyl 
alcohol (110.0 mg, 0.25 mmol) in dichloromethane (5 mL) were added powdered 4Â 
molecular sieves (10 mg) and the mixture was cooled down to -15 °C. TMSOTf (34 |iL, 
0.15 mmol) was added and the reaction mixture was stirred at -15 °C for 30 min. The 
reaction was quenched with triethylamine (0.1 mL) and concentrated. The crude product 
was purified by solid-phase extraction using fluoro flash column. Non-fluorous 
compounds were eluted with 80% MeOH/water and the desired product was eluted by 
100% MeOH (1H, lH,2H,2H-perfluorodecyloxybutenyl-3,4,6-tri-Oacetyl-2-deoxy-2-
acetylamino-P-D-glucopyranoside as a colorless oil, 150.3 mg, 0.17 mmol, 86%). 
AcHN AcHN 
HO 
NH 
Rf = 0.26 (ethyl acetate/hexane/2/3). 
H NMR (CDCI3, 400 MHz): Ô (ppm) 5.82 - 5.63 (m, 2H), 5.25 (dd, 1H, J = 10.0, 9.6 
Hz), 5.03 (t, 1H, J = 10.0 Hz), 4.68 (d, 1H, J = 8.4 Hz), 4.32 (m, 1H), 4.19 (m, 4H), 4.06 
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(m, 1H), 3.99 (m, 2H), 3.80 (m, 1H), 3.65 (m, 1H), 2.04 (s, 3H), 1.99 (s, 3H), 1.98 (s, 3H), 
1.90 (s, 3H). 
13C NMR (CDC13, 160 MHz): 6 (ppm) 170.9, 170.7, 170.3, 169.4, 129.3, 128.9, 99.6, 
72.3, 71.9, 68.6, 66.4, 64.4, 62.1, 61.9(2), 54.7, 23.3, 20.7(2), 20.6. 
MS (ESI) m/z = 886 [M+ Na]+ 
2 GIcNAc 
lH,lH,2H,2H-perfluorodecyloxybutanyl-2-deoxy-2-acetylamino-|3-D-
glucopyranoside. 
lH,lH,2H,2H-perfluorodecyloxybutenyl-3,4,6-tri-0-acetyl-2-deoxy-2-acetylamino-P-D-
glucopyranoside (138.0 mg, 0.16 mmol) was dissolved in MeOH (5 mL) and 5% Pd/C (10 
mg) was added. The reaction mixture was put under hydrogen atmosphere and stirred for 1 
h. It was then filtered over Celite and ethanol was removed under reduced pressure to give 
the hydrogenated product in quantitative yield. To a solution of the resulting compound 
(138.0 mg, 0.16 mmol) in methanol (10 mL) was added K2C03 (66.0 mg, 0.48 mmol) and 
the reaction mixture was stirred for 2 h. The mixture was then neutralized using 
Amberlyst-15 ion-exchange resin and filtered. The solvent was removed under reduced 
pressure and 1 H, 1 H,2H,2H-perfluorodecyloxybutanyl-2-deoxy-2-acetylamino-j3-D-gluco-
pyranoside was obtained as white solid (118.0 mg, 0.16mmol, 100%). 
AcHN 
AcHN 
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Rf = 0.23 (methanol/ethyl acetate/hexane/2/2/3). 
H NMR (MeOD, 400 MHz): 6 (ppm) 4.41 (d, 1H, J = 8.4 Hz), 3.86 (m, 2H), 3.84 (dd, 
1H, J = 12.4, 1.6 Hz), 3.63 (m, 2H), 3.46 (m, 5H), 3.21 (m, 2H), 2.02 (m, 2H), 1.95 (s), 
3H), 1.59 (m, 4H). 
13C NMR (MeOD, 160 MHz): 5 (ppm) 172.3, 101.4, 78.2, 77.9, 77.6, 74.7, 70.7, 64.2, 
61.4, 56.0, 25.9, 25.8,21.6(2). 
MS (ESI) m/z = 762 [M + Na]+ 
Additional Information: Experimental details, including copies of 'H NMR spectra, for the 
synthesis and production of the carbohydrate microarrays and the complete ref 2h, and 
competition experiment plots are found in the Appendix at the end of this chapter. 
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CHAPTER 3 
Strategies for the Chemoenzymatic Synthesis of Deoxysugar 
Nucleotides: Substrate Binding versus Catalysis 
A paper published in The Journal of the American Chemical Society2 
Kwang-Seuk Ko, Corbin J. Zea, and Nicola L. Pohl* 
Abstract 
Sugar nucleotidyltransferases, also known as sugar pyrophosphorylases, catalyze 
the formation of a phosphate linkage to produce sugars activated for use by Leloir pathway 
glycosyltransferases and are subjects of protein engineering for chemoenzymatic synthesis 
strategies. Herein we present evidence that this class of enzymes can exercise kinetic 
discrimination in choosing carbohydrates of comparable binding affinity for catalytic 
turnover. Synthetic 6-deoxy, 4-deoxy, and 3-deoxyglucose-1 -phosphate and the natural 
substrate glucose-1 -phosphate were tested with a representative prokaryotic glucose-1-
phosphate uridylyltransferase [EC 2.7.7.9] from Escherichia coli, which is also known to 
accept thymidine triphosphate, and the comparable eukaryotic enzyme from yeast. Percent 
conversion studies show that product yields, as determined by an electrospray ionization 
mass spectrometry-based assay, were much lower after 30 min for the nonnatural 
substrates than for the natural substrate. Surprisingly, kinetic analysis demonstrates that 
differences in substrate binding affinity do not primarily account for these contrasts in 
2 Reproduced with permission of J. Org. Chem. (2005), 70, 1919-1921. Copyright 2005 American 
Chemical Society. 
product yields. This kinetic analysis is the first evidence that sugar nucleotidyltransferases 
can make use of not only differences in substrate binding affinity, but also kinetic 
differences in discriminating among carbohydrate substrates, and has implications for the 
in vivo and in vitro function and use of these enzymes. 
Introduction 
Numerous studies have begun to delineate the binding determinants of sugars to 
receptors such as lectins and antibodies,1 but relatively little is understood about how 
binding relates to catalysis by the many enzymes involved in carbohydrate biosynthesis. 
These enzymes, particularly sugar nucleotidyltransferases and glycosyltransferases, are 
used extensively for the chemoenzymatic synthesis and in vivo biosynthesis of 
carbohydrate natural products and their analogues.2 The desire to expand the substrate 
range of these enzymes has also sparked protein engineering efforts.3 However, syntheses 
using nonnatural substrates, even those with conservative modifications, often fail for 
reasons that are not clearly understood. Unfortunately, the usual percent conversion studies 
do not shed light on whether the fault lies in low substrate affinity for the enzyme, low 
turnover rates, or both, and therefore, reaction optimization must be empirical. Herein we 
present evidence from the first kinetics analyses of sugar nucleotidyltransferases with 
deoxysugar substrates that these enzymes can exercise kinetic discrimination in choosing 
carbohydrates of comparable binding affinity for catalytic turnover. The consequences of 
this finding for using this class of enzymes for the synthesis of sugar nucleotides, as well 
as for understanding of their biological roles, will be discussed. 
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Sugar nucleotidyltransferases catalyze the formation of a phosphate linkage to 
produce sugars activated for use by Leloir pathway glycosyltransferases (Figure 1). The 
reaction is known to proceed via nucleophilic attack of the sugar-1 -phosphate on the di­
phosphate of the nucleotide triphosphate;4 hence, the carbohydrate portion is somewhat 
removed from the reactive site during catalysis. Although the structures of only a few 
sugar nucleotidyltransferases are presently known 5,6 and no apparent sequence homology 
between enzymes of similar function from eukaryotes and prokaryotes is evident, the 
process is crucial for carbohydrate biosynthesis. Sugar nucleotidyltransferases have been 
proposed as potential antibiotic targets,5 but a more profound knowledge of differences in 
carbohydrate substrate recognition between bacteria and humans is needed to design 
compounds with the necessary selectivity. Greater knowledge of these enzymes also will 
aid in their use for the synthesis of nonnatural sugar nucleotides as glycobiology tools and 
precursors for in vitro glycosylation strategies. 
buffer, nucleotide 
triphosphate, Mg2+ 
.OH sugar ^OH 
HO-A-0 nucleotidyltransferase H0-A-O 
HO-^Tl O ». HO-ÎV/VA O O 
H00-P-0- H°0—P-O-P-Oi n R' i i i O" O O" 
monitor m/z OH OH 
Figure 1 Sugar nucleotidyltransferases catalyze the synthesis of activated sugar 
nucleotides, such as uridinediphosphoglucose (2) when R' = uridine, from sugar-1-
phosphates, such as glucose-1 -phosphate (1) and nucleotide triphosphates. Analysis of 
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product formation by ESI-MS allows the facile kinetic analysis of the reaction independent 
of the structure of the carbohydrate portion of the sugar-1 -phosphate. 
A major impediment to studying sugar nucleotidyltransferases is the lack of an 
assay that can quickly determine kinetic parameters and inhibition constants for a range of 
compounds. The use of coupled assays7 or radioactive assays8 limits the use of nonnatural 
substrates. HPLC-based assays9, require separation protocols for every new substrate and 
are so relatively time-consuming to probably have inhibited kinetics studies that require 
analysis of multiple reaction points in triplicate. Our recent development of an electrospray 
ionization mass spectrometry (ESI-MS)-based assay10 enables the rapid determination of 
kinetic parameters for both natural and nonnatural substrates of this class of enzymes and 
prompted our investigation into the origins of substrate discrimination by sugar 
nucleotidyltransferases to optimize their use in synthesis. 
Results and discussion 
A sugar nucleotidyltransferase from yeast that activates the most common naturally 
occurring sugar, glucose, is commercially available, and therefore, we commenced our 
studies with probing the tolerance of this enzyme to conservative substrate modifications. 
The systematic removal of hydroxyl moieties should provide substrates that still fit into the 
enzyme active site; however, previous work with a bacterial enzyme has shown that even 
such minor changes can significantly impact product yields.9b We therefore first undertook 
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the synthesis of the required 6-, 4-, 3-, and 2-deoxyglucose-1 -phosphates9b (dGlc-1-
phosphate) (Figure 2) to probe the origin of these differences in product yields. 
Figure 2 Synthetic substrates 6dGlc-1 -phosphate (3), 4dGlc-1 -phosphate (4), 3dGlc-l-
phosphate (5), and 2dGlc-1 -phosphate (6) used to test the substrate tolerance of UDP-
glucose pyrophosphorylases from yeast and E. coli. 
Substrate Synthesis. Commercially available methyl-glucoside 711 was treated with 
dimethyl benzaldehyde acetal and camphorsulfonic acid to give benzylidene 8 in 76% 
yield. Benzylation of hydroxyl groups was accomplished by using benzyl bromide and 
sodium hydride. Reduction of benzylidene with lithium aluminum hydride gave compound 
9 in 80% (Scheme 1) yield.12 The primary hydroxyl group at C-6 was protected with tosyl 
chloride and reduced with LiAlH4 to produce the desired deoxygenated sugar 10 in 
quantitative yield. Acidic hydrolysis of the anomeric methyl ether provided a free 
anomeric hydroxyl group. Although l//-tetrazole is often used to aid phosphoramidite 
couplings,13 the recently reported AT-(phenyl)imidazolium triflate14 proved superior in 
catalyzing the addition of dibenzyl diisopropylphosphoramidite. The desired phosphate 
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was produced after oxidation of the phosphite with mCPBA in 93% yield. Finally, 
hydrogénation of benzyl ether followed by treatment with acidic ion exchange resin 
provided 3 in 97% yield. 
SCHEME 1. Preparation of 6-deoxyglucose-l-phosphate.a 
PhO^VO 
a Reagents and conditions: a) PhCH2(OCH3)2, DMF, CSA, 76%; b) BnBr, NaH, DMF, 
84%; c) LAH/AICI3, 1:1 Et20/CH2C12, 80%; d) TsCl, pyridine, rt, quantiative; e) LAH, 
Et20, rt, quantitative yield; f) CH3C02H, 3.0 M H2S04, 85 °C, 73%; g) (z'Pr)2NP(OBn)2, 
CH3CN, 4 À MS, A/-(phenyl)imidazolium triflate; mCPBA, 93%; h) Pd/C, H2, CH3OH, 
97%. 
For the synthesis of 2-deoxyglucose-1 -phosphate (6), commercially available acetylglucal 
11 was converted to compound 1215 in 3 steps as previously reported. Compound 12 was 
subjected to phosphorylation condition followed by hydrogenolysis as described above for 
synthesis of compound 6 (Scheme 2). 
SCHEME 2. Preparation of 2-deoxyglucose-1 -phosphate.3 
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OAc /OBn .OH 
AcO"T^R _ BnO ^ a - b  r  HO^^°x O AcO-V^s^ • BnO-^—' \ HO^^~A- 11 
OH O-P-O-
11 12 6 O 
a Reagents and conditions: a) (zPr)2NP(OBn)2, CH3CN, 4 Â MS, iV-(phenyl)imidazolium 
inflate; mCPBA, 84%; b) Pd/C, H2, CH3OH. 89%. 
Compound 8 was selectively benzylated at C-2 position to give compound 13 in 84% yield 
(Scheme 3). The secondary hydroxyl group in compound 13 was converted to Barton's 
ester1614 by using 1,1'-thiocarbonyldiimidazole. Reduction of Barton's ester with Bu3SnH 
produced 3-deoxyglucose derivative 15. Acidic cleavage of benzylidene resulted in the 
formation of diol which was protected with benzyl bromide to give compound 16. 
Removal of anomeric methyl group followed by phosphorylation and hydrogenolysis 
produced compound 5. 
SCHEME 3. Preparation of 3-deoxyglucose-l-phosphate.a 
PhOTO-\ n PhO^VO-\ n 
- sra -Ï- _i 
» I C - i j 
BnO r\nu i,! BnO -OCH3 N dmvOCH3 
13 NV 14 
.OBn .OH 
Ph0^ oS^ q d.» . '.9." . HO-^S, ° 
B
"°OCHS Bn° OCH HO O-P-O 3 I O" 
15 16 5 
a Reagents and conditions: a) BnBr, NaH, DMF, 84%; b) 1,1 thiocarbonyl diimidazole, 
THF, reflux, 91 %; c) Bu3SnH, Toluene, reflux, 86 %; d) 2 N H2S04, MeOH, 89 %; e) 
BnBr, NaH, DMF, 89 %; f) H3CQ2H, 3.0 M H2SQ4, 85 °C, 73%; g) (iPr)2NP(OBn)2, 
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CH3CN, 4 À MS, Af-(phenyl)imidazolium Inflate; mCPBA, 93%; h) Pd/C, H2, CH3OH, 
97%. 
The 4,6-O-benzylidene 8 was selectively opened with TES and TEA to produce the 
secondary alcohol 1717 in 96 % yield (Scheme 4). The secondary alcohol 17 was converted 
to Barton's ester followed by reduction with Bu3SnH to give 4-deoxy compound 18. 
Acidic hydrolysis of the anomeric methyl ether followed by phosphorylation with dibenzyl 
diisopropylphosphoramidite and catalytic amount of /V-(phenyl)imidazolium triflate and 
hydrogenolysis of benzyl ether provided compound 4. 
SCHEME 4. Preparation of 4-deoxyglucose-l-phosphate.a 
a, b 
/OBn /OH 
Bn0^ ocH3 ^  
18 4 
a Reagents and conditions; a) BnBr, NaH, DMF, 84%; b) TES, TFA, CH2C12, 96 %; 
c)l,l'- thiocarbonyl diimidazole, THF, reflux, 96 %; d)Bu3SnH, Toluene, reflux, 79 %; e) 
H3CC02H, 3.0 M H2S04, 85 °C, 73%; f) (/Pr)2NP(OBn)2, CH3CN, 4 À MS, N-
(phenyl)imidazolium triflate; mCPBA, 93%; g) Pd/C, H2, CH3OH, 97%. 
Relative substrate acceptance of UDP-glucose pyrophosphorylases. With the four required 
deoxy glucose-1 -phosphates in hand, we could test the ability of the commercially available 
yeast enzyme, a representative eukaryotic enzyme, to accept these nonnatural substraes. 
The acceptance of the natural substrate (1) and various deoxy glucose-1 -phosphates (3, 4, 
5, and 6) by the yeast UDP-glucose pyrophosphorylase enzyme was tested in the presence 
of 0.02 U of enzyme, 10 mM uridine 5'-triphosphate (UTP) or 2'-deoxy-thymidine 5'-
triphosphate (dTTP), and 10 mM Mg2+. The relative acceptance rate is defined as the ratio 
of nonnatural substrate (3, 4, 5, and 6) to the natural substrate (1) converted in the 
corresponding nucleotide diphosphate sugar. As shown in Figure 3B, the yeast UDP-
glucose pyrophosphorylase enzyme only accepted the 6-deoxysubstrate 3 in the presence 
of UTP. No product formation was observed in the absence of the enzyme, Mg2+, the 
nucleotide triphosphate, or the a-D-hexopyranosy 1-1 -phosphate. Unfortunately, the 
commercial enzyme was rather selective and therefore did not show promise for 
chemoenzymatic synthesis of activated deoxy glucose analogs. Therefore, a recombinant 
bacterial enzyme was investigated next. Fortunately, the relative acceptance of the UDP-
glucose pyrophosphorylase from Escherichia coli10of the nonnatural substrates in the 
presence of UTP and dTTP was much better than the yeast enzyme (Figure 3A). Only the 
2-deoxysubstrate 6 failed to generate product in the presence of UTP. However, the 
percent conversions were significantly lower for the deoxysubstrates than the natural 
substrate, despite no obvious negative steric factors. 
Glc-1-P-
6dGtc-1-P-
4dGlc-1-P-
3dGk-1-P-
2dGlc-1-P-
FIGURE 3. Relative substrate acceptance of UDP-glucose pyrophosphorylase from E. coli 
(A.) and yeast (B.) in the presence of UTP (solid bar) and dTTP (open bar) after 30 min. 
Kinetic analysis. To ascertain whether the differences in product yields were the result of 
decreased substrate binding or decreased turnover efficiencies, a kinetic analysis of the 
reactions was necessary. We therefore determined the kinetic parameters of the substrate -
enzyme systems in which turnover was noted in the relative acceptance study. The kinetic 
parameters were measured by varying the concentration of the modified substrates 3, 4, 
and 5 (2-100 p,M) at a constant UTP or dTTP concentration (300 |iM) in the presence of 
10 mM Mg+2 and 0.02 U of UDP-glucose pyrophosphorylase from E. coli or yeast. The 
reactions were quenched after 5 min and the initial reaction rate was determined by the 
change in concentration of UDP or dTDP-dGlc-1 -phosphate measured via ESI-MS. The 
kinetic values Km and Vmax, Table 1, were determined from nonlinear regression of the 
Michealis-Menten plots (See Supporting Information). 
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Table 1. Kinetic analysis of glucose-1 -phosphate uridylyltransferases. 
source substrates 
KM 
(|iM) 
%nax 
(|iM/min) 
kca/Kprf 
(s"1 flM"1) 
E. coli 1 + UTP3 12 ± 2 1.15 ±0.06 1.45 
1 + dTTP3 13 ± 2 0.90 ±1.05 1.05 
3  +UTP 15  ±3  0.57 ± 0.03 0.58 
3 + dTTP 17  ±3  0.39 ± 0.03 0.35 
4  +UTP 
17  ±3  0.47 ± 0.03 0.42 
5  +UTP 
18 ± 3 0.27 ± 0.01 0.23 
yeast 1 + UTP3 7 ± 1 3.8 ±0.1 10.9 
1 + dTTP 11  ±2  1.84 ±0.09 3.4 
a Reference 24. 
Surprisingly, independent of the enzyme source, all of the substrates 1, 3, 4, and 5 had 
essentially identical Km values for the E. coli enzyme. However, Vmax values decreased 
from the natural substrate (1) to the nonnatural substrates (3, 4, and 5) thereby explaining 
the difference in product yields that were seen in the relative acceptance study. The yeast 
enzyme exhibited a slightly lower affinity for 2 and the Vmax value dropped two-fold 
replicating what was noted for the E. coli enzyme. 
Clearly, differences in substrate affinity do not explain the differences in product yields for 
these two UDP-glucose pyrophosphorylases. It has been proposed that a 
glycosyltransferase involved in blood group determinant biosynthesis can distinguish 
between UDP-galactose and UDP-Af-acetylgalactosamine based on kinetics rather than 
binding affinity;18 however, this reaction involves both bond-making and bond-breaking 
directly on the sugar ring. That sugar nucleotidyltransferases can use this same strategy to 
select among carbohydrate substrates even though the sugar is three atoms from the site of 
bond formation is a surprising observation. However, the consequence is that use of higher 
enzyme concentrations rather than higher substrate concentrations can provide optimal 
yields of sugar nucleotides. 
Conclusion 
In addition to the implications for using these enzymes as catalysts for the synthesis 
of sugar nucleotides, this kinetic analysis is the first evidence that sugar 
nucleotidyltransferases can make use of not only differences in substrate binding affinity, 
but also kinetic differences in discriminating among carbohydrate substrates. This finding 
has several implications. Sugar nucleotidyltransferase substrates, such as 3, that are turned 
over preferentially by prokaryotic enzymes when compared to eukaryotic enzymes could 
serve as prodrugs if the resulting products block glycosyltransferase activity. Protein 
engineering efforts cannot expect mutations that allow steric access of the sugar to the 
binding pocket to necessarily result in efficient turnover of the modified substrate. 
Chemoenzymatic reactions may benefit from an increase in enzyme concentration rather 
than substrate concentration to increase product yields. The same may be true for the 
turnover of nonnatural substrates in vivo. Upregulation of sugar nucleotidyltransferases 
also might result in the undesired turnover of alternate substrates that could lead to 
negative phenotypes. Finally, since the level of active enzyme is hard to quantify until that 
activity is known, newly isolated proteins believed to have sugar nucleotidyltransferase 
activity should be screened against a library of possible substrates to accurately determine 
the biological function of the enzyme. 
Experimental Section 
General methods 
Reaction solvents were distilled from calcium hydride for dichloromethane and from 
sodium metal and benzophenone for diethyl ether. Amberlyst 15 ion-exchange resin was 
washed repeatedly with methanol before use. All other commercial reagents and solvents 
were used as received without further purification. The reactions were monitored and the 
Rf values determined using analytical thin layer chromatography (tic) with 0.25 mm EM 
Science silica gel plates (60F-254). The developed tic plates were visualized by immersion 
in p-anisaldehyde solution followed by heating on a hot plate. Flash chromatography was 
performed with Selecto Scientific silica gel, 32-63 (im particle size. All moisture-sensitive 
reactions were performed in flame- or oven-dried glassware under a nitrogen atmosphere. 
Bath temperatures were used to record the reaction temperature in all cases run without 
microwave irradiation. All reactions were stirred magnetically at ambient temperature 
unless otherwise indicated. *H NMR, 13C NMR, and 31P spectra were obtained with a 
Bruker DRX400 at 400 MHz, 100 MHz, and 162 MHz respectively. 'H NMR spectra were 
reported in parts per million (5) relative to CDC13 (7.27 ppm) as an internal reference. 13C 
NMR spectra were reported in parts per million (8) relative to CDCI3 (77.23 ppm) or 
CD3OD (49.15 ppm). 31P NMR spectra were reported in 8 relative to H3PC>4 (0.00 ppm) as 
an internal reference. 
Methyl 4,6-0-benzylidene-a-D-glucopyranoside (8): 
Methyl a-D-glucopyranoside (19.4 g, 100 mmol) in DMF (250 mL) and comphorsulfanic 
acid (6.9 g, 30 mmol) was treated with benzaldehyde dimethyl acetal(15.0 g, 100 mmol) 
and stirred at 65 °C for 16 h under aspirator. The reaction was cooled to room temperature, 
quenched with triethylamine (30 mL), diluted with ethyl acetate (300 mL), and washed 
with distilled water(2 x 50 mL), saturated aqueous sodium bicarbonate(3 x 50 mL) and 
distilled water(2 x 50 mL). The solvent was removed under reduced pressure. The product 
was separated by flash chromatography, which was white solid (22.8 g, 80.0 mmol, 76%). 
!H NMR and 13C NMR spectra match those previously reported.25; methyl 2,3,4-tri-O 
benzyl-6-O-tosyl-a-D-glucopyranoside: p-Toluene sulfonyl chloride (1.10g, 5.77 mmol) 
was added to a solution of methyl 2,3,4-tri-O-benzyl glucopyranoside (2.22 g, 4.79 mmol) 
in pyridine (45 mL) at room temperature for 3 h. The mixture was concentrated down 
under reduced pressure. The residue was purified by silica gel column chromatography 
(ethyl acetate/hexane, 1/1, v/v) to afford methyl 2,3,4-tri-O-benzyl-6-0-tosyl-a-D-gluco-
pyranoside as a yellowish syrup (2.90 g, 4.68 mmol, quantitative yiel); 
Rf 0.81 (ethyl acetate/hexane, 1/1, v/v); 
H NMR (400 MHz, CDC13) Ô 7.99-7.16 (m, 19 H, 3 Ar, 1 tosyl), 5.00 (d , 1 H, J = 10.8 
Hz), 4.86 (d, 1 H, J = 10.8 Hz), 4.83 (dd, 2 H, /, = 6.3, 72 = 11.1 Hz), 4.69 (d, 1 H, J = 
12.0 Hz), 4.56(d, 1 H, / = 2.7), 4.46 (d, 1 H, J = 10.8 Hz), 4.17 (m, 1 H), 4.01 (t, 1 H, J = 
12.4 Hz), 3.82 (m, 1 H), 3.52 (dd, 1 H, J x = 3.6, J = 9.6 Hz), 3.50 (m, 1 H), 3.30 (s, 3 H, -
OCH3), 2.40 (s, 3 H, tosyl-CH3); 
13C NMR (100 MHz, CDC13) 5 145.1-127.3 (aromatics), 98.3, 82.1, 80.0, 76.0, 75.2, 73.7, 
68.8, 68.7, 55.6,21.9. 
MS (ESI) m/z = 641 [M+Na]+; 
Methyl 2,3,4-tri-Obenzyl-6-deoxy-a-D-glucopyranoside (10): 
To a solution of methyl 2,3,4-tri- Obenzyl-6-0-tosyl-a-D-glucopyranoside (2.32 g, 3.75 
mmol) in Et20 (45 mL) was added a solution of lithium aluminum hydride (0.043 g, 1.13 
mmol) in Et2Q (35 mL) at room temperature for 2 h. The mixture was diluted with Et2Q (2 
x 50 mL), acidified with 2 N HCl (2 x 45 mL), and washed with water (2 x 50 mL). The 
solvent was removed under reduced pressure. The residue was purified by silica gel 
column chromatography (ethyl acetate/hexane, 1/1, v/v) to afford 10 as a yellowish syrup 
(1.65 g, 3.68 mmol, 98%); 
Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
H NMR (400 MHz, CDC13) 6 7.42-7.26 (m, 10 H, Ar), 5.01 (d, 1 H, / = 10.8 Hz), 4.92 
(d, 1 H, J = 10.8 Hz), 4.88 (dd, 2 H, J t = 12.0, J2 = 13.6 Hz), 4.69 (d, 1 H, J = 12.0 Hz), 
4.65 (d, 1H, J = 10.8 Hz), 4.56 (d, 1 H, / = 3.6 Hz), 3.99 (t, 1 H, / = 9.2 Hz), 3.76 (m, 1 
H), 3.54 (dd, 1 H, 71 = 3.6, J2 = 9.6 Hz), 3.40 (s, 3 H, -OCH3), 3.15 (t, 1 H, J = 9.2 Hz), 
1.27 (d, 3 H, J = 6.4 Hz); 
13C NMR (100 MHz, CDC13) 6 139.0-127.9 (aromatic), 98.2, 84.0, 82.1, 80.5, 76.0, 75.6, 
73.6, 66.8,55.3, 18.2. 
MS (ESI) m/z = 471 [M+Na]+; 
2,3,4-tri-0-benzyl-6-deoxy-a-D-gIucopyranose: 
Compound 10 (2.18 g, 4.86 mmol) was treated with glacial acetic acid (45 mL) and 3.0 M 
sulfuric acid (2.3 mL) at 85 °C for 3 h. The mixture was cooled to ambient temperature 
and then diluted with ice water (60 mL) extracted by toluene (80 mL). The organic layer 
was washed with saturated aqueous sodium bicarbonate (3 x 45 mL), water (2 x 40 mL), 
and brine (50 mL). The solvent was removed under reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 
84% an yield of anomeric mixture as 56/44 a/p mixture 2,3,4-tri-0-benzyl-6-deoxy-a-D-
glucopyranose as a white solid (0.99 g, 2.28 mmol, 56%) and (3 compound (0.78 g, 1.79 
mmol, 44%); 
Rf 0.26 (ethyl acetate/hexane, 3/7, v/v); 
H NMR (400 MHz, CDC13) 8 7.41-7.29 (m, 30 H, Ar), 5.15-5.14 (d, 1 H,/, = 3), 4.97-
4.95 (t, 1 H, J = 2.4 Hz), 4.93-4.87 (m, 4 H), 4.86-4.76 (m, 4 H), 4.73-4.62 (m, 4 H), 4.04-
3.89 (m, 2 H), 3.67-3.54 (m, 2 H), 3.49-3.35 (m, 2 H), 3.25-3.11 (m, 2 H), 1.31 (d, 3 H, J 
= 6.4 Hz), 1.26 (d, 3 H, / = 6.4 Hz); 
13C NMR (100 MHz, CDC13) 8 138.9-125.6 (aromatics), 97.4, 91.3, 84.7, 83.9, 83.6, 83.6, 
81.8, 80.7, 76.0, 75.9, 75.6, 75.1, 73.5, 71.6, 67.2, 18.2, 18.2. 
MS (ESI) m/z = 434 [M]+; 
Dibenzyl-(2,3,4-tri-0-benzyI-6-deoxy-a-D-glucopyranosyl) phosphate: 
A solution of 2,3,4-tri-6>-benzyl-6-deoxy-a/j3-D-glucopyranose (0.32 g, 0.74 mmol) in 
acetonitrile (6 mL) was added to a mixture of dibenzyl diisopropyl phosphoramidite (0.35 
mL) and N-phenyl imidazolium triflate (0.33 g) in dry acetonitrile (8 mL). The TLC 
showed no starting material left (Rf 0.75, ethyl acetate/hexane, 1/1, v/v). The solvent was 
evaporated under reduced pressure and then 3-chloroperoxybenzoic acid (0.13 g, 0.76 
mmol) was added to a solution of the mixture in 15 mL dichloromethane at -50 °C; the 
resulting solution was stirred at 0 °C for 30 min. The mixture was diluted with CH2CI2 (30 
mL) and a 20% Na2SQ3 solution (40 mL) was added and stirred at room temperature for 3 
h. The organic layer was washed with saturated NaHC03 (3 x 30 mL), water (3 x 30 mL), 
brine (40 mL), and dried over magnesium sulfate. The product was isolated by silica gel 
column chromatography (chloroform/diethyl ether, 9/1, v/v) to afford 87% of dibenzyl-
(2,3,4-tri-0-benzyl-6-deoxy-a-D-glucopyranosyl) phosphate as a white solid (0.23 g, 0.33 
mmol, 52% for a compound, 0.22 g, 0.31 mmol, 48% for P compound); 
Rf 0.34 (chloroform/diethyl ether, 9/1 v/v); 
NMR (400 MHz, CDC13) 8 7.31-7.24 (m, 25 H, 5 benzyl), 5.98 (dd, 1 H, J x = 3.2, J2 
= 8.8 Hz), 5.07 (m, 4H), 4.88 (dd, 2 H, J t = 10.8, J2 = 11.2 Hz), 4.75 (dd, 2 H, J j = 6.0 
Hz, J 2 = 11.2 Hz), 4.63 (dd, 2 H, J, = 11.2, J2 = 19.2 Hz), 3.38 (m, 2 H), 3.57 (m, 1 H), 
3.14 (t,l H,J = 9.2 Hz), 1.26 (d, 3H,/ = 6.4 Hz); 
13C NMR (100 MHz, CDC13) Ô 138.7, 138.6, 138.5, 138.3, 138.2, 129.9, 129.6, 128.6, 
128.5, 128.5, 128.4, 128.2, 128.0, 127.9, 127.9, 127.9, 127.8, 127.7, 95.4, 83.0, 81.0, 79.7, 
75.7, 75.4, 73.0, 69.3, 69.1, 17.8; 
31P NMR (162 MHz, CDC13) 6 2.92. 
MS (ESI) m/z = 717 [M+Na]+ 
Disodium 6-deoxy-cc-D-glucopyranosyl phosphate (3): 
A solution of dibenzyl-(2,3,4-tri-0-benzy 1-6-deoxy-a-D-glucopyranosy 1) phosphate (0.20 
g, 0.28 mmol) in MeOH (15 mL) was stirred with 20 wt.% palladium hydroxide on carbon 
(0.08 g) with saturated sodium bicarbonate (3 mL) under atmospheric H2 (gas) at ambient 
temperature for 12 h. The mixture was filtered over Celite and the filtrate was 
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concentrated under reduced pressure to afford 3 as a white solid (0.07 g, 0.29 mmol, 98%, 
weighed after treating with an acidic ion-exchange resin to pH 4 resulting in the exchange 
of one sodium ion. *H NMR, 13C NMR, and 31P NMR spectra match those previously 
reported.^; 
Rf 0.14 (methanol/ethylether/hexane, 5/1/1 v/v/v); 
MS (ESI) m/z = 243 [M-H]'; 
3,4,6-tri-0-benzyl-2-deoxy-a/0-D-glucopy ranose (12)16: 
The product was isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, 
v/v) to afford 12 as the white solid (0.43 g, 1.0 mmol, 51% for a compound, 0.39 g, 0.89 
mmol, 49% for P compound); 
Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
H NMR (CDCb, 300 MHz) 5 7.37-7.23 (M, 15 H, Ar), 5.41 (d, 1 H, J = 2.4 Hz), 4.91 (d, 
1 H, / =10.8 Hz), 4.67 (dd, 2 H, /1 = 9.0, J 2 = 12.3 Hz), 4.54 (m, 4 H), 4.05 (m, 1 H), 
3.67 (dd, 2 H, J x = 7.8, J2=\\A Hz), 3.51 (m, 1 H), 2.30 (m, 1 H), 1.68 (m, 1H); 
13C NMR (CDC13, 300 MHz) Ô 138.8, 138.6, 138.5, 138.5, 138.2, 138.2, 128.7, 128.7, 
128.7, 128.6, 128.6, 128.6, 128.3, 128.2, 128.0, 127.9, 127.9, 127.9, 127.9, 127.8, 94.4, 
92.4, 79.4,78.8, 78.0 75.2,75.1, 73.7, 73.7,72.0,71.7,71.0,69.5, 69.5, 38.2, 35.7; 
MS (ESI) m/z = 434 [M]+; 
Dibenzyl-(3,4,6-tri-6>-benzyl-2-deoxy-(x-D-glucopyranosyl) phosphate: 
A solution of 3,4,6-tri-0-benzyl-2-deoxy-oc/P-D-glucopyranose (0.32 g, 0.74 mmol) in 
acetonitrile (6 mL) was added to a mixture of dibenzyl diisopropyl phosphoramidite (0.35 
mL) and N-phenyl imidazolium triflate (0.33 g) in dry acetonitrile (8 mL). The TLC 
showed no starting material left (Rf 0.75, ethyl acetate/hexane, 1/1, v/v). The solvent was 
evaporated under reduced pressure and then 3-chloroperoxybenzoic acid (0.13 g, 0.76 
mmol) was added to a solution of the mixture in 15 mL dichloromethane at -50 °C; the 
resulting solution was stirred at 0 °C for 30 min. The mixture was diluted with CH2CI2 (30 
mL) and a 20% Na2S03 solution (40 mL) was added and stirred at room temperature for 3 
h. The organic layer was washed with saturated NaHC03 (3 x 30 mL), water (3 x 30 mL), 
brine (40 mL), and dried over magnesium sulfate. The product was isolated by silica gel 
column chromatography (chloroform/diethyl ether, 9/1, v/v) to afford 87% of dibenzyl-
(3,4,6-tri-0-benzyl-2-deoxy-a-D-glucopyranosyl) phosphate as a white solid (0.23 g, 0.33 
mmol, 52% for a compound, 0.22 g, 0.31 mmol, 48% for (3 compound); 
Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
H NMR (CDCI3, 300 MHz) Ô 7.37-7.23 (m, 50 H, Ar), 4.61 (m, 2 H), 4.50 (m, 4 H), 4.09 
(m, 2 H), 3.67 (m, 3 H), 3.50 (m, 2 H), 2.30 (m, 1 H), 1.71 (m, 1 H); 
13C NMR (CDCI3, 300 MHz) ô 138.9, 138.8, 138.6, 138.3, 135.8, 135.7, 128.9, 128.9, 
128.8, 128.8, 128.8, 128.7, 128.7, 128.7, 128.6, 128.6, 128.6, 128.6, 128.3, 128.3, 128.3, 
128.3, 128.2, 128.2, 128.2, 128.2, 127.9, 127.9, 127.9, 127.8, 127.8, 127.8, 94.4, 92.3, 
79.6, 78.8, 77.8, 75.1, 73.7, 72.0, 71.7, 70.9, 69.6, 69.5, 67.446.4,46.3, 35.9; 
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MS (ESI) m/z = 717 [M+Na]+; 
Disodium 2-deoxy-a-D-glucopyranosyl phosphate (6): 
A solution of dibenzyl-(3,4,6-tri-0-benzyl-2-deoxy-a-D-glucopyranosyl) phosphate (0.15 
g, 0.22 mmol) in MeOH (10 mL) was stirred with 20 wt.% palladium hydroxide on carbon 
(0.01 g) with saturated sodium bicarbonate (1.0 mL) under atmospheric H2 (gas) at ambient 
temperature for 12 h. The mixture was filtered over Celite and the filtrate was conce­
ntrated under reduced pressure to afford 6 as a white solid (0.05 g, 0.21 mmol, 97%, 
weighed after treating with an acidic ion-exchange resin to pH 4 resulting in the exchange 
of one sodium ion. 
MS (ESI) m/z = 243 [M-H]"; 'H NMR, 13C NMR, and 31P NMR spectra match those 
previously reported.^ 
Methyl 2-£>benzyl-4,6-Obenzylidene-a-D-glucopyranoside (13): 
A compound of methyl-4,6-0-benzylidene-a-D-glucopyranoside (4.5 g, 14.3 mmol) was 
refluxed in dry toluene (250 mL) at 95 °C for 8 h with a Dean-Stark apparatus. The 
dimutyltin dimethoxide (3.95 mL) was added to the solution of methyl 4,6-O-benzylidene-
a-D-glucopyanoside at room temperature under nitrogen gas. The mixture was refluxed 
for 3h and then added benzylbromide (2.04 mL, 16.7 mmol) and tetrabutyl ammonium 
iodide (7.2 g, 19.5 mmol). The mixture was stirred at 92 °C under N2. After 2.5 days, TLC 
was completely converted to products. The mixture was concentrated under reduced 
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pressure. The residue was purified by silica gel column chromatography (ethyl 
acetate/hexane, 1/1, v/v) to afford 13 as the white solid (4.57 g, 11.3 mmol, 79 %). 
Rf 0.60 (ethyl acetate/hexane, 1/1, v/v); 
MS (ESI) m/z = 411 [M+Na]+; 
H NMR (CDC13, 300 MHz) 8 7.53-7.33 (m, 10 H, Ar), 5.53 (s, 1 H), 4.80 (d, 1 H, J = 
12.3), 4.80 (d, 1 H, J = 12.3), 4.71 (d, 1 H, J = 12.3), 4.63 (d, 1 H, J = 3.6), 4.28 (dd, 1 H, J 
= 4.5), 4.17 (t, 1 H, J = 9.3), 3.83 (ddd, 1 H, J = 4.5), 3.71 (t, 1 H, J = 9.9), 3.50 (t, 1 H, J = 
9.9), 3.47 (t, 1 H, J = 9.3), 3.39 (s, 3 H, -OCH3); 
13C NMR (CDCI3, 300 MHz) 6 138.5-126.6, 102.3, 98.6, 77.2, 74.3, 71.6, 69.9, 64.5, 
55.6, 30.6, 16.9; 
Methyl 3-(l,1 '-thiocarbonyl imidazole)-4,6-Obenzylidene-a-D-glucopyranoside (14): 
l,l'-thiocarbonyl diimidazole (1.69 g, 9.5 mmol) was added to a solution of a compound 
of 13 (2.55 g, 6.3 mmol) in THF (40 mL) at 25 °C and then the mixture was stirred at 70 
°C under N2 for 4 h. The solution was concentrated in reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 14 
as an yellowish syrup (2.95 g, 5.7 mmol, 91 %); 
Rf 0.29 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 521 [M+Na]+; 
H NMR (CDCI3, 300 MHz) 6 8.20 (t, 1 H, J = 1.2 Hz), 7.30 (m, 10 H), 7.04 (dd, 1 H, Jx 
= 0.6, J2 = 1.5 Hz), 6.38 (t, 1 H, / = 9.6 Hz), 5.47 (s, 1 H), 4.82 (d, 1 H, / = 3.6 Hz), 4.65 
(m, 2 H), 4.54 (d, 1 H, J = 12.6 Hz), 4.31 (dd, 1 H,/1= 4.8, J2 = 10.2 Hz), 3.98 (dd, 1 H, 
Jl = 4.5, J2 = 9.6 Hz), 3.74 (m, 3 H), 3.47 (s, 3 H); 
13C NMR (CDCI3, 300 MHz) 5 183.7, 137.3, 137.1, 136.8, 136.8, 130.8, 129.4, 129.4, 
128.8, 128.8, 128.6, 128.5, 128.4, 128.2, 118.6, 101.8, 98.6, 81.6, 79.6, 79.4, 77.2, 73.6, 
69.1,62.5,55.8; 
Methyl 2- Obenzyl-4,6- Obenzylidene-3-deoxy-a-D-glucopyranoside (15): 
A compound of 14 (1.89 g, 3.7 mmol) in dry toluene (5 mL) was added dropwise 45 min. 
to a stirred of refluxing toluene (20 mL) and tributyltin hydride (2.1 g, 7.4 mmol, 2 eq.) 
under nitrogen. The solution was cooled to room temperature after the TLC was 
completely migrated to product, and then concentrated. The mixture was extracted with hot 
acetonitrile (60 mL) and washed with hexane (2 x 30 mL). The solvent was removed under 
reduced pressure. The product was isolated by silica gel column chromatography (ethyl 
acetate/hexane, 2/3, v/v) to afford 15 as an yellowish syrup (1.3 g, 3.2 mmol, 86 %); 
Rf 0.71 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 395 [M+Na]+; 
*H NMR (CDCI3, 300 MHz) Ô 7.51-730 (m, 10 H, Ar), 5.51 (s, 1 H), 4.70 (d, 1 H, J = 3.6 
Hz), 4.69 (d, 1 H, J = 12.3 Hz), 4.59 (d, 1 H, J = 12.3 Hz), 4.26 (dd, 1 H, J j = 4.2, J2 = 
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9.9 Hz), 3.77 (m, 1 H), 3.74 (d, 1 H, / = 10.2 Hz), 3.65 (m, 1 H), 3.55 (m, 1 H), 3.46 (s, 3 
H), 2.31 (m, 1 H), 2.06 (dd, 1 H, J j = 11.4, J2 = 23.1 Hz); 
13C NMR (CDC13, 300 MHz) 6 138.1, 137.6, 129.4, 129.3, 128.7, 128.6, 128.2, 128.1, 
126.4,102.0, 98.2, 76.9, 74.1, 71.3, 69.6, 64.2, 55.4, 30.3; 
Methyl 2-0-benzyl-3-deoxy-a-D-glucopyranoside: 
The 2 % sulfuric acid (0.22 g, 2.1 eq.) was added to the solution of methyl 2-Obenzyl-4,6-
Obenzylidene-3-deoxy-a-D-glucopyranoside (1.02 g, 2.63 mmol) in methanol (30 mL) at 
room temperature for 3 h. The solution was concentrated under reduced pressure and 
extracted with ethyl acetate (40 mL) and washed with water. The solvent was removed 
under reduced pressure. The product was isolated by silica gel column chromatography 
(ethyl acetate/hexane, 2/3, v/v) to afford methyl 2-£>benzyl-3-deoxy-a-D-glucopyranoside 
as the white solid (0.63 g, 2.3 mmol, 89 %); 
Rf 0.23 (methanol/ethyl acetate/hexane, 0.5/2/3, v/v); 
MS (ESI) m/z = 291 [M+Na]+; 
H NMR (CDCI3, 300 MHz) Ô 7.35-7.28 (m, 5 H, Ar), 4.63 (d, 1 H, J = 3.3 Hz), 4.59 (dd, 
2 H, J j = 12.6, J 2 = 24.0 Hz), 3.77 (d, 1 H, J = 4.2 Hz), 3.59 (m, 1 H), 3.49 (t, 1 H, J = 
4.2 Hz), 3.46 (m, 1 H), 3.40 (s, 3 H), 2.60 (s, 2 H, 2 -OH), 2.20(m, 1 H), 1.85 (dd, 1 H, J, 
= 11.4, J 2 = 23.1 Hz); 
13C NMR (CDCI3, 300 MHz) S 138.2, 128.7, 128.1, 128.1, 97.4, 73.8, 72.2, 71.3, 66.2, 
62.8, 55.2, 33.3; 
Methyl 2,4,6-tri-Obenzyl-3-deoxy-a-D-glucopyranoside (16): 
Sodium hydride (0.21 g, 50 % of oil) was slowly added into a solution of methyl 2-0-
benzyl-3-deoxy-a-D-glucopyranoside (0.61 g, 2.28 mmol) in DMF (20 mL) at room 
temperature under nitrogen. Benzylbromide (0.67 mL, 5.5 mmol) was added to the 
solution. The mixture was stirred at room temperature for 4 h under N2 and then diluted 
with ethyl acetate (70 mL) and washed with water (40 mL x 3), aq. saturated sodium 
bicarbonate (15 mL x 2). The solution was dried with magnesium sulfate. The solvent was 
removed under reduced pressure. The product was isolated by silica gel column 
chromatography (ethyl acetate/hexane, 7/3, v/v) to afford 16 as the white solid (0.90g, 2.0 
mmol, 89%); 
Rf 0.81 (ethyl acetate/hexane, 5/5, v/v); 
MS (ESI) m/z = 471 [M+Na]+; 
NMR (CDC13, 300 MHz) ô 7.37-7.18 (m, 15 H, Ar), 4.70 (d, 1 H, J = 3.3 Hz), 4.62 
(dd, 2 H, J j = 2.1, J2 = 12.3 Hz), 4.59(dd, 2H,y, = 2.1, J2 = 12.3 Hz), 4.49 (d, 1 H, J = 
12.0 Hz), 4.36 (d, 1 H, / = 11.4 Hz), 3.72 (m, 3 H), 3.54 (m, 2 H), 3.41 (s, 3 H), 2.33 (m, 1 
H), 1.86 (dd, 1 H,/, = 11.4, J2 = 23.1 Hz); 
13C NMR (CDCI3, 300 MHz) Ô 138.4, 138.3, 138.3, 128.7, 128.6, 128.6, 128.6, 128.6, 
128.3, 128.1, 128.1, 127.9, 127.9, 127.9, 127.8, 97.4, 73.8, 73.7, 72.0, 71.3, 71.0, 70.7, 
68.9, 55.1,30.3, 16.6; 
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2,4,6-tri-0-benzyl-3-deoxy-a/p-D-glucopyranose: 
Compound 16 (0.84 g, 1.9 mmol) was treated with glacial acetic acid (25 mL) and 3.0 M 
sulfuric acid (1.3 mL) at 85 °C for 3 h. The mixture was cooled to ambient temperature 
and then diluted with ice water (40 mL) extracted by toluene (80 mL). The organic layer 
was washed with saturated aqueous sodium bicarbonate (3 x 45 mL), water (2 x 40 mL), 
and brine (50 mL). The solvent was removed under reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 
84% an yield of anomeric mixture as 75/25 a/(3 mixture 2,4,6-tri-0-benzyl-3-deoxy-a/p-D-
glucopyranose as a white solid (0.51 g, 1.2 mmol, 75%) and (3 compound (0.17 g, 0.39 
mmol, 25%); 
Rf 0.85 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 434 [M]+; 
NMR (CDC,3, 300 MHz) Ô 7.36-7.17 (m, 30 H, Ar), 5.26 (d, 1 H, / = 3.3 Hz), 4.82 (d, 
1 H, J = 12.0 Hz), 4.68 (m,2 H), 4.58 (m, 6 H), 4.53 (m, 2 H), 4.38 (m,2 H), 4.00 (m, 1 H), 
3.74 (m, 2 H), 3.66 (m, 2 H), 3.56 (m, 3 H), 3.50 (m, 2 H), 3.29 (m, 1 H), 2.54 (m,l H), 
2.37 (m, 1 H), 1.84 (dd, 1 H,/, = 11.4, J2 = 23.1 Hz), 1.50 (dd, 1 H, J, = 11.7, J2 = 23.3 
Hz); 
13C NMR (CDC13, 300 MHz) ô 138.8, 138.6, 138.6, 138.6, 138.6, 138.6, 138.5, 138.5, 
138.5, 138.5, 138.5, 138.4, 138.4, 128.6, 128.6, 128.6, 128.4, 128.4, 128.2, 128.2, 128.2, 
128.2, 128.1, 128.1, 128.1, 128.0, 128.0, 128.0, 127.9, 127.9, 127.9, 127.9, 99.2, 90.4, 
78.0, 76.3, 73.9, 73.3, 73.7, 72.5, 72.0, 71.5, 71.1, 71.0, 70.7, 69.4, 69.0, 34.8, 29.7; 
Dibenzyl-(2,4,6-tri-0-benzyl-3-deoxy-a/p-D-glucopyranosyl) phosphate: 
A solution of 2,4,6-tri-0-benzyl-3-deoxy-a/p-D-glucopyranose (0.28 g, 0.65 mmol) in 
acetonitrile (6 mL) was added to a mixture of dibenzyl diisopropyl phosphoramidite (0.32 
mL) and iV-phenyl imidazolium triflate (0.30 g) in dry acetonitrile (8 mL). The TLC 
showed no starting material left (Rf 0.75, ethyl acetate/hexane, 1/1, v/v). The solvent was 
evaporated under reduced pressure and then 3-chloroperoxybenzoic acid (0.13 g, 0.76 
mmol) was added to a solution of the mixture in 15 mL dichloromethane at -50 °C; the 
resulting solution was stirred at 0 °C for 30 min. The mixture was diluted with CH2C12 (30 
mL) and a 20% Na2S03 solution (40 mL) was added and stirred at room temperature for 3 
h. The organic layer was washed with saturated NaHC03 (3 x 30 mL), water (3 x 30 mL), 
brine (40 mL), and dried over magnesium sulfate. The product was isolated by silica gel 
column chromatography (chloroform/diethyl ether, 9/1, v/v) to afford 83% of dibenzyl-
(2,4,6-tri-0-benzyl-3-deoxy-a/|3-D-glucopyranosyl) phosphate as a white solid (0.28 g, 
0.40 mmol, 75% for a compound, 0.10 g, 0.13 mmol, 25% for |3 compound); 
MS (ESI) m/z = 717 [M+Na]+; 
31P NMR (D20,400 MHz) 6 1.9; 
H NMR (CDC13, 300 MHz) ô 7.37-7.23 (m, 50 H, Ar), 5.80 (dd, 1 H, J {  =  3.3, J 2  = 8.4 
Hz), 5.02 (m, 9 H), 4.77 (m, 5 H), 4.60 (m, 4 H), 3.75 (m, 4 H), 3.56 (m, 3 H), 2.26 (m, 2 
H), 1.65 (m, 2 H); 
13C NMR (CDC13, 300 MHz) 5138.9, 138.9, 138.9, 138.8, 138.8, 138.7, 138.6, 138.6, 
138.6, 138.6, 138.5, 138. 5, 128.6, 128.6, 128.6, 128.6, 128.6, 128.6, 128.6, 128.6, 128.3, 
128.2, 128.1, 128.1, 128.0, 128.0, 127.9, 127.9, 127.9, 127.9, 127.8, 97.7, 92.4, 83.9, 80.6, 
78.5, 75.3, 75.2, 73.8, 73.6,73.5, 72.6, 72.4, 72.4, 71.2, 71.1 67.0, 69.9, 32.3, 32.3; 
Disodium 3-deoxy-a/p-D-glucopyranosyl phosphate (5): 
A solution of dibenzyl-(2,4,6-tri-0-benzyl-3-deoxy-a/p-D-glucopyranosyl) phosphate 
(0.32 g, 0.46 mmol) in MeOH (15 mL) was stirred with 20 wt.% palladium hydroxide on 
carbon (0.08 g) with saturated sodium bicarbonate (3 mL) under atmospheric H2 (gas) at 
ambient temperature for 12 h. The mixture was filtered over Celite and the filtrate was 
concentrated under reduced pressure to afford 5 as a white solid (0.11 g, quantitative yield, 
weighed after treating with an acidic ion-exchange resin to pH 4 resulting in the exchange 
of one sodium ion. 
MS (ESI) m/z = 243 [M-H]~; *H NMR, 13C NMR, and 31P NMR spectra match those 
previously reported.22 ; 
Methyl 2,3,6-tri-0-benzyl-4-(l,l'-thiocarbonyl imidazole)-a-D-glucopyranoside: 
l,l'-thiocarbonyl diimidazole (1.1 g, 6.3 mmol), was added to a solution of a compound of 
17 (1.94 g, 4.2 mmol) in THF (40 mL) at 25 °C and then the mixture was stirred at 70 °C 
under N% for 4 h. The solution was concentrated in reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 
methyl 2,3,6-tri-0-benzyl-4-(l,1 '-thiocarbonyl imidazole)-a-D-glucopyranoside as an 
yellowish syrup (2.3 g, 4.0 mmol, 96 %); 
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Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 597 [M+Na]+; 
H NMR (CDC13, 300 MHz) ô 8.05 (t, 1 H, / = 1.2 Hz), 7.41-7.14 (m,15 H), 6.97 (m,l 
H), 5.87 (dd, 1 H, 7! = 9.3, J2 = 9.9 Hz), 4.87 (dd, 2H,/i = 6.6, J2 = 11.7 Hz), 4.68 (d, 1 
H, / = 12.0 Hz), 4.64(d, 1 H, J = 3.6 Hz), 4.58 (d, 1 H, J = 11.7 Hz), 4.43(dd, 2 H, J j = 
11.7, J2 = 13.5 Hz), 4.08 (t, 1 H, / = 9.3 Hz), 3.97 (m, 1 H), 3.70 (dd, 1 H,/, = 3.6, J2 = 
9.3 Hz), 3.58 (dd, 1 H,JX = 3.6, J2 = 10.8 Hz), 3.45 (dd, 1 H, Jx = 4.5, J2 = 10.5 Hz), 3.44 
(s, 3 H); 
13C NMR (CDCI3, 300 MHz) 5183.5, 138.0, 137.9, 137.6, 136.9, 130.9, 128.8, 128.5, 
128.5, 128.5, 128.5, 128.5, 128.4, 128.4, 128.4, 128.3, 128.3, 128.2, 128.0, 127.9, 127.9, 
118.2, 98.4, 80.0, 79.2, 78.6,75.6, 74.0, 73.9, 69.0, 68.3, 55.9; 
Methyl 2,3,6-tri-Obenzyl-4-deoxy-a-D-glucopyranoside (18): 
A compound of methyl 2,3,6-tri-0-benzyl-4-( 1,1'-thiocarbonyl imidazole)-a-D-gluco-
pyranoside (2.04 g, 3.6 mmol) in dry toluene (6 mL) was added dropwise 45 min. to a 
stirred of refluxing toluene (40 mL) and tributyltin hydride (1.26mL, 7.1 mmol, 2 eq.) 
under nitrogen. The solution was cooled to room temperature after the TLC was 
completely migrated to product, and then concentrated. The mixture was extracted with hot 
acetonitrile (60 mL) and washed with hexane (40 mL x 2). The solvent was removed under 
reduced pressure. The product was isolated by silica gel column chromatography (ethyl 
acetate/hexane, 2/3, v/v) to afford 18 as an yellowish syrup (1.26 g, 2.8 mmol, 79 %); 
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MS (ESI) m/z = 471 [M+Na]+; 
NMR (CDCI3, 300 MHz) 8 7.41-7.26 (m, 15 H, Ar), 4.87 (d, 1 H, J = 12.3 Hz), 4.78 
(dd, 2 H, Jx = 11.7, J 2 = 18.3 Hz), 4.74 (m, 2 H), 4.58 (s, 2 H), 3.96 (m, 2 H), 3.51 (m, 3 
H) 3.41 (s, 3 H), 2.10 (m, 1 H), 1.54 (dd, 1 H, Jx = 12.0 J2 = 23.2 Hz); 
13C NMR (CDCI3, 300 MHz) 8 139.2, 138.8, 138.8, 128.6, 128.3, 127.9, 127.9, 127.8, 
127.4, 99.3, 80.7, 75.6, 73.7, 73.7, 72.4, 72.7, 66.9, 55.4; 
2,3,6-tri-0-benzyl-4-deoxy-aP-D-glucopyranose: 
Compound 18 (1.08 g, 2.4 mmol) was treated with glacial acetic acid (45 mL) and 3.0 M 
sulfuric acid (2.3 mL) at 85 °C for 3 h. The mixture was cooled to ambient temperature 
and then diluted with ice water (60 mL) extracted by toluene (80 mL). The organic layer 
was washed with saturated aqueous sodium bicarbonate (3 x 45 mL), water (2 x 40 mL), 
and brine (50 mL). The solvent was removed under reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 65 
% an yield of anomeric mixture as 55/45 a/|3 mixture 2,3,6-tri-O-benzy 1-4-deoxy-a-D-
glucopyranose as a white solid (0.37 g, 0.86 mmol, 55%) and (3 compound (0.31 g, 0.71 
mmol, 45%); 
Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 434 [M]+; 
H NMR (CDCI3, 300 MHz) 6 7.47-7.26 (m, 30 H, Ar), 5.30 (d, 1 H, J =2.1 Hz), 4.96 (d, 
1 H, J = 11.1 Hz), 4.83 (dd, 2 H, J x = 4.8, J2 = 11.7 Hz), 4.70 (m, 7 H), 4.56 (m, 4 H), 
4.23 (m, 1 H), 3.96 (m, 2 H), 3.60 (m, 4 H), 3.46 (m, 4 H), 3.30 (m, 2 H), 2.08 (m, 2 H), 
1.49 (m, 2 H); 
13C NMR (CDCI3, 300 MHz) Ô 138.7, 138.7, 138.6, 138.6, 138.6, 136.5, 128.6, 128.6, 
128.6, 128.6, 128.6, 128.6, 128.6, 128.6, 128.3, 128.2, 128.1, 128.1, 128.0, 128.0, 127.9, 
127.9, 127.9, 127.9, 127.8, 97.7, 92.4, 83.9, 80.6, 78.5, 75.3, 75.2, 73.8, 73.6,73.5, 72.6, 
72.4, 72.4,71.2, 67.2, 33.8; 
Dibenzyl-(2,3,6-tri-0-benzyl-4-deoxy-a-D-glucopyranosyl) phosphate: 
A solution of 2,3,6-tri-0-benzyl-4-deoxy-a-D-glucopyranose (0.38 g, 0.88 mmol) in 
acetonitrile (6 mL) was added to a mixture of dibenzyl diisopropyl phosphoramidite (0.35 
mL) and Af-phenyl imidazolium triflate (0.33 g) in dry acetonitrile (8 mL). The TLC 
showed no starting material left (Rf 0.75, ethyl acetate/hexane, 1/1, v/v). The solvent was 
evaporated under reduced pressure and then 3-chloroperoxybenzoic acid (0.13 g, 0.76 
mmol) was added to a solution of the mixture in 15 mL dichloromethane at -50 °C; the 
resulting solution was stirred at 0 °C for 30 min. The mixture was diluted with CH2C12 (30 
mL) and a 20% Na2SC>3 solution (40 mL) was added and stirred at room temperature for 3 
h. The organic layer was washed with saturated NaHC03 (3 x 30 mL), water (3 x 30 mL), 
brine (40 mL), and dried over magnesium sulfate. The product was isolated by silica gel 
column chromatography (chloroform/diethyl ether, 9/1, v/v) to afford 75% of dibenzyl-
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(2,3,6-tri-0-benzyl-4-deoxy-a-D-glucopyranosyl) phosphate as a white solid (0.25 g, 0.36 
mmol, 55% for a compound, 0.20 g, 0.30 mmol, 45% for (3 compound); 
Rf 0.47 (ethyl acetate/hexane, 2/3, v/v); 
MS (ESI) m/z = 717 [M+Na]+; 
31P NMR (CDC13,400 MHz) 80.89; 
H NMR (CDCI3, 300 MHz) ô 7.41-7.24 (m, 25 H, Ar), 6.23 (dd, 1 H,/, = 2.4, J2 = 5.1 
Hz), 5.08 (m, 6 H), 4.80 (m, 2 H), 4.70 (m, 3 H), 4.52 (dd, 2 H, J j = 9.0, J2 = 11.4 Hz), 
4.15 (m, 1 H), 3.92 (m, 1 H), 3.59 (m, 1 H), 3.45 (d, 2 H, J = 3.6 Hz), 2.41 (m, 1 H), 1.65 
(dd, 1 H, J ! = 9.3, J2 = 18.3 Hz); 
13C NMR (CDCI3, 300 MHz) S 138.4, 138.4, 138.4, 138.3, 138.3, 128.7, 128.7, 128.6, 
128.6, 128.6, 128.6, 128.3, 128.3, 128.3, 128.3, 128.2, 128.2, 128.2, 128.2, 127.9, 127.9, 
127.8, 127.8, 127.8, 97.7, 92.4, 83.9, 80.6, 78.5, 75.3, 75.2, 73.8, 73.6, 73.5, 72.6, 72.4, 
72.4,71.2, 67.2, 33.5; 
Disodium 4-deoxy-a-D-glucopyranosyl phosphate (4): 
A solution of dibenzyl-(2,3,6-tri-0-benzyl-4-deoxy-a-D-glucopyranosyl) phosphate (0.25 
g, 0.36 mmol) in MeOH (15 mL) was stirred with 20 wt.% palladium hydroxide on carbon 
(0.08 g) with saturated sodium bicarbonate (3 mL) under atmospheric H2 (gas) at ambient 
temperature for 12 h. The mixture was filtered over Celite and the filtrate was 
concentrated under reduced pressure to afford 4 as a white solid (0.08 g, quantitative yield, 
weighed after treating with an acidic ion-exchange resin to pH 4 resulting in the exchange 
of one sodium ion. 
MS (ESI) m/z = 243 [M-H]"; *H NMR, 13C NMR, and 31P NMR spectra match those 
previously reported.913 
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CHAPTER 4 
Surprising Bacterial Nucleotidyltransferase Selectivity in the 
Conversion of Carbaglucose-1 -phosphate 
A paper published in The Journal of the American Chemical Society3 
Kwang-Seuk Ko, Corbin J. Zea, and Nicola L. Pohl* 
Abstract 
The drive to understand the molecular determinants of carbohydrate binding as well 
as the search for more chemically and biochemically stable sugar derivatives and 
carbohydrate-based therapeutics has led to the synthesis of a variety of analogues that 
replace the glycosidic oxygen with sulfur or carbon. In contrast, the effect of substitution 
of the ring oxygen on the conformations and enzymatic tolerance of sugars has been 
largely neglected, in part because of the difficulty in obtaining these analogues. Herein we 
report the first synthesis of the carbocyclic version of the most common naturally 
occurring sugar-1-phosphate, glucose-1-phosphate, and its evaluation with bacterial and 
eukaryotic sugar nucleotidyltransferases. In contrast to results with the eukaryotic enzyme, 
the carbaglucose-1-phosphate serves as a substrate for the bacterial enzyme to provide the 
carbocyclic uridinediphosphoglucose. This result demonstrates the first chemoenzymatic 
strategy to this class of glycosyltransferase inhibitors and stable activated sugar mimics for 
cocrystallization with glycosyltransferases and their glycosyl acceptors. This difference in 
3 Reproduced with permission of J. Am. Chem. Soc. (2004), 126, 13188-13189. Copyright 2004 
American Chemical Society. 
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turnover between enzymes also suggests the possibility of using sugar nucleo­
tidyltransferases in vivo to convert prodrug forms of glycosyltransferase inhibitors. In 
addition, we report several microwave-assisted reactions, including a five minute Ferrier 
rearrangement with palladium, that accelerate the synthesis of carbocyclic sugars for 
further studies. 
Introduction 
Herein we report the first synthesis of the carbocyclic version of the most common 
naturally occurring sugar-1 -phosphate, glucose-1-phosphate, and its evaluation with a 
bacterial and a eukaryotic sugar nucleotidyltransferase. In contrast to results with the 
eukaryotic enzyme, the carbocyclic glucose-1-phosphate serves as a substrate for the 
bacterial enzyme to provide the carbocyclic uridinediphosphoglucose. This result 
demonstrates not only the first chemoenzymatic strategy to this class of 
glycosyltransferase inhibitors but also the possibility of using sugar nucleotidyltransferases 
in vivo to convert prodrug forms of glycosyltransferase inhibitors. In addition, we report 
several general microwave-assisted reactions that serve to accelerate the synthesis of 
carbasugars for further studies. 
Sugars mediate a large variety of protein-protein and cell-cell interactions 
implicated in disease states, thereby making carbohydrate-based therapeutics attractive.1 
The drive to understand the molecular determinants of these carbohydrate binding 
interactions as well as the search for more chemically and biochemically stable sugar 
derivatives has led to the synthesis of a variety of analogues that replace the glycosidic 
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oxygen with sulfur or carbon.2 In contrast, the effect of substitution of the ring oxygen on 
the conformations and biological activity of pyranose sugars has been largely neglected, in 
part because of the difficulty in obtaining these analogues. The small amount of existing 
biological data outside glycosidase inhibitors has shown sulfur versions of activated 
nucleotidediphosphosugars to be poor substrates for glycosyltransferases,3 whereas the 
carbocyclic versions serve as inhibitors of these enzymes.4 These substrates are difficult to 
synthesize chemically but led us to consider strategies to form such analogues biologically. 
However, no data are available for the tolerance of sugar nucleotidyltransferases to ring 
oxygen substitutions. 
The ubiquitous Leloir pathway glycosyltransferases require activated sugars that are 
produced by sugar nucleotidyltransferases (Figure 1). The latter enzymes have been 
proposed as possible antibiotic targets,53'58,6 but facile screening assays and knowledge of 
differences in carbohydrate substrate recognition between bacteria and humans are needed 
to design compounds with the necessary selectivity. Presently, only a few structures of 
sugar nucleotidyltransferases are known.5 No sequence homology between enzymes of 
similar function from eukaryotes and prokaryotes is apparent; therefore, differences in 
substrate recognition and turnover could be expected for exploitation in antibiotic design. 
nu NOP 
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Figure 1 Sugar nucleotidyltransferases catalyze the formation of activated nucleotide 
diphosphate sugars that are substrates for, when X = O, but inhibitors of, when X = CH2, 
Leloir pathway glycosyltransferases. 
Results and discussion 
Discovery of the tolerance of sugar nucleotidyltransferases to carbocyclic sugar 
substrates first required the synthesis of carbasugar-1 -phosphates. Several strategies have 
been applied to the synthesis of carbasugars, including radical cyclizations, conversion of 
quinic acid or bacterial metabolites, zirconium-mediated ring contractions, ring-closing 
metathesis, Cope rearrangements, and anionic or transition metal-mediated cyclizations.7,4b 
The Ferrier rearrangement is the most common approach to carbasugars, but mercury is 
often used and the rearrangements require hours. Many reaction times, especially for 
transition metal-mediated reactions, can be significantly shortened with microwave 
assistance.8 Indeed, we found that not only could the Ferrier rearrangement be carried out 
in less time and with higher yields in the presence of palladium dichloride but that the 
synthesis of the necessary precursor 5 could also be hastened by the application of 
microwave-assisted reactions rather than conventional heating (Scheme 1 and Supporting 
Information). Iodination9 of the selectively protected glucose precursor 3 took place in a 
minute; the subsequent elimination reaction took place in a half hour under microwave 
irradiation without any competing side reactions. The development of this series of 
microwave-assisted reactions significantly shortened the time to form the core carbocyclic 
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structure from a protected D-glucose, thereby providing a route that should be applicable 
to a variety of other sugars for studies with sugar nucleotidyltransferases. 
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Scheme 1 
6 
To complete the synthesis of the desired carbaglucose-1-phosphate (2), the free hydroxyl 
group of the Ferrier product 6 was silylated and methylation with Tebbe's reagent yielded 
the corresponding exo-methylene derivative 7 (Scheme 2). Hydroboration/oxidation of 
alkene 7 resulted in alcohol 8 with the desired equatorial configuration in 87% overall 
yield. Alcohol protection by benzylation followed by silyl protecting group removal 
produced free hydroxyl 9. Treatment of 9 with dibenzyl diisopropyl phosphoramidite in 
the presence of a catalytic amount of AHphenyl)imidazolium triflate10 produced a 
phosphite intermediate that was oxidized in situ to the phosphate. Global debenzylation 
afforded the desired carbasugar 2. 
87 
1>TBSa,Jmid«ote, 
DMF, SO '"C, 95% 
"SSS^ 
800 OH BnQoTBS 66,0 OTBS 
« 8 
MM* x- 3SW» 
% «s MWKmcPBA,c#v%.ao% LA-A^\ 9>Pd(OHk.H2,LWOKM% p 
Bn°QH HOQ-P-ONa 
BnO 
» ONa 
Scheme 2 
With the desired carbocyclic analogue in hand, we next compared its interactions 
with representative bacterial and eukaryotic sugar nucleotidyltransferases. A major 
obstacle in testing nonnatural substrates and inhibitors with this class of enzymes has been 
the lack of a rapid assay to determine kinetic parameters for a variety of compounds; 
however, the recent development of an electrospray ionization mass spectrometry (ESI-
MS)-based assay11 circumvents these difficulties. The carbasugar 2 was first incubated 
with a glucose-1 -phosphate uridylyltransferase from Escherichia coli, which is known to 
also accept thymidine triphosphate and is homologous to a range of bacterial sugar 
nucleotidyltransferases.12 Surprisingly, the analogue was turned over to produce the 
carbocyclic version of UDP-glucose. In fact, carbasugar 2 exhibited Km values (17 ± 2 PM) 
similar to those of the natural substrate 1 (12 ± 2 >AM). However, a lower turnover rate 
meant that kcJKm values (s1 MM"1) were 0.0020 for the analogue compared to 1.45 for the 
natural substrate. In contrast, the corresponding sugar nucleotidyltransferase from yeast, 
which is also homologous to the human enzyme, showed no evidence for carbocyclic 
UDP-glucose formation even with 5-fold higher enzyme concentrations. 
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These data provide the first evidence that carbocyclic sugar analogues can serve to 
inhibit the class of enzymes that provide sugar nucleotide donors to glycosyltransferases, 
which make compounds such as the cyclic glucans that render some bacteria resistant to 
standard antibiotics.13 The relatively weak inherent affinity of glycosyltransferase 
substrates has been a large hurdle in the design of potent and, most importantly, selective 
inhibitors for this class of enzymes. This difficulty stems in part from the fact that a large 
portion of the protein binding energy of these charged sugar substrates comes from the 
phosphates and not from the carbohydrate itself. However, the incorporation of a catalytic 
step in addition to a binding step can create a more prominent distinction between 
prokaryotes and eukaryotes. Differences in substrate turnover that have been exploited in 
the design of cancer drugs (cancer cells often upregulate enzymes that convert prodrugs)14 
also can serve as a potential strategy to increase the selectivity of drugs targeted for 
carbohydrate biosynthetic pathways. Compounds can be designed to make use of not only 
the inherent differences in bacterial versus eukaryotic substrate binding pockets but also 
the differences in substrate turnover. 
Conclusion 
We have shown that sugar nucleotidyltransferases provide means for the facile 
chemoenzymatic synthesis of carbocyclic versions of activated sugars for further studies of 
the effects of this substitution on the conformations and properties of carbasugars and for 
cocrystallization studies with glycosyltransferases and their respective glycosyl acceptors. 
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Experimental Section 
General methods 
Trizma base and trizma hydrochloride were purchased from Fischer Scientific Company 
(Hanover Park, IL). Thermostable inorganic pyrophosphatase (IPP) from Thermococcus 
litoralis (EC 3.6.1.1, M0296S) was purchased from New England Biolabs. All other 
chemicals were obtained from Sigma Chemical Co. (St. Louis, MO) unless otherwise 
noted and used without further purification. Yeast UDP-glucose pyrophosphorylase (EC 
2.7.7.9, 9026-22-6) was desalted by buffer exchange using a Microcon Centrifugal Filter 
Device, MWCO 10 kDa (Millipore, Billerica, MA). E. coli UDP-glucose 
pyrophosphorylase was prepared as previously reported.1 Nanopure water (18.1 MHz) 
prepared from a Bamstead E-pure water purification system was employed throughout. 
Reaction solvents were distilled from calcium hydride for dichloromethane and from 
sodium metal and benzophenone for diethyl ether. Amberlyst 15 ion-exchange resin was 
washed repeatedly with methanol before use. All other commercial reagents and solvents 
were used as received without further purification. The reactions were monitored and the 
Rf values determined using analytical thin layer chromatography (tic) with 0.25 mm EM 
Science silica gel plates (60F-254). The developed tic plates were visualized by immersion 
in /7-anisaldehyde solution followed by heating on a hot plate. Flash chromatography was 
performed with Selecto Scientific silica gel, 32-63 |im particle size. All moisture-sensitive 
reactions were performed in flame- or oven-dried glassware under a nitrogen atmosphere. 
Bath temperatures were used to record the reaction temperature in all cases run without 
microwave irradiation. All reactions were stirred magnetically at ambient temperature 
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unless otherwise indicated. !H NMR, 13C NMR, and 31P spectra were obtained with a 
Bruker DRX400 at 400 MHz, 100 MHz, and 162 MHz respectively. 'H NMR spectra were 
reported in parts per million (5) relative to CDCI3 (7.27 ppm) as an internal reference. 13C 
NMR spectra were reported in parts per million (5) relative to CDC13 (77.23 ppm) or 
CD3OD (49.15 ppm). 31P NMR spectra were reported in 8 relative to H3PO4 (0.00 ppm) as 
an internal reference. Microwave-assisted reactions were performed in a CEM (Matthews, 
NC) Model Discover microwave. 
MS Conditions. The instrument calibration conditions were as previously reported.15 
Enzyme Activity Determination. The enzymatic activity determination conditions were also 
as previously reported.15 One unit of enzyme is defined as one micromole glucose-1-
phosphate consumed per minute. 
Standard Curves. Calibration curves of UDP-carbocyclic-glucose and dTDP-carbocyclic-
glucose were created by allowing the E. coli UDP-glucose pyrophosphorylase enzyme to 
react with carbocyclic-glucose-1-phosphate (2-25 |iM) in the presence of UTP and TTP 
(300 p,M) in a reaction mixture containing Tris buffer (25 mM, pH 7.8), IPP (0.2 U), and 
UDP-glucose pyrophosphorylase (0.1 U). Reactions were carried out at 37 °C and after 1 
h, as determined by the complete disappearance of carbocyclic-glucose-1-phosphate by 
ESI-MS, 30 |0,L of the reaction mixture was quenched by addition to 30 (iL of 70% 
methanol/water containing AMP (6 |iM) as an internal standard. The quenched solutions 
were centrifuged 10 minutes at 10,000 x g to precipitate the protein. Aliquots (15 |iL) of 
the reaction mixtures were diluted with 135 jiL of acetonitrile/water/triethylamine 
(35/65/0.2). These samples (30 ^iL) were subjected to analysis via ESI-MS to determine 
the amount of UDP-carbocyclic-glucose (m/z = 563) and dTDP-carbocyclic-6-deoxy-
glucose (m/z = 561) produced as compared to the internal standard, AMP (m/z = 346). The 
relative intensity of the product was then plotted against the concentration of carbocyclic-
glucose-1-phosphate. 
Kinetic analysis. 
Measurement of Km and Vmax of carbocyclic glucose-1-phosphate. The values of KM and 
Vmax for the E. coli UDP-glucose pyrophosphorylase were derived from enzymatic 
reactions run in triplicate and determined from the initial rates of UDP/dTDP-carbocyclic-
glucose formation by monitoring the rate of UDP/dTDP-carbocyclic-glucose formation 
using ESI-MS. The reaction conditions were as previously reported.1 The enzymatic 
reaction was initiated by the addition of carbocyclic-glucose-1-phosphate (2 - 200 |iM) to 
a reaction mixture containing Tris buffer (25 mM, pH 7.6), IPP (0.2 U), UDP-glucose 
pyrophosphorylase (0.01 U), and UTP or dTTP (300 pM). Reactions were carried out at 37 
°C and after 5 minutes 30 (iL of the reaction mixture was quenched by addition to 30 (iL of 
70% methanol/water containing AMP (6 (iM) as an internal standard. The quenched 
solutions were centrifuged 10 minutes at 10,000 x g to precipitate the protein. Aliquots (15 
(iL) of the reaction mixtures were diluted with 135 |iL of acetonitrile/water/triethylamine 
(35/65/0.2). These samples (30 ^iL) were subjected to analysis via ESI-MS to determine 
the amount of UDP/dTDP-carbocyclic-glucose formed. 
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Activity determination of yeast UDP-glucose pyrophosphorylase. The activity of yeast 
UDP-glucose pyrophosphorylase was determined by monitoring the appearance of UDP-
carbocyclic-glucose. The enzymatic reaction was initiated by the addition of carbocyclic-
glucose-1-phosphate (5 mM) to a reaction mixture containing Tris buffer (25 mM, pH 7.6), 
IPP (0.2 U), UDP-glucose pyrophosphorylase (0.05 U), and UTP (10 mM). Reactions were 
carried out at 37 °C and after 30 and 90 minutes 15 fiL of the reaction mixture was 
quenched by addition to 30 |iL of 70% methanol/water containing AMP (3 mM) as an 
internal standard. The quenched solutions were centrifuged 10 minutes at 10,000 x g to 
precipitate the protein. Aliquots (15 |iL) of the reaction mixtures were diluted with 135 fiL 
of acetonitrile/water/triethylamine (35/65/0.2). These samples (3 (iL) were subjected to 
analysis via ESI-MS to determine the amount of UDP -carbocyclic-glucose formed. 
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Figure SI. Calibration curve for UDP-carbocyclic-glucose (•) and dTDP-carbocyclic-
glucose (•). 
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Figure S2. Michealis-Menten plots in the direction of UDP-glucose synthesis for E. coli 
UDP-glucose pyrophosphorylase and carbocyclic-glucose-1-phosphate in the presence of 
UTP (•) and dTTP (•). 
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Table SI. Kinetic analysis of UDP-glucose pyrophosphorylase. Error bars represent the 
standard error in the non-linear regression of three independent trials. 
Source Substrates Km (|iM) Knax (p-M/min) kca/Km (s"1 
Liivr1) 
E. coli 1 + UTPa 12 ±2 1.15 ±0.06 1.45 
1 + dTTPa 13 ±2 0.90 ± 0.05 1.05 
carbo + UTP 17 ±2 0.94 ± 0.03 0.0021 
carbo + dTTP 20 ±2 0.69 ± 0.02 0.0013 
yeast 1 + UTPa 7 ± 1 3.8 ±0.1 10.9 
1 + ATPa 7 ± 1 1.67 ±0.07 4.8 
carbo + UTP N/A 
carbo + ATP N/A 
a Zea, C. J.; Pohl, N. L. Anal. Biochem. 2004, 328, 196-202. 
N/A - no activity 
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Synthetic procedures. 
BnO OCH 
4 
Methyl-6-deoxy-6-iodo-2,3,4-tri-0-benzyl-a-D-glucopyranoside. 
To a solution of methyl-2,3,4-tri-0-benzyl-a-D-glucopyranoside2 (4.2 g, 9.0 mmol) in 
toluene (60 mL) containing triphenylphosphine (4.7 g, 18.0 mmol) and imidazole (3.1 g, 
45 mmol) was added iodine (4.6 g, 18 mmol). The mixture was stirred at 60 °C with 300 
W power in the microwave for 5 min. The mixture was concentrated under reduced 
pressure, and the resulting solid was removed by filtration and rinsed with ethyl acetate (80 
mL). The organic filtrate was concentrated under reduced pressure. The product was 
purified by column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 4 as a white 
solid (5.1 g, 8.9 mmol, 98%). 
Rf 0.78 (ethyl acetate/hexane, 2/3 v/v). 
1H NMR (400 MHz, CDC13) Ô 7.36-7.30 (m, 15 H), 5.00 (dd, 2 H, J, = 10.8 Hz, h = 22.0 
Hz), 4.83 (dd, 2 H, /, = 7.2, J2 = 5.6 Hz), 4.69 (t, 2 H, / = 10.8 Hz), 4.64 <d, 1 H, 7 = 3.2 
Hz), 4.05 (t, 1 H, / = 9.2 Hz), 3.58 (dd, 1 H, Jx = 3.6, J2 = 9.6 Hz), 3.48 (m, 2 H), 3.44 (s, 
3H), 3.37 (d, 1 H, / = 9.2 Hz), 3.33 (m, 1 H). 
13C NMR (100 MHz, CDC13) ô 138.6, 138.1, 138.1, 128.6, 128.6, 128.6, 128.2, 128.0, 
127.8, 98.2, 81.7, 81.6, 80.2, 75.9, 75.5, 73.5, 69.4, 55.6, 7.8. 
MS (ESI) m/z = 597 [M+Na]+. 
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BnO OCH 
5 
Methyl-6-deoxy-2,3,4-tri-0-benzyl-a-D-hex-5-enopyranoside. 
To a solution of the methyl-6-deoxy-6-iodo-2,3,4-tri-0-benzyl-a-D-glucopyranoside (3.8 
g, 6.6 mmol) in DMF (70 mL), l,8-dizabicyclo[5.4.0]undec-7-ene (1.1 mL, 7.2 mmol) was 
added at room temperature. The mixture was stirred at 80 °C with 300 W power in the 
microwave for 30 min. The mixture was diluted with ethyl acetate (120 mL), washed with 
saturated aqueous NaHC03 (3 x 60 mL), and washed with water (2 x 60 mL). The organic 
solvent was removed under reduced pressure. The product was purified by column 
chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 5 as a white solid (2.9 g, 6.5 
mmol, 98%). 
Rf 0.75 (ethyl acetate/hexane, 2/3 v/v). 
1H NMR (400 MHz, CDC13) ô 7.38-7.31 (m, 15 H), 4.96-4.69 (m, 8 H), 4.65 (d, 1 H, / = 
3.2 Hz), 4.00 (t, 1 H, / = 9.2 Hz), 3.94 (m, 1 H), 3.63 (dd, 1 H, /, = 3.2, J2 = 9.2 Hz), 3.45 
(s, 3 H). 
13C NMR (100 MHz, CDC13) ô 153.9, 138.9, 138.3, 138.2, 128.8, 128.7, 128.7, 128.6, 
128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 99.3,97.1, 81.5, 79.8, 79.5, 76.0, 74.8, 73.9, 55.7. 
MS (ESI) m/z = 447 [M+H]+. 
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BnO OH 
6 
2,3,4-tri-O-benzyl-a-D-cyclohexanone. 
To a solution of methyl-6-deoxy-2,3,4-tri-0-benzyl-a-D-hex-5-enopyranose (2.3 g, 5.2 
mmol) in 1,4-dioxane (20 mL) and water (10 mL), PdCl2 (0.37 g, 2.0 mmol) was added at 
room temperature. The mixture was stirred at 60 °C with 300 W power in the microwave 
for 5 min. The mixture was diluted with ethyl acetate (60 mL), washed with saturated 
aqueous NaHC03 (2 x 50 mL), and washed with water (2 x 50 mL). The organic solvent 
was removed under reduced pressure. The product was purified by silica gel column 
chromatography (ethyl acetate/hexane, 2/3, v/v) to afford a 93% yield of the mixture of a/{3 
compounds, 6 as a white solid (1.7 g, 3.8 mmol, 80% of the mixture) and the (3 compound 
(0.41 g, 0.95 mmol, 20% of the mixture). 
R/0.27 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) ô 7.38-7.25 (m, 15 H), 4.94 (dd, 2 H, /, = 10.8, J 2 =  11.2 
Hz),  4 . 7 8  ( d d ,  2  H ,  J x  =  8 . 0 ,  J 2 =  1 1 . 6  H z ) ,  4 . 6 9  ( d ,  1  H ,  J  =  1 1 . 6  H z ) ,  4 . 5 3  ( d ,  1  H ,  J  =  
11.6 Hz), 4.22 (m, 1 H), 4.01 (m, 2 H), 3.76 (m, 1 H), 2.64 (dd, 1 H, Jx = 3.6, J2 = 14.0 
Hz), 2.41 (s, 1 H), 2.40 (m, 1 H). 
13C NMR (100 MHz, CDC13) 5 202.3, 138.4, 137.7, 137.7, 128.6, 128.4, 128.4, 128.1, 
127.9, 127.8, 127.8, 85.3, 81.8, 81.6, 76.0, 73.5, 73.3, 66.7, 42.7. 
MS (ESI) m/z = 455 [M+Na]+. 
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BnO OTBS 
6a 
TBS-2,3,4-tri-0-benzyl-a-D-g/i/co-cyclohexanone. 
To a solution of the 2,3,4-tri-O-benzyl-a-D-cyclohexanone (1.5 g, 3.5 mmol) in DMF (30 
mL), zerf-butyldimethylsilyl (TBS) chloride (1.1 g, 7.0 mmol) and imidazole (0.5 g, 7.0 
mmol) were added at room temperature. The mixture was stirred at 50 °C. The solid 
byproduct was removed by Alteration and rinsed with ethyl acetate (40 mL). The resulting 
filterate was diluted with ethyl acetate (60 mL), washed with saturated aqueous NaHCOg 
(3 x 50 mL), and washed with water (2 x 50 mL). The organic layer was concentrated 
under reduced pressure. The product was isolated by silica gel column chromatography 
(ethyl acetate/hexane, 2/3, v/v) to afford 6a as a solid (1.8 g, 3.3 mmol, 95%). 
Rf 0.63 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) ô 7.40-7.30 (m, 15 H), 4.97 (d, 1 H, J = 12.0 Hz), 4.88 (dd, 2 
H, J\ = 10.8, J2 = 20.4 Hz), 4.78 (s, 2 H), 4.62 (d, 1 H, 7= 11.6 Hz), 4.32 (m, 1 H), 4.11 (t, 
1 H,/= 8.8 Hz), 4.04 (d, 1 H, J = 9.2 Hz), 3.71 (dd, 1 H, J, = 2.0, J2 = 8.8 Hz), 2.52 (m, 1 
H), 2.47 (m, 1 H), 0.95 (s, 9 H), 0.10 (d, 6 H, J = 4.4 Hz). 
13C NMR (100 MHz, CDC13) 6 204.2, 138.6, 138.3, 137.9, 128.4, 128.3, 128.2, 128.1, 
127.8, 127.6, 127.5, 127.2, 85.8, 82.3, 81.9, 75.7, 73.5, 73.1,67.9, 45.2, 25.8, 18.2, -4.3. 
MS (ESI) m/z = 570 [M+Na]+. 
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BnO OTBS 
7 
TBS-2,3,4-tri-0-benzyl-a-D-flr/uco-hex-5-enopyranoside 
A 0.5 M solution of Tebbe reagent in toluene (1.2 mL, 2.1 mmol) was added dropwise to a 
solution of TBS-2,3,4-tri-0-benzyl-a-D-gluco-cyclohexanone (0.48 g, 0.9 mmol) and 
pyridine (2 mL) in THF (8 mL) at -40 °C. The mixture was stirred at room temperature for 
1 h and then the mixture was cooled to -40 °C, quenched dropwise with a saturated 
NaHC03 (15 drops), stirred at room temperature for 30 min, filtered through a short 
column of Celite, and concentrated. The product was purified by column chromatography 
(ethyl acetate/hexane, 2/3, v/v) to yield 7 as a white solid (0.4 g, 0.8 mmol, 93%) 
R/ 0.67 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) S 7.48-7.31 (m, 15 H), 5.36 (br s, 1 H), 4.97 (br s, 1 H), 4.92 
(d, 2 H, J = 2.8 Hz), 4.79 (d, 2 H, J = 6.8 Hz), 4.74 (d, 2 H, J = 3.2 Hz), 4.31 (dd, 1 H, Jx = 
5.2, Jx = 7.6 Hz), 4.19 (m, 1 H), 3.89 (m, 2 H), 3.47 (m, 1 H), 2.46 (dd, 1 H, J\ = 5.6, J2 = 
18.42 Hz), 2.12 (m, 1 H), 0.95 (s, 9 H), 0.13 (d, 6 H, 7 = 4.4 Hz). 
13C NMR (100 MHz, CDC13) S 167.8, 139.3, 139.0, 138.8, 128.5, 128.4, 128.3, 128.2, 
128.2, 128.0, 128.0, 127.7, 127.7, 127.7, 127.5, 127.4, 110.9, 83.5, 83.4, 83.3, 75.7, 73.9, 
72.8, 68.3, 68.2, 38.9, 28.8, 18.4, -4.7, -4.7. 
MS (ESI) m/z = 568 [M+H]+. 
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8 
Carbocyclic TBS-2,3,4-tri-0-benzyl-a-D-glucopyranoside 
To a solution of BH3THF (1.0 M a solution of THF, 2.2 mL, 3 eq.) in anhydrous THF at 0 
°C was added, dropwise, a solution of TBS-2,3,4-tri-0-benzyl-a-D-g/uco-hex-5-
enopyranoside (0.39 g, 0.72 mmol) in anhydrous THF (4 mL). The mixture was stirred at 
room temperature for 2 h and then 3 N NaOH (2 mL) and 30 % H202 (2 mL) were added 
dropwise. The mixture was stirred for 0.5 h and then diluted with CH2C12 (40 mL). The 
mixture was washed with saturated aqueous NaHC03 (3 x 30 mL), water (3 x 30 mL), and 
brine (40 mL) and then dried over magnesium sulfate. The product was isolated by silica 
gel column chromatography (chloroform/ethyl ether, 9/1, v/v) to afford 8 as a white solid 
(0.35 g, 0.62 mmol, 87 %). 
Rf 0.42 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR 1H NMR (400 MHz, CDC13) 6 7.31-7.24 (m, 15 H), 4.78-4.54 (m, 6 H), 4.08 (m, 
1 H), 4.00 (m, 2 H), 3.62 (m, 2 H), 3.36 (m, 1 H), 2.24 (m, 1 H), 1.90 (m, 1 H), 1.50 (m, 1 
H), 0.90 (s, 9 H), 0.06 (d, 6 H, J = 5.6 Hz). 
13C NMR (100 MHz, CDC13) 6 138.9, 138.7, 138.5, 128.5, 128.4, 128.2, 128.1, 128.0, 
127.9, 127.8, 127.7, 127.6, 127.4, 82.4, 82.0, 81.9, 73.7,69.7, 65.6, 39.4, 25.9, 18.2, -4.5. 
MS (ESI) m/z = 586 [M+Na]+. 
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Carbocyclic TBS-2,3,4,6-tetra-0-benzyl-a-D-glucopyranoside. 
Sodium hydride (0.04 g, 1.8 mmol) was slowly added into a solution of compound 8 
(0.723 g, 1.56 mmol) in DMF (30 mL) at room temperature. Benzylbromide (0.22 mL, 1.8 
mmol) was added to the solution. The mixture was stirred at room temperature for 4 h 
under N2, diluted with ethyl acetate (60 mL), washed with water (40 mL x 3), and aqueous 
saturated sodium bicarbonate (35 mL). The solution was dried over magnesium sulfate. 
The solvent was removed under reduced pressure. The product was purified by silica gel 
column chromatography (ethyl acetate/hexane, 7/3, v/v) to afford 8a as a solid (0.78 g, 
1.40 mmol, 90%). 
Rf 0.64 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) ô 7.39-7.23 (m, 20 H), 4.83-4.47 (m, 8 H), 4.10 (m, 1 H), 
3.82 (m, 1 H), 3.72 (t, 1 H, 7=8.4 Hz), 3.57 (m, 1 H), 2.34 (m, 1 H), 2.06 (m, 1 H), 1.43 
(m, 1 H), 0.94 (s, 9 H), 0.09 (s, 6 H). 
13C NMR (100 MHz, CDC13) 6 139.4, 139.0, 138.9, 138.6, 128.5, 128.4, 128.4, 128.3, 
128.2, 128.2, 128.0, 127.9, 127.8, 127.8, 127.7, 127.7, 127.5, 127.4, 127.3, 79.9, 79.9, 
79.8, 79.8, 73.8, 73.1, 72.1, 71.2, 70.5, 37.2, 26.1, 18.3, -4.5. 
MS (ESI) m/z = 676 [M+Naj+. 
102 
OBn 
BnO 4 
BnO-
9 OH 
1H-1H COSY NMR to confirm the stereochemistry 
Carbocyclic 2,3,4,6-tetra-O-benzyl-a-D-glucopyranose. 
To a solution of carbocyclic TBS-2,3,4,6-tetra-0-benzyl-a-D-glucopyranoside (0.72 g, 1.1 
mmol) in THF (10 mL) was added dropwise a 1 M solution of tetrabutylammonium 
fluoride (2.2 mL, 5.5 mmol) in THF at 0 °C. The cooling bath was removed and the 
reaction mixture stirred for 1 h at room temperature and then diluted with ethyl acetate (40 
mL). The mixture was washed with saturated aqueous NaHCOg (2 x 20 mL), water (3 x 20 
mL), and brine (30 mL) and then dried over magnesium sulfate. The organic layer was 
washed with brine, dried over anhydrous Na2S04, and concentrated under reduced pressure 
to give a crude product which was purified by column chromatography to obtain 
compound 9 (0.55 g, 1.0 mmol, 93%) as an oil. 
R/0.35 (ethyl acetate/hexane, 2/3 v/v). 
1H NMR (400 MHz, CDC13) ô 7.35-7.25 (m, 20 H), 4.68-4.50 (m, 8 H), 3.96 (m, 1 H, 1-
H), 3.85 (t, 1 H, J = 5.2 Hz, 3-H), 3.67 (t, 1 H, J = 4.4 Hz, 4-H), 3.60 (m, 3 H, 2-H, 6-H), 
2.71 (br s, 1 H, -OH), 2.30 (m, 1 H, 5-H), 1.88 (m, 1 H, 7-H), 1.56 (m, 1 H, 7-H). 
13C NMR (100 MHz, CDC13) ô 138.7, 138.5, 138.5, 138.3, 128.5, 128.4, 128.4, 128.3, 
128.3, 128.0, 127.9, 127.9, 127.8, 127.8, 127.7, 127.6, 79.9, 79.9, 79.8, 79.8, 73.6, 73.2, 
72.6, 70.6,67.7, 36.5, 28.5. 
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MS (ESI) m/z = 455 [M+Na]+. 
—\ 
OBn 
BnO" 
BnO O 
BnO j II O—P—OBn 
9a OBn 
Carbocyclic Dibenzyl-(2,3,4,6-tetra-0-benzyl-a-D-glucopyranosyl) phosphate. 
The compound 2,3,4,6-tetra-0-benzyl-6-deuterium-a-D-glucopyranose (0.32 g, 0.59 
mmol) in acetonitrile (4 mL) was added to a mixture of dibenzyl diisopropyl 
phosphoramidite (0.35 mL) and N-phenyl immidazolium Inflate (0.33 g) in anhydrous 
acetonitrile (8 mL). When the tic showed no remaining starting material (Rf 0.75, ethyl 
acetate/hexane, 1/1, v/v ), the solvent was removed under reduced pressure. Then 3-
chloroperoxybenzoic acid (0.13 g, 0.76 mmol) was added to the solution of the mixture in 
15 mL dichloromethane at -50 °C and the resulting solution was stirred at 0 °C for 30 min. 
The mixture was diluted with CH2C12 (30 mL). A 20 % aqueous Na2S03 (40 mL) solution 
was added and the mixture was stirred at room temperature for 3 h. The organic layer was 
washed with saturated aqueous NaHC03 (3 x 30 mL), water (3 x 30 mL), and brine (40 
mL) and then dried over magnesium sulfate. The product was isolated by silica gel column 
chromatography (chloroform/ethylether, 9/1, v/v) to afford 9a as a white solid (0.38 g, 0.48 
mmol, 80%). 
Rf 0.34 (chlorofomi/ethylether, 2/3 v/v). 
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1H NMR (400 MHz, CDC13) ô 7.31-7.17 (m, 30 H), 5.06-4.39 (m, 12 H), 3.78 (m, 1 H), 
3.71 (t, 1 H, J = 4.4 Hz), 3.61 (m, 2 H), 3.43 (t, 1 H, J = 7.6 Hz), 2.27 (m, 1 H), 2.17 (m, 1 
H), 1.60 (m, 1 H). 
13C NMR (100 MHz, CDC13) ô 138.5, 138.5, 138.1, 137.87, 136.1, 136.1, 128.8, 128.6, 
128.6, 128.6, 128.4, 128.4, 128.4, 128.3, 128.1, 127.9, 127.9, 127.9, 127.9, 127.8, 127.8, 
127.7,127.5, 127.5, 76.4, 76.4, 76.4, 76.3, 76.3, 76.3, 73.3, 73.0, 72.2, 69.2, 69.1, 36.6, 
26.3. 
31P NMR (162 MHz, CDC13) 8 2.79. 
MS (ESI) m/z = 822 [M+Na]+. 
Carbocyclic disodium a-D-glucopyranosyl phosphate 
A solution of 9a (0.20 g, 0.25 mmol) in MeOH (15 mL) was stirred with 20 wt. % 
palladium hydroxide on carbon (0.08 g) with saturated sodium bicarbonate (3 mL) under 
atmospheric H2 (gas) at ambient temperature overnight. The mixture was filtered over 
Celite and the filtrate was concentrated under reduced pressure to afford 2 as a white solid 
(0.065 g, 0.25 mmol, quantitative). 
H< 
2 ONa 
R/0.14 (methanol/ethyl ether/hexane, 5/1/1 v/v/v). 
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1H NMR (400 MHz, D20) 6 4.31 (br s, 1 H), 3.77 (br s, 1 H), 3.64 (m, 3 H), 3.41 (m, 1 H), 
2.02 (m, 1 H), 1.84 (m, 1 H), 1.54 (m, 1 H). 
13C NMR (100 MHz, CD3OD) 5 75.0, 73.0, 70.9,70.6,63.2, 38.5, 24.5. 
31P NMR (162 MHz, D20) Ô 2.92. 
MS (ESI) m/z = 257 [M+Na]+. 
Additional Information: Experimental details, including copies of *H NMR spectra, for the 
synthesis and production of the carbohydrate microarrays and the complete ref 2h, and 
competition experiment plots are found in the Appendix at the end of this chapter. 
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CHAPTER 5 
A Mass-Differentiated Library Strategy for Functional Proteomic 
Identification of Sugar Nucleotidyltransferase Activities from Cell 
Lysates 
A paper to be submitted to The Journal of the American Chemical Society 
Kwang-Seuk Ko, Rahman M. Mizanur, and Nicola L. Pohl* 
Introduction 
Sugar nucleotidyltransferases (NTs) are a ubiquitous class of enzymes that serve to 
activate sugars for most glycosyltransferases. These enzymes are central to primary and 
secondary metabolism and their activities have been correlated to disease states such as 
diabetes and to the state of virulence of pathogens such as Giardia} Activity-dependent 
labeling of enzymes is a powerful method to identify proteins in a complex mixture with 
specific chemical functions.2 However, this proteomics strategy is limited to enzymes such 
as proteases and glycosidases with key nucleophilic residues in their active sites and 
therefore cannot be readily applied to identifying the presence of sugar 
nucleotidyltransferases. Herein we report a rapid method to identify a range of sugar 
nucleotidyltransferase activities of purified proteins or in cell lysates using a library 
designed for mass spectrometry-based analysis. 
Unlike the hydrolytic enzymes identified by activity-based labeling protocols, sugar 
nucleotidyltransferases require two substrates: a sugar-1-phosphate and a nucleotide 
triphosphate (NTP). This class of enzymes is often assayed by monitoring of the reverse 
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reaction—cleavage of a sugar nucleotide by pyrophosphate. However, a cell extract could 
contain other proteins that lead to the disappearance of sugar nucleotides. In addition, 
some sugar NTs can readily accept more than one sugar-1 -phosphate or more than one 
NTP as substrates; therefore, conditions to monitor the reaction in the synthetic direction 
are necessary for the facile characterization of sugar NT activities. Several methods have 
been developed to monitor the reaction in the synthetic direction: HPLC-based assays,3 
radioactivity-based assays,4 coupled assays that require various other enzymes,5 and most 
recently mass-spectrometry-based assays.6 Ideally, enzyme activity could be monitored 
quickly with a range of substrates in a limited number of reactions to conserve sample 
rather than in multiple parallel reactions.7 Mass-spectrometry appears best-suited for such 
a proteomics-based approach. 
Results and discussion 
The basic strategy of a chemical proteomics approach to detecting sugar NT 
activities (Figure 1) relies on the differentiation of all possible substrates by mass to track 
their conversion in one-pot to sugar nucleotide products. However, although some of the 
naturally occurring sugar-1 -phosphates and sialic acid itself do not share molecular 
weights (Figure 2), several potential library members cannot be distinguished using mass 
spectrometry. Also, the library cannot contain any inhibitors of sugar NT activity for the 
triumph of this one-pot approach. 
To address the first problem, the mass redundancy of the three common sugar 
phosphates based on glucose, galactose and mannose was broken by introduction of 
I l l  
deuterium labels (Figure 3). Lithium aluminum deuteride reduction of the known 
aldehyde8 or carboxylic acid9 produced monodeuterated galactose and dideuterated 
glucose analogs. Protection of the resulting alcohols, followed by hydrolysis of the 
anomeric methyl group, allowed the selective installation of an anomeric phosphate via the 
phosphite.10 Finally, the phosphorylated compounds were deprotected by hydrogénation 
with Pd(OH)2 and the resulting compounds were converted into their sodium salts using an 
ion exchange resin to provide the new deuterium labeled sugar-1-phosphates 5 and 6. 
Cvf-OH 
sugar-1 - ° 
phosphate library 
with sialic acid 
Figure 1. Strategy for identification of multiple sugar nucleotidyltransferase activities in a 
cell extract or purified protein preparation. 
O 9 ^-OH HO—i ÇH 
h c m — H °  v ^ S v  H °  v ^ l ? \  7^°» ^ .= 
1, m/z 229 2, m/z 243 3, m/z 258 4, m/z 259 
5, m/z 260 8, m/z 308 6, m/z 261 7, m/z 300 
NTP PPi 
anzyme(s) 
(pure or f 
pell exti 
a OND(M)P 
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-Z fingerprint by mass 
spectrometry 
ATP m/z [M-1] 506 GTP m/z [M-1] 521 
CTP m/z [M-1 ] 482 dTTP m/z [M-1] 481 
UTP m/z I M-1] 483 
Figure 2. Mass-differentiated library of substrates for sugar nucleotidyltransferases. 
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Figure 3. Synthesis of deuterium labeled glucose- and galactose-1-phosphates. 
Sugar nucleotidyltransferases are known to operate by a bi-bi mechanism in which 
the NTP is bound first to the active site, followed by the sugar-1-phosphate.11 Some sugar 
NTs display promiscuity with regards to the NTP and therefore can produce more than one 
product. However, many enzymes can at least bind alternate NTPs even if they are not 
turned over and therefore be inhibited by the presence of NTPs. Indeed, incubation of the 
library containing the sugar-1 -phosphates and sialic acid with the five nucleotide 
triphosphates used to make activated sugar nucleotides (Figure 2) and with a well-
characterized sugar nucleotidyltransferase lla did not result in detection of the expected 
range of products in the mass spectrum. Even the presence of the correct NTP substrate did 
not overcome the presence of the inhibitory compounds. 
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Figure 4. ESI-MS monitoring of the reactants and products in the presence of an E. coli 
K12 cell extract with UTP. A, Reaction at 0 min; B, reaction after 30 min. Compounds 1-8 
(see Figure 1); 9, AMP; 10, UTP; 11, UDP-xylose; 12, UDP-fucose; 13, UDP-
glucosamine; 14, UDP-mannose; 15, UDP-galactose; 16, UDP-glucose and 17, UDP-/V-
acetylglucosamine. 
Next, the sugar substrate library was incubated with only one nucleotide 
triphosphate at a time and either the yeast sugar nucleotidyltransferase known to produce 
both ADP- and UDP-activated glucose as well as with a promiscuous archaeal sugar 
nucleotidyltransferase. An electrospray ionization mass spectrometry (ESI-MS) based 
technique, developed recently for the sugar NT assay, was employed effectively to monitor 
the formation of product or disappearance of starting substrates in a one-pot enzymatic 
reaction. Incubation of the yeast enzyme with substrate library (Figure 1) and UTP or ATP 
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yielded UDP- or ADP-glucose respectively and no product was detected when the reaction 
was carried out containing both UTP and ATP in the reaction vessel. In a previous study 
we have found that yeast enzyme is very specific to its natural substrate and accepts only 
glucose 1-phosphate in presence of UTP or ATP and ATP was shown to be a competitive 
inhibitor63 which correlates our present finding. Then the same approach was employed to 
reevaluate the function of a promiscuous hyperthermostable homologous enzyme113 from 
Pyrococcus furiosus. The enzymatic reaction, carried out at 80 °C, has turned over all the 
previously known phosphorylated sugars in presence of UTP including the mono- and 
dideuterated sugar-1-phosphates and a new substrate, xylose 1-phosphate, which was 
previously an unknown substrate for this enzyme. It also turned over several sugar 1-
phosphates, as expected, in presence of dTTP. No activated sugar was detected in ESI-MS 
when the reaction was run in presence of ATP, CTP and GTP. These findings completely 
corroborate our previous report and strongly verify the utility of library approach in order 
to detect the function of sugar NTs in vitro. The sensitivity and strength of this library 
approach was utilized further to monitor the sugar NTs activities in crude cell extract from 
a well known E. coli strain. Like wise, soluble cell extract from E. coli K12 turned over a 
variety of sugar 1-phosphates in presence of ATP, GTP, dTTP and UTP. (Figure 4 and 
Table SI). No product was detected when the reaction was carried out with CTP, the 
reason of which is unclear. It might be due to that CTP utilizing enzyme was degraded by 
the proteases or was not induced properly during growth of the E. coli strain. 
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Conclusion 
The current library contains the sugars commonly found in many mammalian and 
bacterial organisms, but it can easily be extended to include sugar-1 -phosphates found in 
plants. In this study we have shown that instead of having any adverse effects, chemically 
modified deutarated glucose- and galactose-1-phoshates have simplified the ESI-MS 
detection of activated sugars in one-pot enzymatic reaction. Apart from verifying substrate 
specificities of known sugar nucleotidyltransferases from eukaryotic and archaeal sources, 
this substrate library approach is particularly important for screening the sugar NTs 
activities in cell extract and also to monitor the inhibitors of the particular enzyme. This 
mass-differentiated library approach would be suitable for screening multiple enzymes in a 
given cell extract ideally from any sources without having any genetic recombination and 
extensive purification of the enzymes. 
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Experimental Section 
General Methods. 
General materials and methods. Trizma base and trizma hydrochloride were purchased 
from Fisher Scientific Company (Hanover Park, IL). Thermostable inorganic 
pyrophosphatase (IPP) from Thermococcus litoralis (EC 3.6.1.1, M0296S) was purchased 
from New England Biolabs (Ipswich, MA). All other chemicals were obtained from Sigma 
Chemical Co. (St. Louis, MO) unless otherwise noted and used without further 
purification. Yeast UDP-glucose pyrophosphorylase (EC 2.7.7.9, 9026-22-6) was desalted 
by buffer exchange using a Microcon Centrifugal Filter Device, MWCO 10 kDa 
(Millipore, Billerica, MA). E. coli UDP-glucose pyrophosphorylase was prepared as 
previously reported.1 Nanopure water (18.1 MHz) prepared from a Bamstead E-pure water 
purification system was employed throughout. Reaction solvents were distilled from 
calcium hydride for dichloromethane and from sodium metal and benzophenone for 
diethyl ether. Amberlyst 15 ion-exchange resin was washed repeatedly with methanol 
before use. All other commercial reagents and solvents were used as received without 
further purification. The reactions were monitored and the Rf values determined using 
analytical thin layer chromatography (TLC) with 0.25 mm EM Science silica gel plates 
(60F-254). The developed TLC plates were visualized by immersion in p-anisaldehyde 
solution followed by heating on a hot plate. Flash chromatography was performed with 
Selecto Scientific silica gel, 32-63 Dm particle size. All moisture-sensitive reactions were 
performed in flame- or oven-dried glassware under a nitrogen atmosphere. Bath 
temperatures were used to record the reaction temperature in all cases run without 
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microwave irradiation. All reactions were stirred magnetically at ambient temperature 
unless otherwise indicated. H NMR, 13C NMR, and 31P spectra were obtained with a 
Broker DRX400 at 400 MHz, 100 MHz, and 162 MHz respectively. *H NMR spectra were 
reported in parts per million (Ô) relative to CDCI3 (7.27 ppm) as an internal reference. 13C 
NMR spectra were reported in parts per million (6) relative to CDC13 (77.23 ppm) or 
CD3OD (49.15 ppm). 31P NMR spectra were reported relative to H3PO4 (0.00 ppm) as an 
internal reference and were obtained with complete proton decoupling. 
Bacterial strain and enzymes. Escherichia coli K12 cells were grown on Luria-Bertani 
(LB, Sigma, St. Louis, MO) medium at 37 °C for over night on an incubator shaker at 225 
rpm. Cells were harvested by centrifugation at 3600 x g for 10 min at 25 °C and were 
disrupted by sonication (Fisher model 100 Sonic Dismembranator, Fisher Scientific, 
Pittsburgh, PA), after which unbroken cells and debris were removed by centrifugation (30 
min at 10,000 x g). The supernatant was used as cell extract to check sugar 
nucleotidyltransferase activity. The recombinant UDP-a-D-glucose pyrophosphorylase 
(UGPase) (UTP:a-D-glucose-l-phosphate uridylyltransferase, EC 2.7.7.9) from P. 
furiosus, expressed in E. coli BL21 (DE3) Codon Plus® cells, was purified by affinity 
column chromatography according to the method described previously.2 Purified yeast 
UGPase was obtained from Sigma (St. Louis, MO) and was used after buffer exchange as 
described previously.12 
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Mass Spectrometry. A Shimadzu LCMS 2010 quadrupole mass spectrometer (Shimadzu 
Scientific Instruments, Columbia, MD) equipped with an electrospray ionization (ESI) 
source was used in negative ion mode. The capillary temperature and the spray voltage 
were kept at 220 °C and 4.5 kV, respectively. The instrument was calibrated by direct 
infusion of polyethylene glycol (PEG) 200, 600, 1000, (1.5 JAL/L, 2 jxL/L, and 15 [xL/L, 
respectively) and raffinose (50 mg/L) in water/methanol (1:1, v:v) containing ammonium 
acetate (0.19 mM), 0.1% formic acid and 0.1% acetonitrile. For sample analysis the 
solvent acetonitrile/water/triethylamine, (35/65/0.2) was constantly infused into the ion 
source at 250 [xL/min by the attached Shimadzu HPLC pump and the samples were 
injected (30 |iL) via the autosampler adapted to fit two 96-well plates. A preliminary MS 
chromatogram was obtained by scanning from 50-700 m/z. To increase the signal to noise 
ratio, the instrument was set for selected ion monitoring (SIM) mode and all relevant m/z 
ions were monitored for further analysis of the enzymatic reactions. Inclusion of an 
Agilent Extend CI8 column (2.1x50 mm, Agilent, Palo Alto, CA) in the system further 
increased the signal to noise ratio and decreased the appearance of sodium ion adducts by 
10-15% without separation of reaction components. Postrun software (LCMS Postrun 
version 2.02, Shimadzu Scientific Instruments, Columbia, MD) was used to analyze the 
data from the ESI-MS chromatogram. Peaks were integrated to determine the relative 
intensity of each ion species monitored as compared to an internal standard. 
Sugar nucleotidyltransferase activity screening assay. The enzymatic activity of UGPases 
from P. furiosus and yeast were determined as was described previously by the 
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consumption of glucose-1-phosphate in the direction of UDP-glucose biosynthesis.13 The 
reaction mixture in a total volume of 100 [xL for sugar nucleotidyltransferase substrate 
screening assay consisted of the following components: 
a) Library of sugars containing eight substrates (5 mM for each, except for GlcNAclP 
and NeuAc, for which 1 and 2 mM concentrations were used respectively). 
b) NTP (ATP/CTP/GTP/dTTP/CTP) (5 mM). Each NTP was used independently in a 
separate reaction. 
c) Inorganic pyrophosphatase (0.2U/mL). 
d) MgCla (3 mM for P. furiosus enzyme and 10 mM for yeast enzyme and E. coli 
extract. 
e) Buffer (25 mM, Phosphate buffer pH 7.5 for P.furiosus enzyme and Tris-HCl pH 
7.6 for the other enzyme or extract). 
f) Appropriate concentration of purified enzyme or cell extract. 
For the control reaction, nanopure water was used instead of an enzyme or cell extract. 
The reaction components were preincubated at the appropriate temperature (90 °C for the 
P. furiosus enzyme; 37 °C for yeast and E. coli) for 5 min before addition of the sugar 
substrate library. Fifteen (15) |xL of the reaction mixture was quenched by the addition of 
70% methanol/water (30 |xL). The quenched solutions were centrifuged for 10 min at 
10,000 x g to precipitate the protein. Aliquots of the reaction mixtures were diluted with 
135 |iL of acetonitrile/water/triethylamine (35/65/0.2). These samples (5 |xL) were 
subjected to analysis via ESI-MS to detect the formation of NDP-sugars in comparison 
to a control reaction containing no enzyme. 
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Table SI. NDP-sugars formed after 30 min incubation of the sugar substrate library with 
individual nucleotide triphosphates (NTP) and the specified enzyme or cell extracts. Nd= 
No product was detected. 
Source of ATP product (m/z) CTP product GTP product dTTP product (m/z) UTP product (m/z) 
enzyme (m/z) (m/z) 
E. coli extract ADP-GlcN (587) 
ADP-Man (588) 
ADP-Gal (589) 
ADP-Glc (590) 
Nd GDP-Fuc (588) dTDP-Glc (565) UDP-Xyl (535) 
UDP-Fuc (549) 
UDP-Man (565) 
UDP-Gal (566) 
UDP-Glc (567) 
UDP-GlcNAc (606) 
P. furiosus Nd Nd Nd dTDP-Man (563) 
dTDP-Gal (564) 
dTDP-Glc (565) 
UDP-Xyl 
UDP-Fuc 
UDP-GlcN (558) 
dTDP-GlcNAc (604) UDP-Man 
Nd UDP-Gal 
UDP-Glc 
UDP-GlcNAc 
UDP-Glc 
Yeast ADP-Glc Nd Nd 
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Table S2. The m/z ratio of the sugar-1-phosphate library and their corresponding products 
after reaction with various nucleotide triphosphates (NTPs). 
Sugar-1 -phosphate ATP CTP GTP dTTP UTP 
XyloselP (229) 1 558 534 574 533 535 
FucoselP (243) 2 572 548 588 547 549 
GlcNIP (258) 3 587 563 603 562 564 
ManlP (259) 4 588 564 604 563 565 
Deu-GallP (260) 5 589 565 605 564 566 
Deu2-GlclP (261) 6 590 566 606 565 567 
GlcNAclP (300) 7 629 605 645 604 606 
Sialic acid (308) 8 716 613 732 692 694 
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Synthetic Procedures. 
D 
COOH 
Bnol OMe 
10 
Methyl-2,3,4-tri-0-benzyl-a-D-(6,6-2H2)glucopyranoside14 
To a solution of compound 93 (0.50 g, 1.04 mmol) in Et20 (15 mL) was added a solution 
of lithium aluminum deuteride (43.0 mg) at ambient temperature for 2 h. The mixture was 
diluted with Et20 (2 x 50 mL), acidified with 2 N HCl (2 x 45 mL), and washed with water 
(2 x 50 mL). The solvent was removed under reduce pressure. The residue was purified by 
silica gel column chromatography (ethyl acetate/hexane, 1/1, v/v) to afford 10 as a syrup 
(0.48 g, 1.03 mmol, 98%) 
R/0.72 (ethyl acetate/hexane, 1/1 v/v). 
MS (ESI) m/z = 489 [M+Na]+; *H NMR and 13C NMR spectra match those previously 
reported.3 
Methyl-2,3,4,6-tetra-0-benzyl-a-D-(6,6-2H2)glucopyranoside 
Sodium hydride (27.0 mg, 1.13 mmol) was slowly added into a solution of compound (10, 
0.44 g, 0.94 mmol) in DMF (30 mL) at ambient temperature. Benzyl bromide (0.14 mL, 
1.13 mmol) was added to the solution. The mixture was stirred at ambient temperature for 
10 11 
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4 h, diluted with ethyl acetate (60 mL), and then washed with water (3 x 40 mL) and 
saturated aqueous sodium bicarbonate (15 mL). The solution was dried over magnesium 
sulfate. The solvent was removed under reduced pressure. The product was isolated by 
silica gel column chromatography (ethyl acetate/hexane, 7/3, v/v) to afford 11 as the white 
solid (0.47 g, 0.86 mmol, 89%). 
R/0.72 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) Ô 7.48-7.81 (m, 20H), 4.99 (d, 1H, J= 10.8 Hz, PhCH), 4.83 
(d, 1H, J = 4.0 Hz, PhCH), 4.80 (m, 2H, PhCH2), 4.69 (m, 2 H, PhCH2), 4.63 (d, 1H, J = 
3.6 Hz, CrH), 4.48 (m, 2H, PhCH2), 4.60 (m, 2 H), 4.50 (d, 1H, J = 4.0 Hz), 3.99 (t, 1H, J 
= 9.2 Hz, C3-H), 3.75 (d, 1H, J = 10.0 Hz, C5-H), 3,65 (t, 1H, J = 10.0 Hz, C4-H), 3.55 (dd, 
1H, 7=9.6, 3.6 Hz, C2-H), 3.38 (s, 3H, -OCH3). 
13C NMR (100 MHz, CDC13) 5 138.9, 138.4, 138.3, 138.0, 128.5, 128.5, 128.4, 128.2, 
128.1, 128.0, 127.9, 127.9, 127.8, 127.8, 127.7, 127.7, 98.3 (CO, 82.2 (C3), 79.7 (C2), 77.7 
(C4), 75.9 (PhCH2), 75.1 (PhCH2), 73.5 (PhCH2), 73.5 (PhCH2), 70.0 (C5), 55.3 (-OCH3). 
MS (ESI) m/z = 579 [M+Na]+ 
11 
BnO 
Brti 
12 
2,3,4,6-tetra-0-benzyl-a/p-D-(6,6-2H2)glucopyranose 
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Compound 11 (0.4 g, 0.7 mmol) was treated with glacial acetic acid (25 mL) and 3.0 M 
sulfuric acid (0.7 mL) at 85 °C for 1.5 h. The mixture was cooled to ambient temperature 
and then diluted with ice water (45 mL), extracted with toluene (50 mL), and then washed 
with saturated aqueous sodium bicarbonate (3 x 25 mL), water (2 x 30 mL), and brine (30 
mL). The solvent was removed under reduced pressure. The product was isolated by silica 
gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 12 as a white solid 
(0.33 g, 0.68 mmol, 84%). 
R/0.46 (ethyl acetate/hexane, 2/3 v/v). 
1H NMR (400 MHz, CDC13) 8 7.41-7.20 (m, 40 H), 5.27 (d, 1 H, J= 2.8 Hz), 4.99 (m, 3 
H), 4.86 (m, 4 H), 4.74 (m, 3 H), 4.60 (m, 3 H), 4.52 (m, 3 H), 4.10 (dd, 2 H,J= 20.8, 10.0 
Hz), 3.80 (s, 1H), 3.62 (m, 4 H), 3.44 (m, 1 H). 
13C NMR (100 MHz, CDC13) 6 138.8, 138.6, 138.5, 138.3, 138.1, 138.0, 137.9, 137.8, 
128.6, 128.5, 128.5, 128.5, 128.2, 128.1, 128.1, 128.1, 128.0, 128.0, 128.0, 127.9, 127.8, 
127.8, 127.8, 127.8, 127.7, 97.6, 91.3, 84.7, 83.2, 81.8, 80.0, 77.9, 77.9, 75.8, 75.8, 75.1, 
75.1,74.8,74.5, 73.4,73.2,70.1. 
MS (ESI) m/z = 542 [M]+ 
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Dibenzyl-(2,3,4,6-tetra-0-benzyl-a-D-(6,6-2H2)glucopyranosyl) phosphate 
The compound of 2,3,4,6-tetra-0-benzyl-6-dideuterium-a-D-glucopyranose (0.30 g, 0.55 
mmol) in dichloromethane (4 mL) was added to a mixture of dibenzyl N,N-
diisopropylphosphoramidite (0.25 mL) and AT-phenyl imidazolium triflate (0.21 g) in 
anhydrous acetonitrile-dichloromethane (1:1) (8 mL). The TLC showed no starting 
material left (Rf 0.75, ethyl acetate/hexane, 1/1, v/v) and then the mixture was cooled down 
to -50 °C. 3-chloroperoxybenzoic acid (0.15 g) in anhydrous dichloromethane (5 mL) was 
added. The resulting solution was stirred at 0 °C for 30 min. The mixture was diluted with 
30 mL CH2CI2, 40 mL 20% NazSOg solution was added and the stirred at ambient 
temperature for 3 h. Organic layer was washed with saturated NaHC03 (3x 30 mL), water 
(3 x 30 mL), brine (40 mL) and dried over magnesium sulfate. The product was isolated by 
silica gel column chromatography (chloroform/diethylether, 9/1, v/v) to afford the desired 
phosphate (13) as a white solid (0.29 g, 0.36 mmol, 65%). The (3 anomer could also be 
isolated (0.12 g, 0.15 mmol, 27%). 
R/0.32 (chloroform/diethylether, 9/1 v/v). 
1H NMR (400 MHz, CDC13) 5 7.41-7.20 (m, 30 H), 6.05 (dd, 1 H, /= 6.4, 3.2 Hz), 5.11 
(m, 4  H) ,  4 .99  (dd ,  2H,  J  =  23 .2 ,  19 .6  Hz) ,  4 .86  (dd ,  2H,  J  =  9 .2 ,  5 .2  Hz) ,  4 .71  (d ,  1  H , /  =  
7.6 Hz), 4.58 (dd, 2 H, J = 17.2, 10.8 Hz), 4.49 (d, 1 H,/ = 12.4 Hz), 3.99 (dd, 2 H, J = 
9.6,9.6 Hz), 3.77 (t, 1 H, J = 9.6 Hz), 3.70 (m, 1 H). 
13C NMR (100 MHz, CDC13) 6 137.9, 137.7, 136.0, 136.0, 135.9, 135.9, 128.8, 128.7, 
128.6, 128.6, 128.5, 128.5, 128.3, 128.2, 128.1, 128.1, 128.0, 128.0, 128.0, 127.9, 127.9, 
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127.8, 127.8, 127.7, 127.6, 127.5, 127.0, 95.8 (d, Jc? = 6.0 Hz), 81.2, 79.4, 79.4, 75.8, 
75.3,73.6, 73.5, 73.2,72.7,72.6, 69.5,69.4,69.4,69.4, 69.3, 69.2,68.1, 67.4, 67.4, 65.1. 
MS (ESI) m/z = 825 [M+Na]+ 
Disodium a-D-(6,6-2H2)glucopyranosyl phosphate 
A solution of 13 (0.30 g, 0.38 mmol) in MeOH (15 mL) was stirred with 20 wt. % 
palladium hydroxide on carbon (80.0 mg) and saturated aqueous sodium bicarbonate (3 
mL) under atmospheric H2 (gas) at ambient temperature overnight. The mixture was 
filtered over Celite and the filtrate was concentrated under reduced pressure to afford 6 as 
a white solid (0.11 g, 0.37 mmol, 98%). 
R/0.13 (methanol/ethyl acetate/hexane, 5/1/1 v/v). 
1H NMR (400 MHz, D20) 6 5.28 (dd, 1 H,/ = 7.2, 3.2 Hz), 3.74 (d, 1 H,/= 10.0 Hz), 
3.61 (t, 1 H, 7 = 9.6 Hz), 3.35 (m, 1 H), 3.24 (t, 1 H, J = 9.6 Hz). 
13C NMR (100 MHz, D20) Ô 93.5 <d, JCP = 5.2 Hz), 73.0, 72.0, 71.9, 71.8,69.6. 
31P NMR (162 MHz, D20) Ô 2.78 
MS (ESI) m/z = 239 [M-Na]' 
OBn ONa 
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BnO nu 
BnO 
BnO OMe 
14 
Methyl-2,3,4-tri-0-benzyl-6-aldehyde-(x-D-galactopyranoside15 
To a solution of 14 (0.78 g, 1.69 mmol) in CH2C12 (15 mL) was added a solution of Dess-
Martin periodinane (0.86 g) with stirring for 30 min. The reaction mixture was diluted with 
diethyl ether (40 mL) and added sodium thiosulfate (8 mL) in saturated aqueous sodium 
bicarbonate. The layers were separated, and the organic phase was washed sequentially 
with saturated aqueous sodium bicarbonate (2 x 35 mL) and water (2 x 35 mL), and 
extracted with diethylether (2 x 40 mL). The combined organic phases were dried over 
magnesium sulfate to provide the crude aldehyde (15) which was carried on directly 
without further purification (0.78 g, 1.7 mmol, quantitative). 
R/0.64 (ethyl acetate/hexane, 3/7 v/v). 
MS (ESI) m/z = 485 [M+Na]+; *H NMR and 13C NMR spectra match those previously 
reported. 
15 16 
Methyl-2,3,4-tri-0-benzyl-a-D-(6-2Hi)galactopyranoside 
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To a solution of compound 15 (0.50 g, 1.04 mmol) in Et20 (15 mL) was added a solution 
of lithium aluminum deuteride (43.0 mg) at ambient temperature for 2 h. The mixture was 
diluted with Et20 (2 x 50 mL), acidified with 2 N HCl (2 x 45 mL), and washed with water 
(2 x 50 mL). The solvent was removed under reduce pressure. The residue was purified by 
silica gel column chromatography (ethyl acetate/hexane, 1/1, v/v) to afford 16 as a syrup 
(0.48 g, 1.0 mmol, 98%) 
Rf 0.72 (ethyl acetate/hexane, 1/1 v/v). 
1H NMR (400 MHz, CDC13) 8 7.51-7.34 (m, 15 H), 5.02 (d, 1 H, J= 11.2 Hz), 4.99 (dd, 
2H, J = 18.4, 12.0 Hz), 4.75 (m, 2H), 4.66 (dd, J = 25.6, 12.4 Hz), 4.11 (dd, 1 H, J = 10.0, 
3.6 Hz), 3.95 (dd, 1H, J = 10.0, 3.2 Hz), 3.88 (d, 1 H, J = 2.4 Hz), 3.67 (m, 1 H), 3.49 (m, 
1H), 3.36 (s, 3H), 2.03 (s, 1 H). 
13C NMR (100 MHz, CDC13) 8 138.8, 138.5, 138.4, 128.6, 128.5, 128.5, 128.5, 128.2, 
128.2, 128.0, 127.9, 127.8, 127.7, 127.7, 98.9, 79.2, 76.6, 75.3, 75.2, 74.6,73.6, 73.6, 70.5, 
62.0(m), 55.4. 
MS (ESI) m/z = 488 [M+Na]+ 
16 17 
Methyl-2,3,4,6-tetra-0-benzyl-a-D-(6-2H1)galactopyranoside 
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Sodium hydride (0.04 g, 1.8 mmol) was slowly added into a solution of a compound (16, 
0.72 g, 1.56 mmol) in DMF (30 mL) at ambient temperature. Benzyl bromide (0.22 mL, 
1.8 mmol) was added to the solution. The mixture was stirred at ambient temperature for 4 
h under N2, diluted with ethyl acetate (60 mL), and then washed with water (3 x 40 mL) 
and aqueous saturated sodium bicarbonate (35 mL). The solution was dried over 
magnesium sulfate. The solvent was removed under reduced pressure. The product was 
isolated by silica gel column chromatography (ethyl acetate/hexane, 7/3, v/v) to afford 17 
as a solid (0.78 g, 1.4 mmol, 90%). 
R/0.71 (ethyl acetate/hexane, 1/1 v/v). 
1H NMR (400 MHz, CDC13) Ô 7.44-7.24 (m, 20 H), 5.10 (d, 1 H, J= 11.6 Hz), 4.88 (dd, 
2H, J = 11.6,6.8 Hz), 4.75 (dd, 2H, J = 18.4, 12.0 Hz), 4.73 (d, J = 3.2 Hz), 4.63 (t, 1H, J 
= 14.0 Hz), 4.45 (dd, 2 H, / = 34.0, 11.6 Hz), 4.08 (dd, 1 H, J = 10.0, 3.6 Hz), 3.98 (m, 2 
H), 3.92 (d, 1H, J = 6.4 Hz), 3.54 (m, 1 H), 3.40 (s, 3H). 
13C NMR (100 MHz, CDC13) ô 128.9, 138.8, 138.6, 138.1, 128.5, 128.5, 128.4, 128.4, 
128.3, 128.2, 128.2, 127.9, 127.9, 127.8, 127.8, 127.8, 127.7, 127.7, 127.6, 98.9, 79.2, 
76.6, 75.3, 74.8,73.7, 73.6, 73.4,73.2, 69.3, 69.2(m), 55.5. 
MS (ESI) m/z = 578 [M+Na]+ 
17 
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2,3,4,6-tetra-0-benzyl-a-D-(6-2H1)galactopyranose 
Compound 17 (0.4 g, 0.72 mmol) was treated with glacial acetic acid (25 mL) and 3.0 M 
sulfuric acid (0.7 mL) at 85 °C for 1.5 h. The mixture was cooled to ambient temperature 
and then diluted with ice water (45 mL), extracted by toluene (50 mL) and then washed 
with saturated aqueous sodium bicarbonate (3 x 25 mL), water (2 x 30 mL), and brine (30 
mL). The solvent was removed under reduced pressure. The product was isolated by silica 
gel column chromatography (ethyl acetate/hexane, 2/3, v/v) to afford 18 as a white solid 
(0.33 g, 0.68 mmol, 84%). 
R/0.68 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) Ô 7.51-7.34 (m, 20 H), 5.31 (d, 1 H, J= 3.6 Hz), 4.99 (dd, 
2H, J = 13.2, 2.4 Hz), 4.86 (m, 2H), 4.74 (m, 2 H), 4.62 (m, 2H), 4.49 (d, 1 H, 7= 11.6,4.8 
Hz), 4.40 (dd, 1 H, J = 16.4, 7.6 Hz), 4.20 (d, 1 H, J = 6.0 Hz), 4.07 (dd, 1 H,/= 9.6, 3.6 
Hz), 3.99 (m, 2H), 3.80 (m, 1 H), 3.56 (m, 1 H), 3.47 (d, 1 H, J = 6.4 Hz). 
13C NMR (100 MHz, CDC13) ô 138.8, 138.6, 138.5, 138.3, 138.1, 138.0, 137,9, 137.8, 
128.5, 128.5, 128.5, 128.4, 128.4, 128.4, 128.3, 128.1, 128.1, 127.9, 127.8, 127.8, 127.7, 
127.7, 127.6, 127.6, 127.6, 127.0, 97.9, 91.9, 82.3, 80.8, 78.9, 76.9, 76.7, 75.2, 74.9, 74.8, 
74.6, 73.7, 73.6, 73.5, 73.4, 73.1, 73.0, 69.4, 69.3(m). 
MS (ESI) m/z = 541 [M]+ 
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Dibenzyl-(2,3,4,6-tetra-0-benzyl-a-D-(6-2Hi)galactopyranosyl) phosphate 
The compound of 2,3,4,6-tetra-0-benzyl-6-deuterium-a-D-galactopyranose (0.32 g, 0.59 
mmol) in acetonitrile (4.0 mL) was added to a mixture of dibenzyl N,N-
diisopropylphosphoramidite (0.35 mL) and /V-phenyl imidazolium triflate (0.33 g) in dry 
acetonitrile (8.0 mL). After the TLC showed no remaining starting material (Rf 0.75, ethyl 
acetate/hexane, 1/1, v/v), the solvent was evaporated under reduced pressure and then a 
solution of 3-chloroperoxybenzoic acid (0.13 g, 0.76 mmol) in dichloromethane (15 mL) 
was added to the mixture at -50 °C. The resulting solution was stirred at 0 °C for 30 min. 
The mixture was diluted with CH2C12 (30 mL), treated with a 20% Na2S03 solution (40 
mL), and then stirred at ambient temperature for 3 h. The organic layer was washed with 
saturated NaHC03 (3 x 30 mL), water (3 x 30 mL), and brine (40 mL) and then dried over 
magnesium sulfate. The product was isolated by silica gel column chromatography 
(chloroform/diethylether, 9/1, v/v) to afford the desired phosphate 19 as a white solid (0.21 
g, 0.27 mmol, 46%). The (3 anomer could also be isolated (0.20 g, 0.25 mmol, 42%). 
R/0.34 (chloroform/diethylether, 9/1 v/v). 
1H NMR (400 MHz, CDC13) 6 7.46-7.19 (m, 30 H), 5.98 (dd, 1 H, J = 6.4, 3.2 Hz), 5.07 
(m, 6 H), 4.75 (m, 4 H), 4.55 (d, 1 H, 7= 11.2 Hz), 4.34 (dd, 2H, J = 23.2, 11.6 Hz), 4.14 
(m, 2 H), 3.98 (m, 1H), 3.87 (dd, 1 H, J = 10.0, 2.8 Hz), 3.51 (d, 1 H, J= 7.2). 
13C NMR (100 MHz, CDC13) 6 138.5, 138.4, 138.1, 137.8, 135.9, 135.9, 128.6, 128.5, 
128.5, 128.4, 128.3, 128.3, 128.3, 128.2, 128.1, 128.0, 127.8, 127.7, 127.7, 127.6, 127.5, 
96.8 (d, JCp = 6.2 Hz), 78.1, 75.8, 75.7, 74.9, 74.6, 73.4, 73.3, 73.0, 71.5, 69.3, 69.3, 69.2, 
69.2,69.0, 69.0. 
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MS (ESI) m/z = 824 [M+H]+ 
Bi 
19 OBn 
H 
ONa 
Disodium a-D-(6-2Hi)galactopyranosyl phosphate 
A solution of 19 (0.20 g, 0.25 mmol) in MeOH (15 mL) was stirred with 20 wt. % 
palladium hydroxide on carbon (0.08 g) with saturated sodium bicarbonate (3 mL) under 
atmospheric H2 (gas) at ambient temperature overnight. The mixture was filtered over 
Celite and the filtrate was concentrated under reduced pressure to afford 5 as a white solid 
(65 mg, 0.25 mmol, 99%). 
R/0.14 (methanol/diethylether/hexane, 5/1/1 v/v/v). 
1H NMR (400 MHz, D20) 8 5.35 (dd, 1H, J = 7.2, 3.6 Hz), 4.04 (d, 1H, J = 4.8 Hz), 3.85 
(d, 1H, J= 3.2 Hz), 3.78 (m, 1 H), 3.63 (m, 1H), 3.57 (d, 1H, J = 4.0 Hz). 
13C NMR (100 MHz, DzO) 8 93.7 (d, JcP = 5.5 Hz), 71.0, 69.6, 69.4, 69.0, 68.9,61.8(m). 
31P NMR (162 MHz, D20) 8 2.92. 
MS (ESI) m/z = 238 [M-Na]" 
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BnO-\—°x 
BnO-*—V% O 
BnO o-P-OBn 
OBn 
Dibenzyl-(2,3,4-tri-0-benzyl-o/p-D-xylopyranosyl) phosphate 
The compound 2,3,4-tri-O-benzyl-a/p-D-xylopyranose1 (81.7 mg, 0.2 mmmol) in 
acetonitrile (4 mL) was added to a mixture of dibenzyl diisopropyl phosphoramidite 
(0.087mL) and /V-phenyl immidazolium triflate (60.5 mg) in anhydrous acetonitrile (8 
mL). When the tic showed no remaining starting material (Rf 0.75, ethyl acetate/hexane, 
1/1, v/v ), the solvent was removed under reduced pressure. Then 3-chloroperoxybenzoic 
acid (43.7 mg, 0.25 mmol) was added to the solution of the mixture in 15 mL 
dichloromethane at -50 °C and the resulting solution was stirred at 0 °C for 30 min. The 
mixture was diluted with CH2C12 (30 mL). 20 % aqueous Na2S03 (40 mL) solution was 
added and the mixture was stirred at room temperature for 3 h. The organic layer was 
washed with saturated aqueous NaHC03 (3 x 30 mL), water (3 x 30 mL), and brine (40 
mL) and then dried over magnesium sulfate. The product was isolated by silica gel column 
chromatography (chloroform/diethyl ether, 9/1, v/v) to afford 76% of dibenzyl-(2,3,4-tri-
O-benzyl-a/p-D-xylopyranosyl) phosphate as a white solid (51.2 mg, 0.08 mmol, 52% for 
a compound, 47.2 mg, 0.07 mmol, 48% for (3 compound); 
Rf 0.34 (chloroform/ethylether, 2/3 v/v).: H NMR and 13C NMR spectra match those 
previously reported.16 
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MO o-P-O" 
• 
O" 
Disodium a/p-D-xylopyranosyl phosphate 
A solution of dibenzyl-(2,3,4-tri-0-benzyl-a/{3-D-xylopyranosyl) phosphate (80.3 g, 0.12 
mmol) in MeOH (15 mL) was stirred with 20 wt. % palladium hydroxide on carbon (0.08 
g) with saturated sodium bicarbonate (3 mL) under atmospheric H2 (gas) at ambient 
temperature overnight. The mixture was filtered over Celite and the filtrate was 
concentrated under reduced pressure to afford disodium a/{3-D-xylopyranosyl phosphate as 
a white solid (27.1 mg, 0.12 mmol, quantitative). 
R/0.14 (methanol/ethyl ether/hexane, 5/1/1 v/v/v).: H NMR and 13C NMR spectra match 
those previously reported.17 
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CHAPTER 6 
Synthesis of Isobutyl-C-galactoside(IBCG) as an 
Isopropylthiogalactoside(IPTG) Substitute for Increased Induction 
of Protein Expression 
A paper published in the Organic Letter4 
Kwang-Seuk Ko, Jerred Kruse, and Nicola L. Pohl* 
Abstract 
Addition of isopropyl-(3-D-thiogalactopyranoside (IPTG) to bacterial cultures is 
often used to induce expression of plasmid-based genes for the production of recombinant 
proteins under control of the lac promoter, but a simple method to circumvent the inherent 
instability of this compound has not been addressed experimentally. Herein we report the 
first synthesis of isobutyl-C-galactoside (IBCG), the C-glycoside analogue of IPTG, and 
show that IBCG is superior to IPTG in inducing protein expression over long induction 
times. 
Introduction 
Addition of isopropyl-{3-D-thiogalactopyranoside (IPTG) to bacterial cultures is a 
long-standing way to induce expression of plasmid-based genes for the production of 
recombinant proteins under the control of the lac promoter, but is not without its share of 
4 Reproduced with permission of Org. Lett. (2003), 5, 1781-1783. 
Copyright 2003 American Chemical Society. 
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problems.1 The S-glycoside analogue binds to the lac repressor in Escherichia coli, thereby 
preventing binding of the repressor protein to DNA and blocking gene transcription 
(Figure l).2 From the standpoint of experimental practicality, IPTG and its solutions 
should be stored below room temperature to prevent decomposition over time. In addition, 
multiple additions of IPTG are often necessary for longer induction times as the compound 
degrades under culture conditions. A more stable version of IPTG would be desirable to 
circumvent these issues and provide greater control of protein expression, especially over 
long periods of induction. Herein we report the first synthesis of the C-glycoside analogue 
of IPTG and show that it cannot only serve as a functional replacement of IPTG in 
inducing expression of proteins under control of the lac promoter, but it actually appears to 
be superior to IPTG for long induction times. 
lac 
repressor-
inducer 
lac 
repressor gene transcription 
DNA DNA 
Figure 1 Small molecules such as IPTG, ailolactose, and IBCG can bind to the lac 
repressor to allow gene transcription machinery access to DNA for the production of 
proteins. 
Replacement of the C-O anomeric linkage in naturally occurring ^-glycosides with a C-S 
or C-C bond is known to engender hydrolytic stability, providing derivatives capable of 
adopting similar conformations and hence retaining function.3 However, the S-glycosidic 
linkage suffers from its susceptibility to both chemical and enzymatic oxidation and 
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cleavage reactions. The ^-glycoside IPTG serves as an analogue of ailolactose, which is 
formed from lactose in the bacterial cell. Apparently, only the galactose portion of the 
larger carbohydrate is necessary to disrupt the repressor protein/DNA binding interaction. 
Substitution of the 6-OH of galactose with methyl or hydrogen, for instance, destroys its 
induction capabilities.lb In contrast, the sulfur of the galactosidic bond is not implicated in 
a particular binding interaction that would be destroyed in the absence of lone pairs as seen 
by inspection of the recent X-ray structure of the E. coli lac repressor bound to IPTG.4 
Therefore, substitution of the anomeric atom appeared feasible provided the increased 
conformational mobility of the carbon side chain did not interfere with binding or 
significantly diminish cell permeability. 
Synthetic routes to IPTG5 do not lend themselves directly to the synthesis of the C-
glycoside. Fortunately, recent advancements in the synthesis of these types of saccharide 
structures provide many practical options. 
Results and discussion 
Two synthetic routes to the isobutyl-C-galactoside (IBCG, 1) analogue were 
pursued in parallel (Scheme 1). In the first, treatment of galactose pentaacetate 2 with 
methallyltrimethylsilane in the presence of boron trifluoride etherate6 gave a mixture of a 
and (Banomers, which were separated by silica gel column chromatography to provide the 
(3-anomer 3 in 48% yield. While this scheme did provide the desired compound after 
hydrogénation of the alkene and Zemplen deacylation, separation of the anomeric mixture 
was tedious. Alternatively, an approach relying on a Grignard reaction previously applied 
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to glucose derivatives7 was developed. Commercially available bromoacetogalactose8 4 
was treated with excess isobutylmagnesium bromide to provide exclusively the desired {5-
anomer of the C-linked glycoside. A proton-proton COSY NMR spectrum9 confirmed die 
anomeric configuration of the isolated product by evidence of the 9 Hz coupling between 
protons 1 and 2 of the galactose ring. Deprotection of the acetyl groups with sodium 
methoxide resulted in the desired IBCG.9 The latter route easily allowed gram-scale 
synthesis of the analogue. 
Scheme 1. Synthesis of IBCG8 
AcO vOAc melhallyitnmethytstane, AcO -0Ac |A o BF3OB2, CHgClj,. 48% 
AcO-X-^l>OAc • AcO %r 
OAe "9* l-bromo-2-metbyi- QAe AcO y propane, ElgO: AcgO, AcO y 
\ \ , 0  p y r i t s n e ,  6 9 %  L \ _ o  
ACO-A^A AcO^^L^x^ 
5 
NaOMe, 
MeOH, 99% 
1 ) % Pd<OHfeC,MeOH, 97% 
2) NaOMe, MeOH, 99% 
To compare the ability of the C-glycoside to take the place of IPTG in the induction 
of protein expression, assays of promoter activity that rely on production of a fluorescent 
protein were pursued.10"13 Reporters for gene activity in bacteria that rely on green 
fluorescent protein (GFP) and its variants have become very popular as they have been 
141 
validated by direct comparison to traditional reporter assays that use either 
chloramphenicol acetyltransferase10 or (3-galactosidase.11 For bacterial studies, the 
enhanced green fluorescent protein12 (EGFP) is particularly useful as it is not toxic to E. 
coli like the wild-type GFP itself and the protein folds and autocatalyzes formation of its 
fluorophore with a half-Ufe of less than 45 min rather than hours. Therefore, the gene for 
EGFP (BD Biosciences) was ligated into a pET vector plasmid, using Ncol and EcoRI to 
have control of EGFP protein expression with a lac promoter system and to have low 
background protein expression levels. This plasmid was transformed into E. coli BL21 
DE(3) cells for protein expression studies. The cells were grown to an optical density of 
0.7 (at 600 nm) and then protein production was induced with either IBCG or IPTG. The 
fluorescence emission at 507 nm after excitation at 488 nm, normalized for the number of 
cells, was plotted as a function of time (Figure 2) as previously reported.13 As expected, in 
the absence of IBCG and IPTG, the culture showed no activity at the lac promoter. In 
contrast, EGFP fluorescence was considerably larger among induced cells in the presence 
of IBCG or IPTG. After induction times of greater than 4 h, the IBCG induced cells show 
even greater fluorescence than the IPTG induced cells. This surprising result suggests that 
the C-glycoside analogue may act as a superior promoter or that it is more stable in the 
culture conditions over time. 
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Figure 2 Comparison of the expression of the enhanced green fluorescent protein under lac 
promoter control in BL21 DE(3) cells over time by the increase of fluorescence emission 
(at 507 nm after excitation at 488 nm) corrected for cell densities: blank, uninduced cells; 
IPTG, addition of 5.78 mM final concentration of IPTG; and IBCG, addition of 5.78 mM 
final concentration of IBCG. Experiments were run in duplicate. Rlu = relative light units. 
Conclusion 
Clearly, the more stable C-glycoside analogue IBCG serves as a surrogate for the 
commonly used inducer of protein expression IPTG and shows advantages at long 
induction times. In addition, solutions of the analogue do not need to be made as frozen 
aliquots, but can be autoclaved in water and stored at room temperature for ready addition 
of the inducer to cell cultures. The latter property is especially valuable for small-scale 
culture induction and for cases in which a more precise concentration of inducer is 
desirable. These results and the earlier X-ray structural work are both consistent with the 
supposition that the anomeric linkage of the natural inducer allolaetose does not form any 
critical binding interactions with the lac repressor protein. In addition, the C-glycoside 
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retains cell permeability. This work suggests that, in studies on biological systems 
dependent on (^-glycosides, lone pairs in the glycosidic linkage are not necessarily 
required and the C-glycosides may offer distinct advantages beyond stability over S-
glycosides in mimicking carbohydrate activities and functions. 
Experimental Section 
General methods: Reaction solvents were distilled from calcium hydride for 
dichloromethane and from sodium metal and benzophenone for diethyl ether. Amberlyst 
15 ion-exchange resin was washed repeatedly with methanol before use. The Grignard 
reaction was performed in oven-dried glassware. The 1-bromo-a-D-galactose-tetraacetate 
was dissolved in anhydrous toluene and the solvent was removed under reduced pressure; 
the sample was then dried under high vacuum for 3 days. All other commercial reagents 
and solvents were used as received without further purification. The reactions were 
monitored and the Rf values determined using analytical thin layer chromatography (tic) 
with 0.25 mm EM Science silica gel plates (60F-254). The developed tic plates were 
visualized by immersion in p-anisaldehyde solution followed by heating on a hot plate. 
Flash chromatography was performed with Selecto Scientific silica gel, 32-63 ^im particle 
size. All moisture-sensitive reactions were performed in flame- or oven-dried glassware 
under a nitrogen atmosphere. Bath temperatures were used to record the reaction 
temperature in all cases. All reactions were stirred magnetically at ambient temperature 
unless otherwise indicated. *H NMR and 13C NMR spectra were obtained with a Bruker 
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DRX400 at 400 MHz and 100 MHz respectively. 'H-'H correlation experiments were 
obtained with a Bruker Advance DRX500. 
1-isobutyl-/3-D-galactose tetraacetate (5): Magnesium turnings (4.2 g) were suspended in 
diethyl ether (45 mL) and then initiated with a crystal of 1%. 1 -Bromo-2-methylpropane 
(1.37 mL, 12 mmol) was then added to the magnesium suspension. The mixture turned a 
cloudy white after the flask was heated with a heat gun. A solution of 1-bromo-a-D-
galactose tetraacetate 4 (4.307 g, 10.5 mmol) in diethyl ether (10 mL) was added dropwise 
into the Grignard reaction mixture. The reaction went to completion after the mixture was 
heated at reflux for 4 h. The mixture was slowly poured into water (300 mL). Glacial 
AcOH (11 mL) was added. The mixture was separated and the aqueous layer was 
concentrated. The residue was treated with acetic anhydride (150 mL) and pyridine (150 
mL) overnight. The resulting mixture was diluted with water (300 mL), extracted with 
diethyl ether (3 x 250 mL), washed with water (2 x 150 mL), and dried with magnesium 
sulfate. The solvent was removed under reduced pressure. The product was purified by 
flash chromatography (silica gel, 2:3 ethylacetate/hexane) to afford 5 as a white solid (2.80 
g, 7.24 mmol, 69%). 
4 5 
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OAc f OAc / 
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1 -isobutyl-/3-D-galactose tetraacetate (5): A solution of 3 {0.90 g, 2.3 mmol) in MeOH 
(15 mL) was stirred with 20 wt. % palladium hydroxide on carbon (0.08 g) under 
atmospheric H2 at ambient temperature for 5 h. The mixture was filtered over Celite Mid 
the filtrate was concentrated under reduced pressure to afford 5 as a white solid (0.90 g, 
2.3 mmol, 97%). 
Rf 0.35 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) 5 5.36 (d, 1 H, J = 3.2 Hz, H-4), 5.01 (dd, 1 H, h = 8.0 Hz, 
J2 = 8.8 Hz, H-2), 4.96 (dd, 1 H, Jx = 3.2 Hz, J2 = 8.0 Hz, H-3), 4.10 (dd, 1 H, Jx = J2 = 6.8 
Hz, H-6), 3.99 (dd, 1 H, Jx = 4.8 Hz, J2 = 6.4 Hz, H-6), 3.79 (m, 1 H, H-5), 3.39 (dd, 1 H, 
J\ = 9.0 Hz, J2 = 2.0 Hz, H-l), 2.11 (s, 3 H, acyl), 2.00 (s, 3 H, acyl), 1.98 (s, 3 H, acyl), 
1.94 (s, 3 H, acyl), 1.78 (m, 1 H, H-2'), 1.48 (m, 1 H, H-l'), 1.14 (m, 1 H, H-l'), 0.83 <2 d, 
6 H, J = 5.1 Hz, H-3', H-4'). 
13C NMR (100 MHz, CDC13) S 170.7, 170.6, 170.4, 170.1, 74.4, 72.5, 70.0, 68.0, 66.5, 
61.9,40.4, 24.5, 23.7, 21.7, 21.1, 20.9, 20.9, 20.8. 
MS (EIMS) m/z 389 [M+H]+ 
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1-(2'-methylallyl)-/3-D-galactose tetraacetate (3): To solution of (3-D-galactose-
pentaacetate (2.02 g, 5.18 mmol) in dichloromethane (60 mL) was added methallyl-
trimethylsilane (2.66 g, 20.7 mmol) followed by slow addition of Bp3eEt20 (1.64 mL) into 
the solution at -20 °C. The mixture was stirred under N2 overnight. The reaction was 
poured into a saturated solution of NaHCOg. The product was extracted with 
dichloromethane (3 x 60 mL) and the solvent was removed under reduced pressure. The 
product was purified by flash chromatography (silica gel, ethyl acetate/hexane gradient) to 
yield a white solid (0.96 g, 2.5 mmol, 48%). 
R/ 0.23 (ethyl acetate/hexane, 3/7 v/v). 
1H NMR (400 MHz, CDC13) 6 5.38 (dd, 1 H, J=1.2 Hz, H-4), 5.08 (t, 1 H, Jx =9.9 Hz, J2 = 
6.9 Hz, H-2), 4.99 (dd, 1 H/i = J2 = 3.6 Hz, H-3), 4.73 (d, 2 H, J = 17.1 Hz, H-3'), 4.11 
(m, 1 H, H-6), 4.01 (dd, 1 H, Jx = J2 = 6.6 Hz, H-6), 3.82 (t, 1 H,J = 5.7 Hz, H-5), 3.54 <m, 
1 H, H-l), 2.19 (m, 2 H, H-l'), 2.13 (s, 3 H, acyl), 2.03 (s, 3 H, acyl), 2.01 (s, 3 H, acyl), 
1.96 (s, 3 H, acyl), 1.70 (s, 3 H, H-4'). 
13C NMR (100 MHz, CDC13) 5 170.6, 170.5, 170.4, 170.0, 141.6, 112.9, 77.3, 74.3, 72.4, 
69.7, 68.0,61.8,40.4, 23.0, 21.2, 21.1, 20.9, 20.8. 
AcO y°Ac 
AcO 
OAc 
3 
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AcO HO 
5 
1-isobutyl-fi-D-galactose (1): 1 -isobutyl-(3-D-galactose tetraacetate 5 (1.21 g, 3.1 mmol) 
in MeOH (30 mL) was stirred with NaOH (0.22 g) at room temperature for 1.5 h. 
Amberlyst 15 ion-exchange resin was added to neutralize the solution. The mixture was 
filtered over Celite and methanol was evaporated under reduced pressure to afford 1 as a 
white solid (0.68 g, 3.1 mmol, 99%). 
Rf 0.28 (methanol/ethyl acetate/hexane, 1/5/5 v/v/v). 
1H NMR (400 MHz, D20) 5 3.76 (d, 1 H, J = 4.4 Hz, H-4), 3.51 (m, 2 H, H-2, H-3), 3.41 
(m, 1 H, H-5), 3.42 (m, 2 H, H-6), 3.25 (m, 1 H, H-l), 1.70 (m, 1 H, H-2'), 1.30 (m, 1 H, 
H-l'), 1.27 (m, 1 H, H-l'), 0.75 (dd, 6 H, Jx = J2 = 2.4 Hz, H-3', H-4'). 
13C NMR (100 MHz, D20) 5 78.4,78.2, 74.1,71.5,69.2,61.3,40.2, 23.9, 23.2, 20.9. 
MS (EIMS) m/z 221 [M+H]+ 
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CHAPTER 7 
Conclusions and Future Directions 
In this dissertation, the solution, solid-phase, and fluorous-phase synthesis of 
carbohydrates has been studied with applications in biology. We developed the new 
nitrophthalimidobutyric (NPB) acid protecting group to allow coloiimetric monitoring of 
glycosylation/deprotection cycles. Although the NPB group overcame the reaction 
monitoring problem, the solution phase synthesis of oligosaccharides using a fluorous tag 
proved superior as it allowed the use of equivalent donor to acceptor group instead of a 
large excess of the donor. This new fluorous tag-assisted solution phase strategy allows the 
rapid, and potentially automated, modular synthesis of carbohydrates and also their use in 
forming microarrays. A fluorous-based microarray method facilitates the formation of a 
range of carbohydrate chips for the plant and other sciences using synthetic sugars 
produced with the aid of fluorous-tagged synthesis. Ultimately, automation of the fluorous-
phase synthesis protocols initially developed here will allow full exploitation of the power 
of the new fluorous-based microarray technology. In future work, these new techniques 
should be easily applicable to study biological systems including vaccine development, 
cancer drug development, and other compound microarrays. 
In addition, we demonstrated that sugar nucleotidyltransferases could make use of 
not only differences in substrate binding affinity, but also kinetic differences in 
discriminating among carbohydrate substrates. Chemoenzymatic reactions might benefit 
from an increase in enzyme concentration rather than substrate concentration to increase 
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product yields. Sugar nucleotidyltransferases also provided means for the facile 
chemoenzymatic synthesis of carbocyclic versions of activated sugars. Further work 
should include studies of the effects of this substitution on the conformations and 
properties of carbasugars and cocrystallization studies with glycosyltransferases and their 
respective glycosyl acceptors. In addition, combinations of this enzymatic work with the 
fluorous-phase work should be promising. 
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Figure SI. ESI-MS monitoring of the reactants and products in presence or absence of E. 
coli K12 cell extract with UTP. A. Reaction at 0 min; B, control (without cell extract) after 
30 min; C, reaction after 30 min. 1, xylose-1-phosphate; 2, fucose-1 -phosphate; 3, 
glucosamine-1 -phosphate; 4, mannose- 1-phosphate; 5, galactose- 1-phosphate; 6, glucose-1-
phosphate; 7, A/-acetylglucosamine 1-phosphate; 8, sialic acid; 9, AMP; 10, UTP; 11, UDP-
xylose; 12, UDP-fucose; 13, UDP-glucosamine; 14, UDP-mannose; 15, UDP-galactose; 16, 
UDP-glucose and 17, UDP-AZ-acetylglucosamine. Products of the reactions are indicated in 
Table SI. 
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Figure S2. ESI-MS monitoring of the reactants and products in presence or absence of E. 
coli K12 cell extract with ATP. A, Reaction at 0 min; B, control (without cell extract) after 
30 min; C, reaction after 30 min. 1, xylose- 1-phosphate; 2, fucose-1 -phosphate; 3, 
glucosamine- 1-phosphate; 4, mannose-1 -phosphate; 5, galactose-1 -phosphate ; 6, glucose-1-
phosphate; 7, N-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, ATP. Products of 
the reactions are indicated in Table SI. 
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Figure S3. ESI-MS monitoring of the reactants and products in presence or absence of E. 
coli K12 cell extract with CTP. A, Reaction at 0 min; B, control (without cell extract) after 
30 min; C, reaction after 30 min. 1, xylose-1-phosphate; 2, fucose-1 -phosphate; 3, 
glucosamine-1-phosphate; 4, mannose-1 -phosphate; 5, galactose-1 -phosphate; 6, glucose-1-
phosphate; 7, Af-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, CTP. Products of 
the reactions are indicated in Table SI. 
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Figure S4. ESI-MS monitoring of the reactants and products in presence or absence of E. 
coli K12 cell extract with OTP. A, Reaction at 0 min; B, control (without cell extract) after 
30 min; C, reaction after 30 min. 1, xylose-1 -phosphate; 2, fucose-1 -phosphate; 3, 
glucosamine-1-phosphate; 4, mannose-1 -phosphate; 5, galactose- 1-phosphate; 6, glucose-1-
phosphate; 7, Af-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, GTP. Products of 
the reactions are indicated in Table SI. 
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Figure S5. ESI-MS monitoring of the reactants and products in presence or absence of E. 
coli K12 cell extract with dTTP. A, Reaction at 0 min; B, control (without cell extract) after 
30 min; C, reaction after 30 min. 1, xylose-1-phosphate; 2, fucose-1-phosphate; 3, 
glucosamine-1-phosphate; 4, mannose-1 -phosphate; 5, galactose-1-phosphate; 6, glucose-1-
phosphate; 7, N-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, dTTP. Products 
of the reactions are indicated in Table SI. 
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nVz 
Figure 86. ESI-MS monitoring of the reactants and products in presence or absence of P. 
furiosus enzyme and dTTP. A, Reaction at 0 min; B, control (without enzyme) after 30 min; 
C, reaction (with enzyme) after 30 min. 1, xylose-1 -phosphate; 2, fucose-1-phosphate; 3, 
glucosamine-1 -phosphate; 4, mannose-1 -phosphate; 5, galactose-1 -phosphate; 6, glucose-1-
phosphate; 7, JV-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, dTTP. Products 
of the reactions are indicated in Table SI. 
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Figure S7. ESI-MS monitoring of the reactants and products in presence or absence of P. 
furiosus enzyme with UTP. A, Reaction at 0 min; B, control (without enzyme) after 30 min; 
C, reaction (with enzyme) after 30 min. 1, xylose-1 -phosphate; 2, fucose- 1-phosphate; 3, 
glucosamine-1 -phosphate; 4, mannose-1 -phosphate; 5, galactose- 1-phosphate; 6, glucose-1-
phosphate; 7, /V-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, UTP. Products of 
the reactions are indicated in Table SI. 
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Figure S8. ESI-MS monitoring of the reactants and products in presence or absence of yeast 
enzyme with ATP. A, Reaction at 0 min; B, control (without enzyme) after 30 min; C, 
reaction (with enzyme) after 30 min. 1, xylose-1-phosphate; 2, fucose-1-phosphate; 3, 
glucosamine-1 
-phosphate; 4, mannose-1-phosphate; 5, galactose-1 -phosphate; 6, glucose-1-
phosphate; 7, N-acetylglucosamine-1 -phosphate; 8, sialic acid; 9, AMP; 10, ATP. Products of 
the reactions are indicated in Table SI. 
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Figure S9. ESI-MS monitoring of the reactants and products in presence or absence of yeast 
enzyme with UTP. A, Reaction at 0 min; B, control (without enzyme) after 30 min; C, 
reaction (with enzyme) after 30 min. 1, xylose- 1-phosphate; 2, fucose-1-phosphate; 3, 
glucosamine- 1-phosphate; 4, mannose-1 -phosphate ; 5, galactose-1 -phosphate; 6, glucose-1-
phosphate; 7, AT-acetylglucosamine- 1-phosphate; 8, sialic acid; 9, AMP; 10, UTP. Products of 
the reactions are indicated in Table SI. 
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APPENDIX E. CHAPTER 6 H AND 13C NMR SPECTRA 
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